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ABSTRACT OF THE DISSERTATION

MAPPING ANALYTE-SIGNAL RELATIONS IN LC-MS BASED UNTARGETED METABOLOMICS
By
Nathaniel Guy Mahieu

Doctor of Philosophy in Chemistry
Washington University in St. Louis, 2017
Professor Gary J. Patti, Chair

The goal of untargeted metabolomics is to profile metabolism by measuring as many metabolites
as possible. A major advantage of the untargeted approach is the detection of unexpected or
unknown metabolites. These metabolites have chemical structures, metabolic pathways, or cellular
functions that have not been previously described. Hence, they represent exciting opportunities to
advance our understanding of biology. This beneficial approach, however, also adds considerable
complexity to the analysis of metabolomics data - an individual signal cannot be readily identified as
a unique metabolite. As such, a major challenge faced by the untargeted metabolomic workflow is
extracting the analyte content from a dataset. Successful applications of metabolomics bypass this
limitation by throwing away the 99% of the dataset that is not statistically altered between sample
groups.1 This widely accepted approach to untargeted metabolomics is functional for a very narrow
set of applications, but critically, it fails to provide a comprehensive view of metabolism.

xiii

The primary thrust of this dissertation work is to overcome this fundamental barrier in
metabolomic experiments and extract the unique analyte content from metabolomic datasets. To
this end, three algorithms were developed.
(i) We first developed the Warpgroup algorithm to refine the features detected in replicate
samples. Peak detection performed on replicate samples is highly inconsistent. Warpgroup considers
all replicates in concert to determine a set of consensus signals or features – integrations that are
supported by all replicates. This process improves quantitation and significantly reduces the artifact
content of the dataset.2
(ii) Mz.unity was then developed so that one can search for any specified mass-peak relationship.
Features in metabolomic data are highly degenerate and available annotation approaches have been
limited to a small subset of possible degeneracies. Mz.unity addresses this deficiency. This advance
enabled the systematic evaluation of complex and cross polarity adducts as well as a context-based
relationship recovery approach.3
(iii) The credentialing approach was developed to experimentally filter non-biological features and
recovers a reproducible set of biological features. While great effort had been undertaken to
minimize the contribution of contaminants and informatic error to features, it was clear that many
mistakes were still being made.4
The developed algorithms were then applied, in concert, to an untargeted analysis of Escherichia
coli. Together, the application of these algorithms provided the first comprehensive picture of
metabolomic dataset composition. Strikingly, the technologies suggest that the tens of thousands of
signals detected in a typical untargeted metabolomic data set correspond to less than 1,500 analytes –
a result that has large implications for the design and interpretation of untargeted metabolomic
experiments.
xiv

This work constitutes a key advance in our understanding of metabolomic science, and the
contributions enable more robust untargeted analyses of metabolism. Together, these concepts
establish a clear course for the future development of a comprehensive metabolomic data analysis
platform and bring the promise of truly untargeted metabolomics into view.

xv

Chapter 1.

Introduction

The field of metabolomics encompasses any approach that seeks to assay many metabolite
analytes in a single experiment.5,6 The term broadly applies to both targeted and untargeted
techniques. Targeted analyses seek to assay a predetermined set of analytes whose structure and
characteristic signals are known. In contrast, untargeted analyses seek to assay as many analytes as
possible, including unexpected or unknown species. This can encompass components represented
by tens of thousands of signals.7 The scope of metabolomics varies by practitioner; a commonly
employed definition limits metabolites to any biochemically produced analyte with mass less than
1000 Da. This is a rough cutoff, though, as metabolites range in mass; for example cardiolipins reach
over to 1500 Da.
Metabolomics employs a variety of instruments, each with distinct strengths.8 Seminal metabolite
profiling was performed using solution phase Nuclear Magnetic Resonance (NMR) techniques that
provided concentrations of a small set (about 50) of resolvable analyte signals.9,10 Though lacking in
sensitivity, NMR is capable of elucidating molecular structure, probing pathway fluxes, and
determining isotopomer patterns due to its atom-specific information. Mass spectrometry (MS) is
the primary analyzer applied in metabolomics.11 MS offers high sensitivity and can resolve many
thousands of analyte species based on their mass-to-charge ratio. MS also offers some structural
1

information with the ability to fragment analytes. This process reveals masses of the fragments that
provides some insight into the structure of the analyte.
Prior to analysis by MS it is common to employ a separation technique such as liquid
chromatography, gas chromatography, or capillary electrophoresis.12–14 These techniques provide a
somewhat orthogonal separation to MS and aid in the distinction of isobaric metabolite signals.
Separation prior to detection also reduces ionization suppression, increasing quantitative accuracy
and sensitivity.
Metabolism is the network of enzyme-catalyzed reactions that convert small molecule
intermediates into the energy and building blocks that enable life.15,16 Each reaction takes several
reactant metabolites, often two to four and guide them down a reaction path to produce a distinct
set of product metabolites.17,18 A single metabolite species can participate in many of these reactions
and, thus, the entire network can be represented by a large, interconnected graph. (Figure 1) The
Human Metabolome Database (HMDB) currently lists 6302 metabolic reactions, a figure that
underscores the scope of this network.19

Figure 1.1. An example metabolic network. Nodes represent metabolites or multiple metabolites. Edges represent reactions, most of which are
enzyme-catalyzed.*

*

Image by J3D3 (Own work) [CC BY-SA 4.0 (http://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons
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Organisms cope with the demands of survival by controlling fluxes through these pathways.20
From developing embryos to a sprinting cheetah, organisms must cope with changing energy
demands, demands for biosynthetic substrate, and waste-product excretion.21 Most of this regulation
occurs via gene expression and post-translational protein modifications (on timescales ranging from
seconds to days).22–24 These and similar mechanisms act as control points in the metabolic network
operating in accordance with the genetic blueprint of the organism.25 These control points allow an
organism to direct the flow of metabolic flux to satisfy the demands of growth and survival.26,27 In
this light, metabolism can be viewed as the product of many generations of natural selection that
have fine-tuned the metabolic program to the organisms niche. 28–31
In cases where the genetic program becomes damaged, a subset of cells in the organism become
unable to respond appropriately to the environment – this damage results in disease such as cancer
or phenylketonuria. Metabolism is the aggregate output of higher levels of regulation. As such,
physical phenotypes such as disease are often accompanied by corresponding changes in the
metabolic network.32 Thus, a quantitative readout of an organism’s metabolic network can be
strongly predictive of disease states.33 This has proven to be the major application of metabolomics,
- clinical biomarker discovery and correlating observed phenotypes to metabolic changes.34–36
Notably, this aggregation of the complex regulatory cascade into a metabolic state makes
metabolomics an appealing experiment, but this same aggregation limits the application of
metabolomics to elucidation of mechanism. In general, metabolomics provides hints as to where to
investigate further, but can only provide an abstract fingerprint left by the complex process.37
Defining mechanism requires investigation of the upstream effectors employing appropriate
techniques.

3

1.1

Challenges to Untargeted Metabolomics
Untargeted metabolomics seeks to assess as many metabolic intermediates as possible. A major

advantage of the untargeted approach is the detection of unknown metabolites. Reporting on
unsuspected signals enables researchers to uncover surprising, unhypothesized metabolic
interactions and previously unknown metabolic intermediates. This major benefit also adds
considerable complexity to the analysis of metabolomics data.
The nature of the techniques used to analyze samples in untargeted metabolomics produces
immensely complex datasets. Solvent impurities and plastic leachables appear among the metabolite
signals and artifacts are introduced owing to informatic error. Chromatographic peak shapes are
often non-ideal, and single analytes can appear as multiple, distinct chromatographic peaks.
Degeneracy of the detected signals is a major additional source of complexity. Degeneracy refers to
multiple signals arising from a single analyte. There are many causes of degeneracy including
fragmentation, analyte adduction with various charge carriers (e.g., a proton, sodium, potassium,
etc.), and the detection of naturally occurring isotopes (e.g., 13C, 15N, etc.). A final, largely underannotated source of degeneracy is the adduction of an analyte with other species present, including
other analytes and the chemical background.
A notable implication of untargeted approaches is that an individual signal cannot be readily
identified. Similarly an individual signal cannot readily be discerned from the sources of complexity
detailed above.38,39 In traditional, targeted approaches the problem is sidestepped –precise masses, or
fragment transitions are known prior to analysis, and that allows for rapid filtering of most or all
irrelevant features. Unfortunately, application of targeted filtering removes the unhypothesized and
unknown metabolites that make metabolomics such a powerful technique. As such a major
challenge faced by the untargeted metabolomic workflow is extracting the analyte content from a
4

dataset.40,41 This limitation has significantly impeded the interpretation of metabolomic datasets and
further hindered its wider adoption.
Successful applications of metabolomics begin by throwing away the 99% of the dataset that is
not statistically altered between sample groups. This universally accepted approach to untargeted
metabolomics is functional for a very narrow set of applications but critically, it fails to provide a
comprehensive view of metabolism. The primary goal of this dissertation is to overcome this
fundamental, and key barrier in metabolomic experiments and to extract the unique analyte content
from metabolomic datasets.
Feature inflation also causes many detected signals not to be found in metabolomic databases.
Investigators have interpreted the large number of unidentified signals detected in these datasets to
imply that there are hundreds to thousands of unknown metabolites in these datasets.42 This has
varying implications for the experimental design of metabolomics experiments as well as biological
experiments in general. A secondary goal of this dissertation is to estimate the number of analytes
detected in an untargeted metabolomic experiment.
Ultimately, I posit that irrelevant signal and degeneracy in metabolomic datasets account for over
99% of the signal therein and has significantly impeded metabolomics success. To address these
artifacts and degeneracies I develop three algorithms – Warpgroup, Credentialing, and mz.unity.
Finally I apply the developed algorithms in concert to an analysis of Escherichia coli and produce the
most comprehensive picture of the composition of a metabolomic dataset to date. These results
demonstrate a clear path forward for the future of metabolomic analysis.

5

1.2

Experimental Techniques
In the last section I outlined the goals for metabolomics and the current challenges to those

goals. In this section I delve into the experimental methodology we employ to perform untargeted
metabolomics, and how those methods contribute to the aforementioned challenges.

Figure 1.2. A photo of an LC-MS workstation, the components of which are discussed below. (Left) A portion of the Q-Exactive Mass Spectrometer.
The prominent portion of the instrument is the electrospray source chamber. Entering the chamber from the top is the nebulizer that contains
the electrospray needle. (Center) A Dionex Ultra Performance Liquid Chromatograph. Capillaries that carry solvent and analytes can be seen
bridging between the LC and source. The bottom is an auto sampler that aspirates and introduces analytes into the sample flow. Above that is a
temperature controlled compartment containing the column. At top is the UPLC pump that generates the high pressure gradient. (Right) A
computer where the informatic processing that is a major component of the workflow takes place.

1.3

Liquid Chromatography
Very early chromatographic separations were performed by Schönbein who placed paper slips in

liquid mixtures, observing the overlapping bands as they traveled at different rates.43 This early
separation of components formed the basis of modern chromatography. Paper chromatography

6

improved throughout the 20th century eventually inspiring the use of these principles to fractionate
mixtures.
Liquid chromatography enables the separation of a mixture into its constituents on the basis of
their physiochemical characteristics. A mixture is introduced to the chromatographic system as a
narrow band. Separation proceeds when each component moves though the system at different
rates. Key to this separation are the stationary and mobile phases. The stationary phase is employed
to retain or impede the progress of analytes while the mobile phase is employed to facilitate
elution.44
Analytes possess distinct affinities for each the stationary phase and mobile phase. An analyte
that has a high relative affinity for the stationary phase will spend time partitioned there and elute
only after long periods of time. Conversely, an analyte with a high relative affinity for the mobile
phase will partition there and move more closely to the rate of the mobile phase, eluting after a
shorter time. In this way, chromatography leverages the physiochemical characteristics of analytes
to separate them in time.
Owing to the wide range of polarities, not all analytes may be practical to elute using a single
mobile phase.6 Introduction of a gradient in which the mobile phase is altered throughout an
experiment allows a wider range of polarities to be eluted within a reasonable time frame (see Figure
1 for a diagram of the partitioning process at two points during a gradient elution.) As the mobile
phase composition changes, analytes affinities for the mobile phase will change, altering their
partitioning and ultimately eluting them.
Analytical chromatography is a highly refined technique, and different approaches can separate
structural isomers, regioisomers such as cis and trans double bonds, and even stereoisomers with
appropriately chosen stationary and mobile phases.45,46
7

Figure 1.3. The basis for gradient chromatographic separations. (Left) Analytes are more attracted to the stationary phase than the mobile phase. At
this stage the apolar analyte moves slowly through the column. (Right) At some later time the mobile phase strength has increased. The apolar
analyte partitions into the mobile phase and travels more quickly through the column.

Figure 1.4. A diagram of an HPLC instrument. Mobile phase is pumped (left) through a stationary phase containing column (center) and departed
analytes are detected (left).*

* By WyassineMrabetTalk. [GFDL (http://www.gnu.org/copyleft/fdl.html) or CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0)],
via Wikimedia Commons
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The application of chromatography has become highly refined with instruments dedicated to the
task of producing reproducible gradient and flow rate profiles. These reproducible techniques have
enabled the use of retention time as a useful molecular descriptor. With a specific stationary phase,
flow rate, and mobile phase gradient profile, multiple labs can analyze an analyte and observe the
same retention time. In this way retention time is indicative of the species being observed.
Depicted is a split loop injection system in which two flow paths can be selected by a switching
valve. The sample is loaded into an injection loop that the mobile phase flow is bypassing. Upon
injection the valve switches, and the injection loop becomes part of the flow path, washing the
mixture downstream. At this point the mobile phase and mixture reaches the column containing the
stationary phase. Modern columns are manufactured with a variety of substrates, but most
commonly a porous silica material is derivitized to produce a stationary phase with desired
properties. Inside the column, the analytes contained in the mixture are slowed, and begin to
proceed through the column at varying rates. Ultimately, the components elute from the column at
varying times and are then detected. When using mass spectrometry as a detector, an ionization
method is needed; both ionization and mass analysis will be discussed in the following sections.

Figure 1.5. Examples of chromatographic resolution. (Left) The peaks of poorly resolved analytes overlap. (Right) The peaks of well resolved analytes
do not overlap.
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Figure 1.6. Effect of mobile phase flow rate on resolution. A Van Deemter Plot describing the efficiency of a chromatographic separation as a
function of varying mobile phase flow rates. Three terms can be used to model the resolution, each due to a physical process causing peak
broadening. The C term increases with flow rate, the B term decreases with flow rate, and the A term is flow rate independent.

A useful conceptualization of the physical nature of the chromatographic process is summarized
with a discussion of the efficiency of a separation. In addition to selectivity (the relative partitioning
of two analytes), a separation must be efficient, producing analyte bands that are narrow enough to
be distinguished. Described by van Deemter and Zuiderweg47 in 1956, the van Deemter equation
outlines three terms that correspond to physical non-idealities that impact the efficiency of a
separation. (Equation 1) Here, H is a measure that is inversely proportional to efficiency (peak
width) and μ is the linear velocity of the mobile phase (flow rate.)47
𝐵

𝐻 = 𝐴 + 𝜇 + 𝐶𝐶

(1)

The A term in the van Deemter equation is the longitudinal diffusion component, that is inherent
to the stationary phase. As analytes travel through the column, they will take different paths, some
longer and some shorter. Higher quality packings can decrease this term but it is invariant with
respect to the flow rate.
The B term represents the longitudinal diffusion of particles in the mobile phase and is
dependent on the analyte, temperature, and solvent viscosity. Diffusion of the analyte bands occurs
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as long as the analytes are dissolved in the mobile phase – as a result, slow flow rates and longer
analysis times result in more diffusion.
The C term represents an analyte’s resistance to mass transfer between the mobile and stationary
phases. As an analyte diffuses in and out of the pores of the mobile phase, they will spend varying
amounts of time in the pore. At higher flow rates, this variance in time impacts peak widths more –
this is because during the time when one particle was not moving, another has moved rapidly.
The sum of these terms gives the expected efficiency of a separation. Notably, the only penalty
for flowing at higher rates is the C term. Modern columns with very small packings and core shell
packings have mostly eliminated the flow rate-dependent increase of the C term. This allows for
very fast flow rates with little to no efficiency penalty – a major advantage of the small particle size
packings and corresponding high pressure UPLC technique.

1.4

Electrospray Ionization
After elution from a liquid chromatography experiment, analytes exist in the bulk liquid phase.

All mass spectrometry experiments are performed on ions in the gas phase, as such a requisite step is
the transfer of analytes from the bulk liquid to the gas phase and imparting a charge to them. The
coupling of liquid chromatography and mass spectrometry was a challenging goal, the two operating
under opposite extremes of pressure (liquid vs 10-5 torr in the gas phase.)48 Initial work to this end
was performed by Dole in 1968 using polystyrene spheres49 – this work was eventually refined by
Fenn in 1984 into the early electrospray source.50
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Figure 1.7. A schematic of Electrospray ionization. (Top) A potential difference of several thousand volts is applied between the capillary and mass
spectrometer inlet. This high field region induces the Electrospray process. (Bottom) 1. The Taylor cone formed due to charge accumulation
and surface tension. 2. Droplets shrink due to solvent evaporation and coulombic explosion. 3. Gas phase ions are produced by continued
evaporation and charge expulsion from the droplets.*

The modern process of electrospray ionization proceeds by forcing the liquid through a small
needle into a region with high electrostatic fields. This electrostatic region causes charges to
concentrate at the surface of the liquid – the surface tension of the liquid, combined with the
electrostatic repulsion of charges in solution form a cone as described by Taylor in 1964.51 As the
liquid surface grows small toward the apex of the cone droplets bud off and travel down the
potential gradient.52 (Figure 1.7) These droplets shrink, both by solvent evaporation and the
expulsion of smaller charged droplets. This process continues until individual analytes are
introduced to the gas phase, some with a charge.53
The formation of adducts is a key feature of electrospray ionization. The charge imparted to gasphase analytes is often the result of the adduction of an analyte with a charge carrier, often a proton
*

By Evan MAson (Own work) [CC BY-SA 4.0 (http://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons
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(H+) or sodium (Na+).54 Adduction, though is not restricted to small charge carriers and in general
any present species can adduct with the eluting analytes. This process gives rise to many degenerate
ion species that are derivatives of the original analyte – a phenomena that gives rise to much of the
complexity in untargeted metabolomic datasets. Addressing and overcoming this complexity is the
focus of Chapter 4.

1.5

Mass Spectrometry
After ionization, analytes must be transferred from the source region at atmospheric pressure to a

low pressure region of around 10-5 torr.48 This is achieved by a combination of a potential difference
down the ion path and pressure difference between the two regions.55 The ion plume in the
atmospheric pressure region is propelled by the electric potential difference towards the inlet of the
low pressure region. As ions approach the inlet, the rapid acceleration of the bulk gas because of
decreasing pressure causes a turbulent flow through the transfer capillary towards the differentially
pumped regions. As the gas exits the ion transfer capillary, it rapidly expands into the low pressure
region. A series of ion funnels, skimmers, and multipoles act to contain the ions as neutrals are
pumped away. Throughout this process the ions are cooled, and off-axis velocity is dampened by
electric fields until a beam of ions that is suitable for further analysis by a mass analyzer is
produced.56 The pressure reached is a function of the type of mass analysis performed – quadrupolebased analysis operates at pressures around 10-4 torr whereas analyses requiring a long mean free
path (such as TOF or orbitrap experiments) operate at pressures up to 10-10 torr (a mean free path of
several kilometers!)
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Figure 1.8. Resolution’s mass dependence on the Q-Exactive illustrated with three challenging to resolve A1 species. As mass increases instrument
resolution decreases. This results in distinct mass peaks becoming more poorly resolved. (Green) 13C and 2H become indistinguishable at 550
Da. (Red) 13C and 15N become indistinguishable at 1000 Da. (Blue) 15N and 2H become indistinguishable at 1300 Da. Based on
experimentally observed resolutions at 280,000 resolving power.

1.5.1

The Q Exactive: Quadrupole-Orbitrap Mass Spectrometer

The Q Exactive (QE) mass spectrometer is a Fourier Transform (FT) based instrument that
offers ultra-high mass resolving power, high mass accuracy and exquisite sensitivity. The mass
spectrometer couples two mass analyzers, a quadrupole and an orbitrap, with a C-trap and collision
cell intervening.57 The orbitrap is an ion-trapping device, into which a narrow beam of ions is
injected perpendicular too and off center from a central spindle electrode.58 Ions are confined
between the central electrode and the outer shell by electric fields, and begin to orbit perpendicular
to the central electrode due to their initial velocity. The distribution of initial velocities and positions
perpendicular to the central electrode cause the ion packet to spread into a ring around the central
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electrode. Motion of the ion rings parallel to the central electrode follows naturally owing to the offcenter injection of ions into the potential well. Ion motion along this parallel axis is dependent on
the potential well and critically, the mass-to-charge ratio of the ions. (Equation 2) Thus, ion motion
is observed as the image current in the two outer detector plates. This time domain signal can be
transformed into a frequency domain spectrum (with frequency proportional to m/z) by FT.58
𝑘

𝜔 = �𝑚/𝑧

(2)

Injection of ions into the orbitrap was a considerable design challenge – the initial distribution of
position and momentum of ions parallel to the central electrode was limiting frequency
determination. Focusing of ions in this dimension is achieved by the C-trap, which upon injection
compresses the ion packet into a narrow ribbon for injection. As the QE is a trapping instrument,
observation of the ions occurs in a pulsed manner. Depending on the desired mass resolving power,
orbitrap analysis can take as long as 1000 ms (for a resolving power of 256,000.)59 To minimize this
limitation’s effect on duty cycle, ions can be accumulated in the C-trap and fragmented in the
collision cell with parallel acquisition of an orbitrap spectrum.
Even still, the orbitrap is inherently charge limited – as charge density in the orbitrap becomes
too high dephasing of ion packets and saturation of signal amplifiers can occur. For this reason,
duty cycle limitations for the QE are most often due to high ion flux rather than ion sampling
limitations. This has an interesting practical result relevant to untargeted studies – the limit of
detection is dependent on the ion flux during a particular scan. When a particularly abundant group
of ions elute they occupy a large fraction of the charge capacity of the orbitrap. Thusly, the limit of
detection for the entire scan is increased because fewer of other species will be accumulated.
The charge limitations of the orbitrap mass analyzer necessitate a rationing of space in the trap.
Rationing is accomplished by quadrupole mass filtering prior to ion accumulation. In the low
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abundance case, when ion flux is limited, the orbitrap is an exquisitely sensitive instrument, with
comparable sensitivity to triple-quadrupole type instruments. Similar to the triple quadrupole, the
QE offers nearly 100% duty cycle when not charge saturated. Additionally, the QE is able to
observe ions for an extended amount of time and offers high mass resolving power of possible
interferences in the monitored fragments. These factors allow the QE to equal and exceed the triple
quadrupole in targeted sensitivity.

Figure 1.9. A schematic of the Q-Exactive mass spectrometer.*

1.5.2

The Quadrupole-Time-of-Flight Mass Spectrometer

The Quadrupole-Time of Flight Mass Spectrometer (QTOF) is a hybrid instrument coupling a
quadrupole and collision cell to a time-of-flight mass analyzer.60 Time-of-flight mass analysis is
achieved by a high voltage pulse accelerating a packet of ions into a drift region. This pulse imparts
the same amount of kinetic energy to each ion, but ions with different mass-to-charge ratios will
travel at different speeds owing to the conservation of momentum. As such, ions are separated
*

Taken from the Q-Exactive user manual, with permission.
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based on the time it takes them to travel a several meter distance and detected upon impacting a
detector plate. (Equation 3) Differences in the initial positions and velocities of the ions contribute
to peak broadening, this is mitigated by the use of a repulsive electrostatic region that reflects the
ions back in the direction they came from, focusing each mass packet.61
𝑡 = 𝑘�𝑚/𝑧

(3)

The QTOF mass spectrometer is a pulsed instrument, requiring drifting ions to reach the
detector prior to the next pulse of ions. As such, duty cycle on these instruments is around 10%.
Improvements to this include using Hammond transforms and overlapped pulses, as well as gating
of the ions. As opposed to the QE, the QTOF has a very large charge capacity, and is limited
primarily by detector saturation. As such, other ions in the spectrum have no impact on the overall
sensitivity of a scan and the QTOF is suitable for bright ion sources.

Figure 1.10.

*

A schematic of quadrupole-time-of-flight mass spectrometer.*

Taken from the Agilent 6500 QTOF Manual, with permission.
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1.6

Informatic Techniques
The metabolomic workflow involves several processing steps. The contributions herein leverage

the following two informatic techniques to improve upon this workflow.

1.6.1

Dynamic Time Warping

Dynamic Time Warping (DTW) is the name of a class of algorithms that find optimal alignment
between two time series.62 The method takes as input two time series and finds a mapping (warping)
from time in series A to time in series B. These algorithms have been applied to a wide variety of
alignment problems including speech recognition, genetic sequence alignment, and even data that
has no true time component such as image alignment.63,64
Given two time series 𝑋 = (𝑥1 … 𝑥𝑁 ), 𝑌 = (𝑦1 … 𝑦𝑀 ) and some dissimilarity function 𝑑(𝑖, 𝑗) =

𝑓�𝑥𝑖 , 𝑦𝑗 � ≥ 0, dynamic time warping seeks to find the warp path 𝜙 that minimizes the accumulated
distortion 𝑑𝜙 (𝑋, 𝑌) = ∑𝑇𝑘=1 𝑑 �𝜙𝑥 (𝑘), 𝜙𝑦 (𝑘)� ∗ 𝑚𝜙 (𝑘)/𝑀𝜙 between the two timeseries.
(𝑚𝜙(𝑘) /𝑀𝜙 is a normalization factor such that paths with different numbers of steps have

comparible distortion values.) The result is a warp path with k steps 𝜙(𝑘) = (𝜙𝑥 (𝑘), 𝜙𝑦 (𝑘)) where

𝜙𝑥 (𝑘) ∈ {1 … 𝑁} and 𝜙𝑦 (𝑘) ∈ {1 … 𝑀}.62 (Figure 12)

Dynamic time warping approaches are relevant to chromatographic based techniques.65 Between

chromatographic experiments many sources of variation cause shifts in the elution time of
components – sample matrix differences, temperatures, pump fluctuations, column cleanliness, and
even analyte concentrations can impact retention times.66 Prior to statistical analysis of abundances,
correspondence must be determined to link the same analyte detected in each sample. DTW

18

provides an approach to evaluate and mitigate some of these variances that benefits later
correspondence determination. We apply aggressive dynamic time warping in the Warpgroup
algorithm, which is developed in Chapter 3.2

Figure 1.11.

An example of the dynamic time warping alignment of two time series. (Left) Two time series are plotted on the bottom and

the left. The optimal alignment which maps time in the reference to time in the query is plotted in the center. (Right) The same time series
overlaid with the alignment plotted as grey connections between the points.

1.7

Graph Theory
Graph theory is the study of pairwise relationships between objects. It is a broad field that is

applicable to a range of disciplines from rigorous treatment in discrete mathematics to applications
in fields such as computer science and biology.67,68
A graph is comprised of a set of nodes and edges. Edges link exactly two vertices and can be
directed or undirected.69 Graphs can be used to represent a wide variety of problems, such as
pathing through a network of roads (edges) and intersections (nodes) or finding relationships (edges)
between people (nodes) in a social graph.
In Chapter 5 we utilize graphs to represent additional structure in the mass spectrometry data.
Particularly interesting is the relationship graph formed by mass spectral peaks (nodes) that are
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transformations (edges) of a common analyte prior to detection. In general graphs can be used to
represent many relational data structures. As such they are a general concept where specific details
emerge in the context of specific problems.
As applied in this manuscript graphs are used in two ways. In Chapter 3, graphs are used to
represent peaks which could be the same analyte across replicates. Nodes are used to represent
detected peaks and edges are used to represent pairs of peaks which we posit are the same analyte.
In this application, sets of well connected nodes are more likely to be the same analyte. Later, in
Chapter 4, graphs are used to represent the underlying structure in mass spectra. Specifically, nodes
represent detected mass-to-charge peaks and edges represent putative relationships between these
peaks. (Figure 1.12)

Figure 1.12.

An example graph plotted from relationships detected in a mass spectrum. Nodes are the dots. Edges are the lines connecting

the dots.

1.8

Raw Data
Liquid chromatography/mass spectrometry (LC/MS)-based techniques generate a sequential

series of mass spectra at around 10 Hz. The result is a three dimensional dataset with axes of
retention time (RT), mass-to-charge ratio, and intensity. A raw, digitized profile dataset on modern
20

instrumentation (e.g. the Q-Exactive) contains 1x107 m/z and intensity pairs per scan (at 140 k
resolving power). This yields an impressive 1x1010 (ten billion) data points per 30 minute experiment
(at 3 Hz). In practice, many points are zero, and peak detection on profile mass spectra is reliably
performed such that only about 1x106 points are used for the metabolomic analysis.
The metabolomic workflow’s primary goal is the continuing reduction of raw, abstract data
points into an entity representing an observed analyte.

Figure 1.13.

An example of raw mass spectral data. (Top) and extracted ion chromatogram of mass 415.1728-415.2599. (Middle) The mass

spectrum at 10.6 minutes. (Bottom) The same mass spectrum zoomed 100x.
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1.9

Feature Detection
Analytes elute across multiple scans, and mass peaks appearing in several sequential scans with a

Gaussian-like profile are termed features. The first step in the processing of metabolomic data is
peak detection. In general peak detection seeks to gather mass peaks produced by a single analyte,
and observed in sequential scans into a single entity termed a “feature”. A feature is thus a triplet (a
composite of three values) consisting of the mean retention time, mean m/z, and integrated intensity
observed.70
Feature detection is a common challenge and a wide variety of algorithms have been employed.
One commonly employed feature detection algorithm in metabolomics research is centWave71 - it
proceeds via two steps. Initially centWave detects regions of interest, which are regions in the m/z
and RT dimensions with a high density of mass observations – these are putative regions that may
contain a chromatographic peak shape. The second phase of centWave applies a pattern wavelet
based peak detection looking for a peak shape in the chromatographic domain. The ion’s retention
time profile is analyzed after applying a discrete wavelet transform at multiple scales. Peaks that are
observed at many scales are initialized, and peak bounds are specified by descending to the nearest
local minimum. The detected peaks above a specified signal to noise ratio are then retained.
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Figure 1.14.

Discrete wavelet transformation of a bimodal distribution. (Top) The bimodal distribution which is to be transformed.

(Bottom)The wavelet transform of this distribution. The scale of the wavelet transform is plotted on the y-axis. Note that different scales see
drastically different representations.

Peak detection achieves two goals. Importantly this process removes a major fraction of the
signal which does not exhibit a peak shape, and, is therefore, not relevant to the injected sample.
These signals are often chemical background, or other, slowly eluting compounds. Secondly, peak
detection determines the integration region of each feature, thus determining the quantitation which
is later used for statistical analysis and biological inference.
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Figure 1.15.

An example of detected peaks. (Black) The raw chromatographic trace is plotted for a single mass. (Red) A calculated baseline

estimate. (Blue) Detected peaks.

Complicating this task are several sources of variation. From scan-to-scan a single mass-tocharge value is measured with only finite precision. As such, mass error on the order of 1-10 ppm
complicates region of interest determination. The intensity of an ion signal as it is sampled also
includes significant variance (consider the complex ionization process described above), thus, a
chromatographic trace often fluctuates non-monotonically, complicating chromatographic feature
detection. Finally, it is common in complex mixtures that eluting analytes are not fully,
chromatographically resolved. Defining peak bounds for poorly resolved components is challenging
even when performed manually.
The peak detection process reduces the initial 1x106 mass peaks to around 2x104 features. The
output is a list of features and their corresponding m/z, RT, and intensity. This peak list is used for
24

further analysis. Chapter 3 in this dissertation deals with refinements to the peak detection process
while Chapter 4 details a method for further consolidating these peaks into unique analyte groups.
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Chapter 2.

A Roadmap for the XCMS Family of Software Solutions in
Metabolomics *

Global profiling of metabolites in biological samples by liquid chromatography/mass
spectrometry results in datasets too large to evaluate manually. Fortunately, a variety of software
programs are now available to automate the data analysis. Selection of the appropriate processing
solution is dependent upon experimental design. Most metabolomic studies a decade ago had a
relatively simple experimental design in which the intensities of compounds were compared between
only two sample groups. More recently, however, increasingly sophisticated applications have been
pursued. Examples include comparing compound intensities between multiple sample groups and
unbiasedly tracking the fate of specific isotopic labels. The latter types of applications have
necessitated the development of new software programs, which have introduced additional
functionalities that facilitate data analysis. The objective of this review is to provide an overview of
the freely available bioinformatic solutions that are either based upon or are compatible with the
algorithms in XCMS, which we broadly refer to here as the “XCMS family” of software. These
include CAMERA, credentialing, Warpgroup, metaXCMS, X13CMS, and XCMS Online. Together,
* This work is based on the following publication: “A roadmap for the XCMS family of software solutions in metabolomics”. NG Mahieu, JL
Genenbacher, GJ Patti, Current opinion in chemical biology, 2016. NGM provided the overview of processing algorithms, analysis of retention time
drift, the credentialing algorithm and the warpgroup algorithm.
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these informatic technologies can accommodate most cutting-edge metabolomic applications and
offer some advantages when compared to the original XCMS program.

2.1

Introduction
In the last chapter I outlined the techniques applied in LC/MS-based metabolomics. In this

chapter we provide a more in depth explanation of the informatic workflow with specific detail
regarding application of the XCMS software package. XCMS is the most well-known, open-source
metabolomics software and makes applying several algorithmic steps easy. The algorithms
developed in chapters 3, 4, and 5 either refine or extend this functionality but are independent of
XCMS. Overviews of the algorithms developed in chapters 3 and 5 are provided in sections 2.7 and
2.6, respectively. Finally, the algorithm developed in chapter 4 supersedes CAMERA, which is
described in section 2.5.

Data from liquid chromatography/mass spectrometry (LC/MS)-based untargeted metabolomic
experiments are highly complex. Therefore, bioinformatic software is typically required for
processing of the results. At this time, there are many reliable software solutions available.72–80 It is
not the purpose of this review to comprehensively detail each, nor is it our intent to provide any
type of comparative evaluation. Rather, we will exclusively focus on a selection of freely available
software solutions that are interoperable with the XCMS program. Some of these software solutions
bear variants of the XCMS name, while others do not. We broadly refer to the class as a whole as
the “XCMS family”.
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2.2

Defining the Needs: A General Bioinformatic Workflow
Historically, the bioinformatic workflow for processing untargeted metabolomic data has

involved three general steps: feature detection, correspondence determination, and contextdependent analysis of the resulting measured values (Figure 1).81,82 Each is briefly described below.
1. The first and perhaps most important step is feature detection (also known as peak detection
or peak picking). The purpose of this step is to extract from the dataset signals that arise from real
compounds, while attempting to exclude signals resulting from various noise sources.83 Extracted
signals with a unique mass-to-charge ratio and retention time are recorded as features. (Figure 2A)
2. The second step in the workflow is establishing correspondence between the features detected
from different sample runs. Correspondence refers to establishing those features from different
analytical runs that “correspond” to the same analyte. Establishing correspondence is arguably the
most challenging step in the processing of untargeted metabolomic data.82 Although the same
analyte may be detected in multiple experimental runs, the measured mass-to-charge ratio and
retention time of the analyte can vary in each run owing to factors such as temperature fluctuation
and column degradation (Figure 3A). Importantly, many drift factors are compound specific and,
therefore, global-alignment techniques cannot be used for correction (Figure 3B).84
In practice, the majority of investigators performing LC/MS-based metabolomics currently assert
correspondence by aligning the time domains of each run with time-warping techniques. (Figure 2B)
The objective is to correct for drift factors so that features can be grouped between samples by
direct matching of retention time. Although the alignment approach for establishing
correspondence has enabled many laboratories to analyze untargeted metabolomic data successfully,
there remains a great need for robust correspondence determination algorithms, and this remains an
active area of research interest.82
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Figure 2.1. The bioinformatic workflow for processing untargeted metabolomic data with XCMS. The workflow has three general steps: 1. Feature
detection, 2. Correspondence determination, and 3. Additional context-dependent analysis. These steps are numbered in red on the schematic.
After acquisition of LC/MS profiling data, feature detection is performed on the raw data to generate a peaks table (step 1). Next, retention time
drift is corrected (step 2a). The OBI-warp algorithm implemented within XCMS operates on the raw data to determine retention time drift.
This produces a retention-time correction map that, together with the peaks table, is used to establish correspondence and generate a groups
table (step 2b). The peaks table and the groups table are the input for a variety of further analyses. The third step is dependent upon
experimental objectives. In the standard XCMS analysis, step 3 is statistical analysis. The other programs listed use the peaks table and groups
table to achieve different aims such as adduct and artifact annotation, multiple-factor analysis, and isotopic label tacking.

Figure 2.2. Schematic of the centWave and OBI-warp algorithms as implemented within XCMS. A. The first step in centWave is to find consecutive
scans in which peaks are detected within a specific mass error (top). These are referred to as regions of interest (ROIs) Two such ROIs are
displayed here and boxed in red. Second, extracted ion chromatograms are created for each ROI (bottom). Extracted ion chromatograms that
display a peak shape are then added to the peaks table, as illustrated by the green checkmark and arrow. B. OBI-warp aligns a query sample to a
reference sample. Here we illustrate a representative example in which two features are shifted in the query sample compared to the reference
sample. Application of the correction curve to the query (bottom) brings the samples into alignment.
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3. The last step of the workflow is context dependent. Analyses diverge, depending on
experimental goals. In the simple cases when the objective is to compare sample classes, this step
amounts to performing statistical analysis on the intensities of detected features. For more advanced
objectives such as isotope tracing or tandem mass spectral analysis, additional algorithms are
required.

2.3

Introducing XCMS
In 2006, the XCMS software was published as one of the first programs to provide a complete

solution to the bioinformatic workflow outlined above for processing untargeted metabolomic
data.81 The “X” in the XCMS acronym is used to denote that the software can be applied to any
form of chromatography. To date, however, XCMS has been predominantly used to process
LC/MS-based metabolomic data. The original XCMS software used the matchedFilter algorithm to
accomplish feature detection, the retcor.peakgroups algorithm to perform alignment (an application
of LOESS regression to well-behaved peak groups), and the group.density algorithm to group
aligned features across samples on the basis of m/z bins. In recent years, a new algorithm for
feature detection called centWave and a new algorithm for alignment called OBI-warp have been
implemented within XCMS.65,71 It is worth noting that whereas these algorithms have led to better
overall XCMS performance, there is still great opportunity for improvement. It is exciting to
consider, for example, that there are hundreds of published algorithms for peak detection and
correspondence determination that have not yet been implemented within XCMS for comparative
evaluation.82,85
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Figure 2.3. Illustrating the correspondence problem. A. Extracted ion chromatograms of citrate from three samples show that its retention time and
its measured mass-to-charge values vary between three samples run back to back. B. Uncorrected retention time drift of all features detected in
sample 2 as compared to sample 1 (top). Uncorrected drift remaining after OBI-warp correction. (bottom). Note that though correction reduced
the overall drift, there is no global correction which will perfectly align all peaks due to multiple, compound-specific drifts occurring at a single
retention time.

Applying the centWave, OBI-warp, and group.density algorithms within XCMS results in what
are known as the peaks table and the groups table (Figure 1). In the standard application of XCMS,
the peaks table and the groups table are then used to create a diffreport. The diffreport provides
statistics on feature groups that have altered intensities between sample groups.86 When the original
XCMS software was published in 2006, generating such a diffreport in the programming language R
was considered cutting edge. From the diffreport, investigators can count the number of features
detected from a sample to crudely compare metabolomic workflows.87,88 More importantly,
researchers can use the determined p-values and fold changes to find features with statistically
significant changes in intensity between two sample groups. However, the XCMS diffreport also
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has some serious limitations. It does not provide metabolite identifications, which generally require
matching tandem mass spectra from the research sample to the tandem mass spectra of authentic
standards.89 Additionally, the diffreport does not provide a reliable approximation of metabolites
detected as adducts, isotopes, fragments, and artifacts.4,90 Indeed, depending on experimental
conditions, more than 50% of the features on a diffreport can be fragments and artifacts.91 As the
field of metabolomics has evolved over the last decade, there has been a major push to better
annotate the XCMS diffreport. Multiple bioinformatic strategies that are interoperable with the
XCMS program have now emerged to enable identification of adducts, isotopes, artifacts, and in
some cases even structures.92 A selection of these resources is detailed in the sections that follow.
Also note that the XCMS diffreport was designed for evaluating features with altered intensities
between only two sample classes. Yet, there are a growing number of applications with more
sophisticated experimental designs involving multifactorial analysis and stable isotope labeling.
These types of applications require that step 3 of the bioinformatic workflow shown in Figure 1
diverge from that of the standard XCMS program. Thus, new software solutions have been
developed that operate on the peaks table and the groups table with unique algorithms (examples
highlighted below.)

2.4

A Clarification on Terminology
As multiple programs have emerged with variants of the XCMS name, it may be confusing for

new investigators to distinguish which software is appropriate to use for specific applications. As an
example, XCMS2 was the first program to be related in name to the original XCMS software.93
Sometimes the program’s name is written as XCMS2, which may suggest that it implements a new
generation of algorithms for the core functionalities of XCMS. However, XCMS2 only differs from
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XCMS in its ability to process tandem mass spectral data. We will not discuss XCMS2 further in
this review. Processing of tandem mass spectral data will be covered in our discussion of XCMS
Online.
Below, we highlight software programs that are interoperable with XCMS and provide key
solutions to some common challenges in untargeted metabolomics. Most of these programs use the
XCMS peaks table and/or groups table as their inputs. Therefore, collectively, we refer to them as
the XCMS family of software.

2.5

CAMERA: Annotating Isotopologues, Adducts, Clusters, and Fragments
When a metabolite is analyzed by electrospray ionization-mass spectrometry (ESI-MS), it is

usually detected as more than a single ion species in the same mass spectrum owing to the presence
of isotopologues, adducts, clusters, and in-source fragments.94 Because these ion species have
different mass-to-charge values, XCMS reports each as a unique feature.5 This increases the
complexity of the XCMS diffreport and complicates statistical analysis as well as compound
identification.
Given that adducts, clusters, and fragments are generally formed at the source in ESI-MS, they
share the same retention time as the parent compound. Similarly, isotopes usually do not influence
retention.86 Thus, a strategy widely employed to group these types of related features is evaluation of
chromatographic peak shape similarity.95 The approach has been used by several software programs,
but here we describe CAMERA because it was designed for postprocessing of the XCMS output.86
Like XCMS, CAMERA is freely available from the Bioconductor repository.
In addition to grouping related features, CAMERA also attempts to annotate ion species by
applying a rule table. The rule table works for identifying isotopes, frequent adducts such as sodium
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and chloride, and common neutral losses or cluster-ions. Users also have the option to combine
LC/MS data from positive and negative modes to improve the reliability of ion annotations.

2.6

Credentialing: Annotating Artifacts
In a conventional LC/MS-based metabolomic experiment, the XCMS diffreport includes a large

number of “artifactual” features. These features significantly complicate interpretation of the data
because they are not directly associated with the sample but rather arise from contaminants
introduced during analysis or from chemical noise, bioinformatic noise, etc.4 Unfortunately,
information in the XCMS diffreport is insufficient to discriminate artifactual features from biological
features. Artifacts are particularly problematic when attempting to interpret metabolomic data at the
comprehensive level. When evaluating different analytical methods to compare metabolome
coverage, for example, we demonstrated that higher feature numbers do not necessarily correlate
with more detected metabolites.4 In part, this is because artifacts are highly variable and change as a
function of extraction procedure, separation technology, mobile phase, instrumentation, and mass
spectrometer settings.
Currently, approaches to identify artifacts in metabolomic data rely upon stable isotopes.4,90
Although these strategies have proven effective, we should point out that their application is limited
to samples that can be cultured with labels (clinical specimens remain a challenge). One approach for
removing artifacts, known as credentialing, was designed to be interoperable with the XCMS
software.4 In the credentialing scheme, artifactual features are distinguished by growing cells on
heavy isotopic carbon and mixing them with natural-abundance samples at defined ratios. Notably,
only features of cellular origin will have appropriate isotopic partners at the appropriate ratios.
Thus, without structurally identifying every feature, artifacts can be filtered from the dataset
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computationally by using the credentialing software algorithms. With this platform, the number of
“credentialed features” can be used (instead of total features) as a more reliable metric to benchmark
analytical performance.

2.7

Warpgroup
The standard XCMS workflow employs the centWave and group.density algorithms to detect

peaks in each sample independently. In this scheme, the information used to group peaks is only
the average m/z and retention time from all samples analyzed. Further, as each sample’s raw data
are treated in isolation, differences in integration regions between samples contribute to increased
variance in the processed dataset. We developed Warpgroup as an XCMS compatible package that
addresses these limitations with consensus integration bound analysis.2 Warpgroup applies dynamic
time warping and graph analysis to improve the precision of metabolomic data processing.
Warpgroup improvements include: correspondence determination that leverages the local extracted
ion chromatogram topography; detection and grouping of peak subregions; selection of similar
integration bounds for each group; intelligent missing value filling; and reporting of several
parameters which allow the filtering of bioinformatic noise.
The benefits of Warpgroup are the retrospective combination of several independent rounds of
peak detection. For an E. coli dataset, as an example, application of Warpgroup resulted in an
increase in the number of unique detected analytes by 26% and halved the mean coefficient of
variation of all analytes (compared to the XCMS algorithms alone).2 Warpgroup is implemented in a
general manner and is applicable to all time series data, including metabolomic data from other
software packages.

35

2.8

metaXCMS: Finding Shared Alterations Among Multiple Sample Classes
The original XCMS algorithms were designed to compare the intensities of features from only

two sample groups. The challenge of applying simple pairwise comparisons is that knocking out a
single protein can lead to hundreds or thousands of changes in feature intensities because the related
pathways are interconnected.96 For instance, knocking out a protein may decrease the product of
that protein. However, decreased levels of the protein’s product may then itself lead to a cascade of
other context-dependent metabolic alterations. Determining those metabolites that are altered
directly as a result of knocking out a protein from those that are altered indirectly is challenging.
Thus, it has become increasingly common in metabolomics to look for dysregulation shared among
multiple sample groups as a strategy for data reduction. metaXCMS enables such multiple-factor
comparisons by operating on XCMS diffreports.97,98
The power of assessing shared metabolic differences among multiple sample groups is perhaps
best demonstrated by an example. When control C. elegans worms were compared to long-lived C.
elegans worms in which the germ line had been removed by glp-1 mutation, ~44% of the total
detected features (13639) were altered with a p-value <0.05 and a fold change >2.96 From these data
alone, features directly associated with increased life span could not be distinguished from those
features that were altered from glp-1 mutation but that did not affect life span. Because germ-lineinduced extensions in life span are dependent upon the FOXO transcription factor DAF-16, double
mutant daf-16;glp-1 worms are short lived. Thus, a comparison of long-lived glp-1 worms to both
wildtype worms and short-lived daf-16;glp-1 worms with metaXCMS revealed shared features that
were uniquely altered in glp-1 induced longevity. By performing similar analyses of other long-lived
worms with metaXCMS, the number of features directly associated with longevity was ultimately
reduced to six.96
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2.9

X13CMS: Unbiased Mapping of Isotopic Fates
Although the intensities of thousands of features are measured by LC/MS-based untargeted

metabolomics, these data provide only a static snapshot of cellular metabolism and do not generally
capture the complex dynamics of biochemical pathways.99 To quantitate metabolic fluxes and to
determine the contribution of specific nutrients to metabolite/macromolecular synthesis,
investigators typically use isotope-labeled tracers.100 A number of robust approaches, such as
metabolic flux analysis, are well established for these types of studies.72 Most of the approaches use
mass spectrometry or NMR to measure isotopic labeling in a targeted set of compounds.
In recent years, there has been a growing interest to integrate untargeted metabolomic
technologies with stable isotopic tracers. One potential advantage of such an experimental design is
the unbiased and comprehensive tracking of metabolite fates.101,102 By following the metabolism of a
labeled compound fed to a biological system comprehensively as a function of time by using
LC/MS-based metabolomic approaches, new metabolite transformations may be discovered.
Additionally, by comparing labeling patterns between different phenotypes using global
metabolomic technologies, it is possible to identify relative changes in flux distributions.103
The XCMS software is not currently designed to support experiments involving isotopic labels.
Although analysis of isotopic labels can be accomplished by using XCMS together with CAMERA,
the X13CMS software was recently developed specifically to support experimental designs based on
stable isotopes.86,103 To use X13CMS, LC/MS data acquired from samples with and without isotopic
label are first processed by XCMS. The XCMS results are then forwarded to X13CMS, which
identifies isotopologue groups corresponding to isotopically labeled compounds. Grouping of
isotopologues is performed without any a priori knowledge except input of isotopic label(s) used,
instrument mass accuracy, and chromatographic drift tolerance. The labeling pattern of each
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compound determined to be isotopically enriched can be quantitatively compared from multiple
sample groups by using the getIsoDiffReport algorithm implemented within X13CMS.

2.10 XCMS Online: Metabolomics on the Cloud
The bioinformatic resources discussed up to this point are distributed as R packages and operated
through a command-line interface or customized scripts. One major advantage of this format is
flexibility. Researchers can modify the XCMS algorithms to suit their own specific needs. The
modular nature of the original XCMS software has made it interoperable with new generations of
programs for untargeted metabolomics and enabled multiple research laboratories to improve upon
the original XCMS algorithms.65,71,104,105
A limitation of distributing XCMS as an R package is that many users do not have the
programming expertise to use a command-line interface. This can be particularly problematic for
clinical and biological laboratories. In response to this issue, an intuitive graphical interface was
developed to process untargeted metabolomic data; this interface implements many of the
algorithms described in this review including those in XCMS, CAMERA, metaXCMS, as well as
others. The platform, called XCMS Online, is cloud based.106 Investigators upload untargeted
metabolomic data by simply dragging and dropping their files into the program. Parameters are then
selected and processing occurs on the cloud. Researches receive an e-mail notifying them when
processing is complete. Results can then be viewed online, or downloaded for later use. An
advantage unique to XCMS Online is that data are directly searched against the METLIN metabolite
database.107 When users upload both MS and MS/MS data, the matching can be performed on the
basis of accurate mass and fragmentation patterns.92 Thus, within XCMS Online, features on the
diffreport can be annotated as possible isotopes, adducts, or structures.
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2.11 Concluding Remarks
There are many reliable bioinformatic solutions for processing untargeted metabolomic data.
The XCMS software is one platform-agnostic solution that is widely used. The success of XCMS is
related to it being open source and highly modular. This has enabled multiple laboratories to
contribute to its development with algorithms such as centWave and OBI-warp. There are a
multitude of additional algorithms available that are relevant to the processing of untargeted
metabolomic data, and it is recommended that their potential to improve XCMS performance be
evaluated in the future. Given that XCMS is open source and modular, it is also interoperable with
new generations of metabolomic software implemented within R and aimed at achieving advanced
functionalities (e.g., better annotation of features, multifactorial analysis, unbiased tracking of
isotopic labels, etc.). Consequently, the core algorithms within XCMS have become an important
piece of many bioinformatic pipelines. Hopefully the roadmap for these pipelines that we have
provided here will be useful in helping researchers chose a software platform most compatible with
their experimental objectives.
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Chapter 3.

Warpgroup: Increased Precision of Metabolomic Data Processing by
Consensus Integration Bound Analysis *

Motivation: Current informatic techniques for processing raw, chromatography/mass
spectrometry data break down under several common, non-ideal conditions. Importantly,
hydrophilic liquid interaction chromatography (a key separation technology for metabolomics)
produces data that are especially challenging to process.

We identify three critical points of failure

in current informatic workflows: compound specific drift, integration region variance, and naive
missing value imputation. We implement the Warpgroup algorithm to address these challenges.
Results: Warpgroup adds peak subregion detection, consensus integration bound detection, and
intelligent missing value imputation steps to the conventional informatic workflow. When compared
to the conventional workflow, Warpgroup made major improvements to the processed data. The
coefficient of variation for replicate injections of a complex Escherichia Coli extract were halved (a
reduction of 19%). Integration regions across samples were much more robust. Additionally, many
signals lost by the conventional workflow were “rescued” by the Warpgroup refinement, thereby
resulting in greater analyte coverage in the processed data.

* This work is based on the following publication: “Warpgroup: increased precision of metabolomic data processing
by consensus integration bound analysis”. NG Mahieu, JL Spalding, GJ Patti, Bioinformatics, 2015. NGM developed
and evaluated the Warpgroup algorithm, and ran all LC/MS experiments. JLS provided an initial, poorly aligned data.
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Availability and Implementation: Warpgroup is an open source R package available on GitHub at
github.com/nathaniel-mahieu/warpgroup. The package includes example data and XCMS
compatibility wrappers for ease of use.

3.1

Introduction
In the previous chapter an overview of the informatic tasks in metabolomics was provided. In

this chapter we take a deeper look at the peak detection process and develop Warpgroup, an
algorithm that refines the results of peak detection in individual files by combining the results and
computing consensus peak integrations – peak integrations that are supported by all replicates.

Omics-scale separation/mass spectrometry approaches (e.g., LC/MS, GC/MS, CE/MS, etc.)
generate large, three-dimensional data sets consisting of elution time (rt), mass-to-charge ratio (m/z),
and signal intensity information.107 Analytes are separated by their chemical characteristics prior to
being introduced into the mass spectrometer (yielding rt). The mass spectrometer acts as a second
dimension of separation and a detector, providing information on the accurate mass (m/z) and
amount of each analyte (signal intensity). Each sample run can generate gigabytes of data
representing tens of thousands of distinct analytes.108 The processing of raw data is a significant
challenge and the conventional workflow consists of several steps. These steps include mass trace
detection, chromatographic feature detection, inter-sample retention time drift correction, intersample grouping of common features (correspondence determination), and statistical analysis of
feature groups.5 A feature in this context refers to signal that displays a peak shape in both m/z and
rt domains. The result of this data processing is quantification of all unique analytes detected across
multiple sample runs.
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Historically, most chromatography/mass spectrometry experiments have been performed with
reversed-phase chromatography. This well-established separation technique commonly generates
Gaussian peak shapes and exhibits highly reproducible retention times. A simple retention
mechanism based primarily on compound polarity also minimizes compound specific drift.109 One
drawback to reversed-phase separation is a lack of retention for the highly polar compounds such as
sugars and organic acids commonly of interest to metabolomic studies. As a result, many new
separation chemistries have emerged under the umbrella term hydrophilic interaction liquid
chromatography (HILIC), which aim to achieve separation of polar molecules.110 Unfortunately,
analytes measured by HILIC separation exhibit a wide range of non-Gaussian peak shapes as well as
larger, compound-specific retention time drift.111 Current informatic approaches were primarily
developed by using reversed-phase C18 chromatography, and even today most new advances are
benchmarked solely on reversed-phase datasets.71 Thus, the performance of these algorithms
degrades when applied to HILIC datasets.
Detection of features and selection of integration regions is an initial and critical step of the
informatic workflow.112 In cases where peak shapes are simple and peaks exhibit large signal-to-noise
ratios, the detection and integration of peaks is reproducible. Complex metabolomic datasets,
however, contain a high proportion of poorly resolved and low-abundance peaks.113 Additionally,
the non-Gaussian peak shapes exhibited by a large portion of HILIC features impede the robust
selection of integration bounds. These factors complicate peak detection and result in undetected
features as well as integration bounds which describe different regions of a peak in each sample.
(Figure 1, A and B)
The second major informatic step is determination of correspondence. Current feature grouping
techniques rely on the reproducible elution of compounds across multiple experimental runs. The
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elution time of m/z-rt pairs (i.e., features) is the key information used to associate the same
compound detected in different runs.114 In practice, elution times vary from sample to sample due to
many factors. 114 This necessitates correction of retention time drift prior to grouping. Most
techniques assume that drift is a function of retention time alone and thus generate a global
correction curve f(rtA)=rtB.66 This critical assumption is overly simplistic. In practice, retention time
drift is compound dependent (Appendix 1.1 and 1.2).82 Additionally, residual drift becomes greater
when using more vagarious separation strategies such as HILIC, as larger groups of samples are
aligned, and as research studies begin to incorporate inter-laboratory comparisons.115
Given the global correction assumption, most alignment techniques minimize only the average
drift between samples considering all analytes equally.65 (Appendix 1.1 is an optimistic example
displaying the residual drift of technical replicates run over the course of 9 hours.) As such, the
inherent compound-specific drift results in many unaligned peak remaining after correction –
moreover many compounds move even further out of alignment upon global correction. (Appendix
1.2) This poor feature alignment causes major challenges for current peak grouping algorithms.
The density method employed by XCMS, for example, can only group peaks if their maximum
residual drift is less than the distance to the nearest group. (Figure 1C is an example of this failure.)84
Further complexity is added by samples in which a feature is undetected, or when spurious noise is
detected as a feature.
These failings of the current informatic workflow motivated our development of the Warpgroup
algorithm. Warpgroup is an algorithm that utilizes dynamic time warping (DTW) and network graph
decomposition. Herein we achieve five goals: (i.) accurate grouping of features between samples
even in the case of deviation from the global retention time drift, (ii.) splitting of peak subregions
into distinct groups, (iii.) determination of consensus integration bounds within each group such
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that each group represents a similar chromatographic region, (iv.) detection of the appropriate
integration region in samples where no peak was detected, and (v.) reporting of several parameters
that allow filtering of noise groups.

Figure 3.1. (A) Determination of integration bounds is a challenging computational problem. Independent peak detection introduces sample-tosample variance in the integration regions (top). Peak bounds after Warpgroup (bottom). (B) Peak detection often misses peaks in some samples
(top). Warpgroup detects the appropriate regions in each sample to integrate (bottom). (C) Conventional methods are unable to accurately
group peaks when retention time varies more than the separation between peaks (left). Warpgroup successfully groups challenging peaks (right).
(D) An extreme example in which two peaks have merged to varying degrees and peak detection identified different portions of the peak in
different samples (left). Warpgroup correctly identifies the three corresponding regions in each sample (right). All examples are included in the
Warpgroup R package for demonstration.

The Warpgroup algorithm establishes a correspondence between the time domains of each
feature’s extracted ion chromatogram (EIC) trace, utilizing dynamic time warping by default.116,117
Based on this correspondence, Warpgroup evaluates whether all supplied peak bounds represent a
similar chromatographic region using graph community detection.69 Subsequently, it determines
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“consensus integration regions” for each sample and selects the appropriate integration region for
samples with no detected peak. During the time warping and graph analysis, several descriptors of
each group are generated and reported for use in filtering unreliable and noise-containing groups.

3.2

Methods

3.2.1

Overview of the Warpgroup Algorithm

The Warpgroup algorithm is applied after feature detection has been performed. It augments the
conventional retention time correction and feature grouping steps with the addition of group
splitting and consensus bound determination. The benefits of Warpgroup are derived from the
combination of several peak finding rounds through the independently determined alignment
between chromatograms.
The Warpgroup algorithm utilizes two pieces of information. The first is one EIC trace per
sample that includes all of the masses contributing to the peak group. This trace could contain a
single detected peak, or multiple peaks per sample depending on the experimental retention time
drift and mass drift. These traces are used to determine the pairwise alignment between each
sample’s time domain for this putative group of compounds. The second piece of information is a
list of peak bounds detected in the EIC traces. These must have been determined previously by a
peak detection step for at least one sample. The Warpgroup algorithm will use these bounds and the
aligned sample traces to split the detected peak list into groups, each of which represent a distinct
chromatographic region.
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The key assumption made by the Warpgroup approach is that the sample EIC traces exhibit
similar topography. Though not strictly true, this is the common assumption made in current
retention time alignment techniques82 and has been shown here to be a robust basis for Warpgroup
analysis. Under this assumption, we use established methods to warp (shift, expand, and contract)
the time domain of the sample EIC trace such that the difference between two sample traces is
minimized. In this way we establish a relationship between the two time domains, equating the
scans in one sample to the scans in a second for a specific group of compounds (i.e.,
𝑓𝑚,𝑛 (𝑠𝑠𝑠𝑠 𝑖𝑛 𝑠𝑠𝑠𝑠𝑠𝑠 𝑚) = 𝑠𝑠𝑠𝑠 𝑖𝑖 𝑠𝑠𝑠𝑠𝑠𝑠 𝑛. This warping function is taken as the true

correspondence between scans in each sample trace and is used to establish relationships between
the detected peaks as well as to determine the proper integration region in samples where a peak was
not detected.
To this end, the alignment between each sample scan is used to evaluate whether the supplied
peak bounds delineate similar or distinct chromatographic regions of their EIC traces. Peak bounds
which describe similar chromatographic regions should overlap upon transformation into a second
sample’s time domain. We ask, for each peak, if the transformed bounds agree. These yes/no
answers are expressed as linkages between detected peaks (nodes) creating a graph structure. This
graph is split using the walktrap community detection method118 and the resulting communities are
taken as peak groups (i.e., groups of peaks that describe similar chromatographic regions).
For each resulting peak group, the full set of transformed peak bounds is then filtered for outliers
that do not describe a chromatographic region similar to that of the majority of detected peaks. The
mean of the 75th percentile of the remaining, transformed peak bounds for each sample is taken as
the “group-consensus peak bound” for each sample.
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Finally, integration bounds must be determined for samples which have no detected peak
remaining in the group. It is common for features to be detected in some but not all samples,
especially in cases where compounds are of low abundance. Each group’s consensus peak bounds
are transformed into the missing sample's time domain and the median of these transformed
consensus peak bounds is taken as the integration region for the missing sample.
In this way Warpgroup has assured that each peak group contains a region from every sample,
each peak group describes a unique chromatographic region, and all peaks in that group describe a
similar chromatographic region (Figure 1).

3.2.2

Description of the Warpgroup Algorithm

Input
The algorithm takes two pieces of information. A sample × scan sample-trace-matrix (Figure 1,
traces) and a matrix of peak bounds including the peak start, and peak end, and sample index (Figure
1, dots).
Sample Trace Preprocessing
Optionally, each sample trace is smoothed, padded with 0's equal to 10% of the length of the
trace, and normalized to a maximum intensity of 1.0.
Pairwise Sample Warping Matrix Generation
Each pair of sample traces is used to generate a sample × sample warping-matrix (W). Each
matrix entry is a step function 𝑊𝑚,𝑛 = 𝑓(𝑚,𝑛) (𝑥) such that 𝑓𝑚,𝑛 (𝑠𝑠𝑠𝑠 𝑖𝑖 𝑠𝑠𝑠𝑠𝑠𝑠 𝑚) =
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𝑠𝑠𝑠𝑠 𝑖𝑖 𝑠𝑠𝑠𝑠𝑠𝑠 𝑛. (Appendix 1.4) The notation 𝑊𝑖,𝑗 represents the step function converting scans
from the sample in which peak j was detected into the sample in which peak i was detected.

The warp matrices for this work are generated using dynamic time warping to determine the
optimal warp path. Other techniques such as parametric time warping (PTW) have recently been
applied to the correction of retention time drift119 and in general any technique which establishes
alignment between the scans in each sample can be used.
Establishing relationships between the supplied peaks
The supplied peak bounds are transformed from the originating sample’s elution space into each
of the other sample's elution space via the previously determined warping-matrix. Peaks which
delineate the same chromatographic regions will share bounds when transformed from their time
domain into the other samples time domain.
Each pair of peak bounds is compared to populate a peak × peak match-matrix (P). Pairs which
differ by less than the settable cut-off sc.aligned.lim are filled as true.
𝑃𝑖,𝑗 = �𝑏𝑏𝑏𝑏𝑏𝑠𝑝𝑝𝑝𝑝 𝑖 − 𝑊𝑖,𝑗 �𝑏𝑏𝑏𝑏𝑏𝑠𝑝𝑝𝑝𝑝 𝑗 �� < 𝑠𝑠. 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎. 𝑙𝑙𝑙

Splitting the supplied peaks into groups which describe distinct chromatographic regions
Matrix P is represented as a graph structure where matrix indices are the nodes and matrix
elements containing a true value are the edges. (Appendix 1.4) The nodes of this graph are split into
communities using the walktrap community detection method.118
Each of the resulting communities contains one or more detected features. Within each
community (i.e., group), all detected features are taken to represent the same analyte.
Determination of consensus peak bounds for each group
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All detected peaks within each group contribute to the consensus peak bounds such that each
peak represents the same chromatographic region. Grouped peak pairs are transformed into each
sample’s time domain to create a peak × peak transformed matrix (C).
𝐶𝑖,𝑗 = 𝑊𝑖,𝑗 (𝑏𝑏𝑏𝑏𝑏𝑠𝑝𝑝𝑝𝑘 𝑗 )
The mean of the 75th percentile of each column is taken as the consensus peak bounds for the
jth peak.
Determination of integration region for samples without a detected peak
For samples in which there was no detected peak remaining in a group, the consensus peak
bounds are projected into that sample’s time domain.
𝐶𝑖,𝑗 = 𝑊𝑖,𝑗 (𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑏𝑏𝑏𝑏𝑏𝑠𝑝𝑝𝑝𝑝 𝑗 )

The median of these transformed bounds are taken as the missing sample’s peak bounds.

3.2.3

Output

The output of the algorithm is a list, each entry representing one peak group. A group entry is a
matrix with a set of consensus peak bounds for each sample as well as descriptors of the alignment
and grouping process. This output can be used for peak integration, filtering, and statistics.

3.2.4

XCMS Implementation

Warpgroup was developed as a standalone algorithm and as such it can be applied to any suitable
chromatographic data. For convenience, the Warpgroup package includes integration with XCMS
type objects. These functions allow application of the Warpgroup algorithm in the conventional
XCMS manner by calling group.warpgroup(). The returned object is an xcmsSet object with peak
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bounds and groups generated by the Warpgroup algorithm. This resulting xcmsSet does not need
any further fillPeaks() and is ready for statistical analysis, either manually or with XCMS’s
diffreport() function. Further information can be found in Appendix 1.5.

3.2.5

Datasets

Raw Data
We experimentally generated two datasets on which to benchmark Warpgrouping. To evaluate
performance under a relevant set of conditions, we chose to generate one dataset with reversedphase C18 chromatography and the second with amino propyl HILIC.120 Each dataset contained
eleven LC/MS runs of Escherichia coli (E. coli) strain K12, MG1655 metabolic extract. This design
allowed us to inspect the standard error of quantitation on both ideal (C18) and non-ideal (HILIC)
datasets while also observing the algorithms performance as dataset quality degrades at longer times.
Metabolic extract was generated as described previously.4 Briefly, two cultures of E. coli were
grown, one on natural-abundance glucose and a second on uniformly labeled 13C-glucose as the sole
carbon source. E. coli was harvested by pelleting 10 mL of culture at OD600 = 1.0. Pellets were
extracted using 1 mL of 2:2:1 methanol:acetonitrile:water, and reconstituted in 100 μL of 1:1
acetonitrile:water.
Datasets were generated on the Thermo Q-Exactive Plus mass spectrometer interfaced with an
Agilent 1260 capillary liquid chromatography system. Spectra were collected in negative ion mode
with the following HESI II source settings: aux. gas, 15; sheath gas, 30; counter gas, 0; capillary
temperature, 310 ℃; sheath gas temperature, 200 ℃; spray voltage, 3.2 kV; needle diameter, 34 ga;
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s-lens, 65 V; mass range, 85-1165 Da; resolution 140,000; microscans, 1; max inj. time; 200 ms; AGC
target: 3e6.
HILIC was performed as described previously120 using the Phenomenex Luna NH2 (1.0 mm x
150 mm x 3 um) column and a flow rate of 50 μL/minute. Solvents were: A, 95% water + 20 mM
ammonium hydroxide + 20 mM ammonium acetate; B, 100% acetonitrile. An injection volume of 1
μL was used with a gradient of (minutes, %A): 0, 5; 40, 100; 50; 100; 50.5, 40; 54.5, 15; 55, 5; 65, 5.
Reversed-phase chromatography was performed as described previously 120 using the Agilent
Zorbax C18 (0.5 mm x 150 mm x 3 μm) column and a flow rate of 30 μL/minute. Solvents were:
A, water + 0.1% (v/v) formic acid; B, acetonitrile + 0.1% (v/v) formic acid. An injection volume of
1 μL was used with a gradient of (minutes, %A): 0, 95; 45, 0; 55; 0; 56, 95; 65, 95.
Preprocessing
The Warpgroup algorithm implements peak subregion detection, consensus/missing peak
integration bound determination, and group filtering. These steps come after peak detection has
been performed and putative correspondence has been determined. To generate data for
comparisons, peak detection for each of the C18 and HILIC datasets was performed by the
centWave algorithm as implemented in the XCMS R package.71,84,121 Parameters were: C18,
ppm=2.5, peakwidth=c(8,120), HILIC: ppm=2.5, peakwidth=c(8,120). This set of detected peaks
was used as the basis for both the conventional and Warpgroup workflows as described below.
Conventional Workflow
The conventional workflow as referred to here consists of the following listed analysis steps and
parameters taken from XCMS Online recommendations for the Q-Exactive Plus.122 Global retention
time correction is performed with the OBI-warp algorithm (profStep=1, center=1). Features are
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then grouped between samples with the density method (mzwid=0.015). Finally, missing peaks are
filled by integrating the range of m/z and retention times in the group using fillPeaks(). The
resulting filled peak groups contain at minimum one intensity value per sample, but in many
instances include multiple intensity values per sample. When performing statistics, the groupval()
function applies a filter to select a value which will represent each sample. By default this selects the
peak which is closest to the median retention time of the group. All calculations are based on this
groupval() output to make results consistent with diffreport() output as used in the conventional
workflow by XCMS Online.
Warpgroup Workflow
The Warpgroup workflow consists of the following steps. Global retention time correction is
performed with the OBI-warp algorithm (profStep=1, center=1). A rough grouping of features is
established by grouping all features within 3 ppm and 25 scans. In our data sets this rough grouping
ensured that all peaks which could possibly be the same analyte across samples remained in the same
group – this also caused some groups to contain multiple peaks. Here, these rough groups were
refined with the Warpgroup algorithm by a call to group.warpgroup (rt.max.drift = 20,
ppm.max.drift = 3, rt.aligned.lim = 7). The resulting dataset contained one peak per sample in every
group, all of which described the same region. This output xcmsSet was used for all further statistics
and assessment of the Warpgroup algorithm.
Selecting Peak Groups for Comparison
The Warpgroup analysis assumes each detected peak represents a legitimate peak region. Upon
Warpgroup analysis of these regions, a single group in the conventional workflow often results in
multiple warp groups. (Table 2) To make a fair comparison between quantitation of the
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conventional and Warpgroup methods, a selection of groups had to be made. “Shared” peaks
consist of any groups which contain six or more peaks in common between the two workflows. It is
worth noting that the “shared” group subset masks the benefits that Warpgroup provides in low
abundance peak detection and peak sub region detection.

3.2.6

Performance Evaluation

A major goal of the Warpgroup algorithm is the reduction of variance introduced by data
processing. We identified several points in the conventional bioinformatic workflow for processing
untargeted metabolomic data where small errors were being introduced. These small errors were
compounded in each downstream step, resulting in a significant decrease in dataset quality. We
evaluated the impact of Warpgrouping on the two primary errors we noticed: integration bound
selection and peak grouping.
Peak Quantitation
Peak quantitation performance of each workflow was assessed by comparing the coefficient of
variation (CV) across 11 replicate injections. This metric provides an assessment of the entire
workflow. Warpgroup often divides conventional groups into multiple sub-groups, and thus there is
not a one–to-one correspondence between warpgroups and conventional groups. To assess similar
peak groups in both methods, only groups sharing more than 6 of the 11 centWave detected peaks
were included in the coefficient of variation analysis. This ensures a one-to-one correspondence
between groups from both methods but obscures the benefit of any additional, true groups
recovered by Warpgroup.
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Figure 3.2. Standard error of peak quantitation comparison. The coefficient of variation for all peak groups which shared more than 6 centWave peaks
from 11 replicate injections was monitored before (pink) and after (blue) warpgroup. The conventional workflow generates a large number of
high variance peak groups for various reasons; upon warpgrouping these are corrected, resulting in a much lower CV for the replicates.

Grouping Quality
The quality of peak grouping was evaluated for both workflows by manually annotating the
resulting groups. Automated rating of group quality is complex and remains beyond the ability of
current techniques. To generate a metric for the quality of resulting groups we examined 500 groups
generated by each workflow, scoring them for uniformity of included peaks. The scoring system
employed was: 4, identical integration regions for every peak in the group; 3, some minor variation
in the integration regions; 2, major variation in the integration regions; 1, multiple distinct peaks
included in the group; 0, a noise group with no discernable correct integration. Scores were
summarized for comparison of the conventional and Warpgroup workflows.
Further, the number of additional, distinct chromatographic regions the Warpgroup algorithm
detected was quantified. We manually annotated each Warpgroup as redundant, noise, or unique;
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Groups that shared more than 75% of their major chromatographic region, or differed in only the
tails of the peak were annotated as redundant. In some cases, a peak was split into sub regions but
also reported in its entirety. (Figure 1D) We considered this desired behavior and annotated all three
as unique groups.

3.3

Results

3.3.1

Standard error of replicate injections

Peak picking in the conventional workflow is performed on each sample independently, causing
the integration region for each peak to vary slightly from sample to sample. By considering the peak
bounds detected in each sample together, we ensure that the similar integration region is selected for
each peak. In addition, the Warpgroup approach reduces errors in grouping which can contribute to
inaccurate quantitation and statistics. Analysis of 11 replicate injections with two chromatographies
demonstrated the improvement in data processing quality using the Warpgroup method (Figure 2).
The mean CV was halved (a decrease of 13% in the HILIC case and 17% in the C18 case). Pairwise
comparison of each group before and after Warpgroup revealed that, in most but not all cases, the
CV decreased with the application of Warpgroup. (Appendix 1.6)
Quality of resulting groups
Grouping in the conventional workflow is based solely on the assumption that common peaks
will cluster in retention time. As seen in Appendix 1.1 and 1.2, this assumption is not strictly true
and in many cases (such as shown in Figure 1C) groups will include two or more distinct peaks due
to residual drift. We sought to evaluate the quality of peak groups returned by the Warpgroup
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algorithm as compared to the conventional workflow by rating groups on a scale of 0 to 4. As seen
in Figure 3, the Warpgroup algorithm results in a striking increase in peak group quality.
Notably, ratings of 1 correspond to groups which contained multiple, distinct peaks. The
correction of these cases represents an increase in dataset coverage, as the additional groups
“rescued” by Warpgroup represent newly quantified unique signals.

Figure 3.3. Group quality and consistency comparison. The conventional XCMS approach without Warpgroup was compared to the XCMS approach
with Warpgroup. Quality of generated groups was assessed. Groups were manually inspected and rated on a scale of 0-4. Zero scores
corresponded to noise groups with no discernable correct integration. The remaining scores ranged from 1 (integration regions incorporating
different peaks across samples) to 4 (identical integration regions across all samples). Warpgroup (right) showed a major improvement in group
quality as compared to the conventional workflow (left). Warpgroup also showed an expected increase in noise groups.

Given that Warpgroup splits peak groups into distinct regions, there is a tradeoff between the
number of truly unique chromatographic regions and the number of redundant chromatographic
regions that are represented. This tradeoff is controlled by the variable sc.aligned.lim, the only usersettable parameter in our algorithm. This parameter specifies the similarity two sets of peak bounds
must have to be called the same peak. A smaller sc.aligned.lim results in more sensitive peak
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subregion detection but more orphan peaks and a larger number of redundant groups. In practice,
orphaned and redundant peaks are easily filtered by removing all peak groups generated by one or a
few of the originally detected peak bounds.
We evaluated the redundancy of the Warpgroups and the increase in unique signals detected by
manually annotating redundant and noise-only Warpgroups in the HILIC dataset (Table 2). The
conventional workflow’s 18,341 peak groups resulted in 40,719 peak groups after Warpgrouping.
Of these Warpgroups, we manually annotated 33% as redundant and 10% as noise. Considering
these redundancies and noise, the Warpgroup approach resulted in 23,209 unique signals. The
increase in peak groups by 23% represents distinct chromatographic regions that were added to the
dataset and otherwise would have been lost or poorly quantified.

Table 3.1. Coefficient of variation comparisons

A final, more restrictive search for rescued groups was performed. Cases such as that shown in
Figure 1C were identified by searching for conventional groups in which two distinct peaks were
incorrectly combined by conventional grouping due to residual drift. In these cases, peak finding
detected both peaks in most samples but the conventional grouping was unable to properly separate
them. This search yielded 611 peak groups in the HILIC dataset and 1,246 peak groups in the C18
dataset that were successfully rescued by Warpgroup.
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Table 3.1. Group quality comparisons

3.4

Discussion
The exact use cases of Warpgroup are dependent on the data and the problem at hand. We

imagine four distinct goals in the next section and summarize appropriate inputs and expected
outputs. Warpgroup operates optimally after inter-sample peak correspondence has been
established. Though it is possible to supply ungrouped data to the Warpgroup algorithm, there are
several drawbacks to this approach. First, processing time for the dynamic time warping algorithm
scales with the square of the input length. Second, if a feature is present in one sample but missing
from the others, this dissimilar topography can result in incorrect alignments. Finally, establishing
correspondence is a complex challenge for which many more sophisticated solutions have been
suggested.82 These should be used in conjunction with the Warpgroup refinements.
While Warpgroup is not intended to determine peak correspondence, it does make a less
restrictive assumption for peak alignment. Current algorithms assume that peak elution order
remains monotonic across all masses. Warpgroup assumes only that peaks of indistinguishable mass
retain their elution order. This more relaxed assumption allows for rudimentary correspondence to
be established in more complex cases such as that shown in Figure 1C and is a major improvement
to the XCMS-based workflow.123
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3.4.1

Use Cases

There are four modes we consider for the application of Warpgroup.
Consensus bound determination.
In cases where the peak was detected in all samples, only the peak integration region with a small
number of surrounding scans need be included in the EIC matrix. A large value for sc.aligned.lim
can be supplied to avoid splitting of the group into sub regions. When operated in this manner,
Warpgroup is relatively fast. The returned bounds are the consensus integration bounds for that
group. (Figure 1A)
Peak subregion detection.
This use case is identical to case one except an appropriately small value for sc.aligned.lim is
selected, allowing for subregion splitting. This use case is also relatively fast. The returned bounds
will be a list of distinct chromatographic regions. (Figure 1D)
Imputation of integration bounds for samples in which no peak was detected.
In this case, both the undetected and detected peak traces must be included in the EIC matrix.
Because the feature was not detected in at least one sample, the necessary scan range will be
dependent on the expected range in which the undetected peak could fall (i.e., the observed drift). A
large value for the argument sc.aligned.lim should be supplied to avoid splitting the detected peaks
into sub groups. The peak bounds for each missing sample are then returned. (Figure 1B)
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Grouping of peaks which deviate from the global retention time drift.
Warpgroup’s “grouping” of peaks is a result of the subregion detection and splitting. In this
mode, the EIC region supplied to Warpgroup will envelop multiple peak groups and thus take
longer than the above modes. (Figure 1C top) A small value for sc.aligned.lim is supplied if peak
subregion detection is desired, or a larger value if the goal is to distinguish two well separated peaks.
The result will contain a group for each detected peak group.

3.4.2

Output Considerations

One major advantage of the Warpgroup workflow is the ability to detect noise groups. The
warpgroup algorithm includes several peak descriptors for each group after analysis. It is important
to note that Warpgroup output is dependent on the input and contains all resulting groups, including
noise. Due to the splitting approach, this can result in a large increase in group number - many of
which may be redundant. Further, as noise regions have an under-determined warp path, these
regions are often split into distinct regions.
Two descriptors generated by the algorithm can be used to detect and filter these cases. These
descriptors provide a type of quality measurement of the group. The first descriptor is “n” – the
number of peaks originally detected which contribute to this group. This parameter is featured in
the conventional workflow, but Warpgroup provides a more refined metric. Rather than n
representing all features eluting near each other, here n represents the detected features which
describe similar subregions of the chromatogram thus, the metric is much more reliable. In cases of
high n, feature detection agreed upon the region of the chromatogram to call a peak. In cases of low
n, the peak detection did not robustly detect the region and it is likely noise.
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The second descriptor is “warp.consistency”. This metric measures how much the bounds shift
when projected into each time-domain and back. Chromatograms with a well-defined and conserved
topography will generate highly reproducible warp paths. When bounds are projected through these
warp paths, any introduced shift will be small and this metric will be low. When bounds are shifted
through a poorly defined region, shifts will be greater and this metric will be high. It is
recommended to monitor and filter peak groups based on these parameters prior to further analysis.

3.4.3

Challenges

A drawback of the Warpgroup approach is speed. As described in Prince et al., “warping
function… [scaling]… is bounded by computational complexity (the more segmented the warp
function the more computation required.)”82 Warpgroup segments every distinct mass trace and, as
such, the computational demand is high. The dynamic time warping algorithm employed scales with
the length of the input as O(n2). Thus, as correspondence confidence decreases, the length of the
EIC supplied to Warpgroup increases and processing time lengthens rapidly. Conversely, in cases
where correspondence confidence is high or the goal is simply consensus peak bound and subregion
detection for well-grouped peaks, the algorithm remains very fast. Accordingly, the incorporation of
mass and retention time drift correction as well as the establishment of correspondence prior to
Warpgroup is recommended.
Prince et al. raise several limitations of current correspondence methods.82 Though not intended
as a correspondence algorithm, Warpgroup does address some of the challenges these methods face.
Most importantly, Warpgroup makes more realistic assumptions about the component-specific drift
expected in these datasets. Further, as a single reference sample is not used for alignment,
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Warpgroup remains symmetric and robust. The algorithm is easily implemented in most workflows
as it relies on only one required user settable parameter.

3.4.4

Future Directions

Improving the scaling with sample number is an important goal. While the current
implementation is sufficient for many published metabolomic studies, the analysis of larger datasets
remains a priority. Computation can be minimized by several strategies. For many peak groups,
refinement with Warpgroup will be unnecessary, making minor or no modification to the
predetermined group. In these cases, Warpgroup can be omitted for all but the most complex
groups. The major computational step is the establishment of a warp path between each sample.
To reduce computation, the DTW algorithm can be replaced with faster warping algorithms such as
PTW if the data allow. Finally, this implementation calculates the full sample x sample warping
matrix. However, implementation of a sparse matrix approach could be explored.
Although Warpgroup was presented here in the context of LC/MS data, the input and output of
the algorithm are of a general form (multiple time series and regions within those time-series.) As
such, the method is generalizable and can find consensus regions within any time-series data. An
example of Warpgrouping on echocardiogram data124,125 can be found in Appendix 1.8.
The Warpgroup algorithm as presented addresses several major drawbacks of the current
informatic workflow. Still, current processing techniques leave significant room for improvement.
The development of more effective correspondence algorithms is a critical step for the advancement
of the field.82 Additionally, we see promise in leveraging the information embedded in the
component-specific drift observed in these datasets. For example, the drift data may be used to
cluster ions into composite spectra and to inform further identification.
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3.5

Conclusion
In summary, we have found Warpgroup to be an important refinement step for current

integration and correspondence methods. With Warpgroup refinement in place, data processing
results remain robust across a wide range of experimental conditions. Major advantages have been
noted in coverage as well as quantitation, especially in low abundance signals. Further, Warpgroup
output includes additional descriptors which can be used to filter noise and unreliable groups from
the final datasets. Overall we expect the addition of a Warpgrouping step to the informatic
workflow to improve the quality and reliability of untargeted metabolomic analyses.

3.6

Supporting Data
The LC/MS datasets used in benchmarking of the Warpgroup algorithm can be found on our

laboratory website at http://pattilab.wustl.edu/software/warpgroup/. Additional information can
be found in Appendix 1.
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Chapter 4.

Defining and Detecting Complex Peak Relationships in Mass
Spectral Data: The mz.unity Algorithm *

Analysis of a single analyte by mass spectrometry can result in the detection of more than one
hundred degenerate peaks. These degenerate peaks complicate spectral interpretation and are
challenging to annotate. In mass spectrometry-based metabolomics, this degeneracy leads to inflated
false discovery rates, datasets containing an order of magnitude more features than analytes, and an
inefficient use of resources during data analysis. Although software has been introduced to annotate
spectral degeneracy, current approaches are unable to represent several important classes of peak
relationships. These include heterodimers and higher complex adducts, distal fragments,
relationships between peaks in different polarities, and complex adducts between features and
background peaks. Here we outline sources of peak degeneracy in mass spectra that are not
annotated by current approaches and introduce a software package called mz.unity to detect these
relationships in accurate mass data. Using mz.unity, we find that datasets contain many more
complex relationships than we anticipated. Examples include the adduct of glutamate and NAD,
fragments of NAD detected in the same or opposite polarities, and the adduct of glutamate and a
background peak. Further, the complex relationships we identify show that several assumptions

* This work is based on the following publication: “Defining and Detecting Complex Peak Relationships in Mass Spectral Data: The Mz. unity
Algorithm”. NG Mahieu, JL Spalding, SJ Gelman, GJ Patti, Analytical Chemistry, 2016. NGM developed the conceptualization of complex adduction
and developed and evaluated the mz.unity algorithm, and ran all MS experiments. JLS and SJG provided additional data and insight during the writing
process.
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commonly made when interpreting mass spectral degeneracy do not hold in general. These
contributions provide new tools and insight to aid in the annotation of complex spectral
relationships and provide a foundation for improved dataset annotation. Mz.unity is an R package
and is freely available at https://github.com/nathaniel-mahieu/mz.unity as well as our laboratory
Web site http://pattilab.wustl.edu/software/.

4.1

Introduction
In the last chapter we refined the results of peak detection. In this chapter we investigate the

nature of the detected peaks. Specifically we attempt to recover relationships between the detected
peaks such that we can consolidate degeneracy and remove uninformative signals.

Adduction, fragmentation, and the natural abundance of heavy isotopes can cause a single analyte
to generate more than one hundred spectral peaks in mass spectrometry-based datasets. This is
referred to as peak degeneracy and it is a major source of the complexity that confounds data
interpretation. Spectral peak degeneracy is challenging to annotate and its complexity can exceed the
ability of manual annotation in some cases. More recently, automated solutions have been
developed to aid in the annotation of mass spectral data.86,117,126–129 However, current annotation
approaches fail to account for the full gamut of possible peak relationships. Further, several
common assumptions made in these annotation approaches do not hold in general. Here we present
mz-sum, a complete framework for describing complex peak relationships in mass spectrometry
data, and mz.unity, an R package that enables the search and exploration of these relationships.
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4.1.1

Sources of Degeneracy

Figure 4.1. An illustration of analyte transformations resulting in degeneracy in detected, spectral peaks. Only two analytes are present, but they
contribute to a total of 6 peaks.

The exact conditions under which a mass spectrum is collected have a strong influence on the
peaks and types of peak relationships observed. The majority of spectral degeneracy is generated
during ionization, which is the process by which analytes are converted from bulk-phase, neutral
species to gas phase ions. Electrospray ionization (ESI) is one commonly employed ionization
technique. Here we focus on the peak relationships associated with ESI for clarity, but these
approaches can be tailored to any ionization technique.
During ESI, analytes undergo various transformations before being detected as mass spectral
peaks (Figure 1). The set of possible transformations provide the scope of the peak annotation
problem. ESI involves the spray of analyte solution through a charged needle generating gas phase
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droplets that evaporate until charged gas-phase compounds remain.50 Two general types of analyte
transformations are produced in this process, adduction and fragmentation.
Multiple chemical species that remain non-covalently bound after droplet evaporation are called
an adduct. The adduct is a single gas phase ion and will give rise to a single peak, but its formula is
the combination of multiple distinct species. In the simplest case, the second chemical species is a
proton but others such as sodium and solvent adducts can also be formed. In general, any species
present during ionization can adduct with any other species (this includes other analytes).
In contrast, fragmentation is the breakage of bonds prior to MS detection. Often only one of the
portions liberated during a single bond cleavage event is detected, but in some cases both are present
in the resulting mass spectrum.130 Bond cleavages can occur at various locations in a molecule and
therefore a single structure can generate many fragment species.
An important contrast between the annotation of adducts and fragments is the constraint on
possible relationships. For adduction, the space of possible relationships is limited by the species
present at the time of ionization. Because a mass spectrum provides an exceptional record of present
species, we can reasonably limit our search to those species. In contrast, fragment relationships are
limited only to subformula of the parent and are therefore more challenging to annotate.95,131 In this
work, we use mz.unity to putatively annotate two specific subsets of fragments discussed below.
Isotopes are a third source of degeneracy that are independent of the ionization process.
Elements such as carbon are found in nature with varying numbers of neutrons (e.g., 12C and 13C).
This natural abundance of heavy isotopes causes a single chemical formula to give rise to multiple
masses, each corresponding to various numbers of heavy elements. Each of these heavy forms will
be detected as a distinct mass peak.
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4.1.2

Definitions

Analyte: the chemical species which is of interest in the analysis. Often a metabolite species but
can include other molecules such as environmental exposures (e.g., pesticides).
Peak: a mass-to-charge ratio and intensity pair found in a mass spectrum.
Feature: a peak which has a Gaussian like shape (a signal which rises and falls smoothly around a
local maximum) in the chromatographic time domain.
Background Peak: a peak which does not have a Gaussian like shape in the chromatographic time
domain.
Mer: an adduct between two analytes. This includes homodimers, heterodimers, and higher nmers.
Distal Fragment: a fragment whose corresponding neutral loss also appears as a peak in the mass
spectrum.
Granular-mz: mass and charge pairs supplied by the user to the mz.unity algorithm. These
represent specific analyte transformations that combine to make peak relationships.
Complex Relationships: mass spectral peak relationships between three or more detected peaks
or relationships between peaks having multiple polarities (i.e., positive ions, negative ions, or neutral
masses).

4.1.3

Motivation

Interpretation of a mass spectrum necessitates the annotation of degenerate peak relationships
such as isotopes, adducts, and fragments. Critical to the field of metabolomics in particular is the
annotation and removal of these degenerate peaks while preserving those that correspond to unique
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metabolites. Annotation has many benefits for metabolomics: (i) redundant features can be
removed, reducing the size of the dataset by more than an order of magnitude; (ii) the concomitant
reduction in statistical tests performed allows for a less stringent multiple hypothesis testing
correction; (iii) confidence in the validity of a detected peak is increased when degenerate peaks are
also detected; (iv) annotated relationships can inform metabolite identification steps; and (v)
investigative efforts can be directed to unique analytes. Although we will focus on examples of peak
degeneracy in metabolite mass spectra in this work, we point out that annotation is also important to
other fields in addition to metabolomics. In proteomics, for example, annotation prior to selection
of ions for MS/MS may reduce instrument cycles spent on degenerate peaks and therefore increase
proteome coverage.132–134 In trace impurity analysis, annotation can explain unknown peaks. In
approaches that rely on feature counting, such as the evaluation of organic compound diversity on
meteorites, annotation is critical to obtain realistic estimates of the total number of unique analytes
detected.42
Current annotation tools utilize rule tables to describe possible peak relationships.86,135 A rule
table is a list of transformations that neutral analytes may undergo prior to detection. Rules are
applied to spectral peaks and a relationship is asserted if two rule-peak pairs predict the same neutral
mass. Unfortunately, this approach can only represent a subset of peak relationships. Limitations
arise because many spectral peaks do not correspond to a single, underlying neutral mass. Thus,
relationships between three or more peaks (as is the case for fragments and multiple-analyteadducts) cannot be expressed or searched. Current rule tables are also not charge-aware and
therefore can only annotate relationships of the same polarity. The limited scope of rule tables
precludes the annotation of many putative peak relationships and, therefore, invites a more
comprehensive approach to annotation.
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To enable comprehensive spectral annotation, we detail two contributions here: mz-sum and
mz.unity. Mz-sum is the simple concept that all peak relationships can be described as gain and/or
loss of charged formulae. Mz.unity builds on this concept to enumerate all possible peak
relationships in a charge-aware manner. Mz.unity is a software package implementing the peak
relationship search and tools to plot and explore putative annotations. Together, mz-sum and
mz.unity enable the detection of additional complex relationships (e.g., the adduct of glutamate and
nicotinamide adenine dinucleotide (NAD), fragments of NAD, and peaks detected in different
polarities) that are not annotated by current approaches. The purpose of mz.unity is to return all
putative peak relationships within a specified mass error. While mz.unity is a functional tool for
exploring spectra and programmatically evaluating relationships within them, we note that it is not
an automated annotation solution and assessment of confidence in any specific peak relationship
requires information beyond mass and charge. However, this contribution provides the groundwork
necessary to enable automated annotation solutions to be developed in the future.

4.2

Experimental Methods

4.2.1

Notation and the Mz-sum Framework

Chemical species having mass “m” and charge “z” are denoted [m]z. For clarity, a mass can be
referred to by a chemical formula or a compound name. When names are used the neutral,
monoisotopic mass is implied. Thus, the following are equivalent: [146.0459]1-, [C5H8NO4]1-, and
[Glutamate - H]1-. Brackets used to denote chemical species can represent either detected mass
spectral peaks or any additional formulae. Each set of brackets represents a distinct species.
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Conversions may be noted within brackets that describe the nature of the species. In the case of
[Glu-H2O-H]1- , we are referring to a glutamate species after water loss and deprotonation.
Annotation seeks to find relationships between detected mass and charge species. Relationships
are represented by equations of brackets that balance the mass and charge on each side. These
equations describe one or more [m]z peaks in terms of gained and lost mass and charge. From the
gained masses and charges, specific transformations can be inferred. For example, the description of
a glutamate-acetate adduct can be written as the following equation: [C5H8NO4 - H]1- + [CH4CO2 H]1- + [H]1+ = [C6H12NO6– H]1-. Mz-sum is the basic assertion that any valid peak relationship will
satisfy mass and charge balance and can be represented by such an equation. With this groundwork
in place, it is now possible to define a search for all peak relationships.

4.2.2

Description of the Mz.unity Algorithm

Given a list of species with masses and charges [m]z, mz.unity searches for combinations of peaks
that satisfy mass and charge balance (a description of the search problem can be found in Appendix
2.1). Additional parameters specify the combinatorial depth with which to search the supplied [m]z
and the acceptable mass error. As follows from the discussion of mz-sum above, this search pattern
is general enough to find any type of peak relationship. Below are examples of the general
relationship types detected by mz.unity. Notably, each of these lies beyond the scope of previous
annotation software. Though compound names are written for clarity, the actual search is performed
by using accurate mass.
Complex Adducts: [Glutamate – H]1- + [NAD-H]1- + [H]1+ = [Glutamate + NAD - H]1Distal Fragments: [Fragment 123.0453]1+ + [Fragment 540.0536]1- - [H]1+ = [NAD-H]1Isotopes:

[Glutamate - H]1- - [14N]0 + [15N]0 = [15N1-Glutamate - H]171

The mz.unity search can be tailored to a specific set of relationships by supplying “granular-mz”
to the search. These user supplied granular-mz represent undetected species which relate spectral
peaks. In the case of adduction, many species present in solution will not be represented in the mass
spectrum. This is because spectra have low and high mass cutoffs and only record ionizable species.
Such granular-mz in the case of adduction would include small ions such as [H]1+, additives such as
[Acetate]0, and solvents such as [Acetonitrile]0. In the adduction and fragmentation examples above,
[H]1+ was a supplied granular-mz.
The most general relationship search would include granular-mz corresponding to the atoms C,
H, N, O, P, and S, as well as an electron. This set of species would be sufficient to link every peak
to every other peak but in almost all cases these relationships would be arbitrary, linking unrelated
analytes. By limiting the set of granular-mz, the mz.unity search can be limited to a specific
condition or relationship type. In the case of ESI spectra, we seek to relate peaks that are
degenerate. This leads to the use of granular-mz that represent transformations occurring during the
analysis process.
Many fragments cannot be detected by mz.unity because fragmentation is unique to each analyte
and challenging to predict. There are two cases in which mz.unity can detect fragments. When a
molecule has two distal charge-sites and fragmentation occurs between them, both portions of the
molecule will be detected. This is especially true when spectra from both polarities are included as
demonstrated below. In this case, the relationship can be detected by mz.unity, even across polarities
(see the fragmentation example above). The second set of detectable fragments is those which occur
often under the experimental conditions employed (i.e., common fragments). Common fragments
can be supplied as granular-mz and searched like any other relationship.
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4.2.3

Output of the Mz.unity Algorithm

The output of an mz.unity search is a matrix (Table 1). Cells reference the supplied [m]z pairs
involved in the relationship. Each row represents a relationship. Within each row, columns prefixed
with “B.” and “M.” correspond to the peaks and granular-mz that sum to the peak referenced in
column “A”. The mass error associated with each relationship is also reported. A convenient
visualization of this output is a graph structure (Figure 2). In this representation, nodes are peaks
and edges are the detected relationships.

Table 4.1.

The output of mz.unity. Row 1 contains the column headers. Cells contain references to supplied mz values. Row 2 represents

a dimer relationship, this is the adduction of two glutamate monomers (1) and a proton (11) to result in the dimer (12). Row 3 represents
glutamate’s (1) loss of sodium (29) and gain of a proton (11) to produce (29).

4.2.4

Availability and Implementation

The mz.unity project is written in R and is available at http://github.com/nathanielmahieu/mz.unity as well as our laboratory Web site http://pattilab.wustl.edu/software/. Installation
instructions, usage examples, data, and analyses presented in this paper can be found in the
repository.
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4.2.5

Limitations of Mz-sum and Mz.unity

Two limitations of mass- and charge-based annotation are mass measurement error and
relationships that have multiple interpretations. Overcoming these limitations requires additional
information beyond mass and charge.
Imperfect Mass Information
As described above, the search for appropriately summing masses and charges is a proxy for
finding sets of peaks that represent equivalent formulae. Ideally, this search would be performed by
using a peak’s underlying formula but in practice this is not possible. All empirical mass
measurements are made with imperfect accuracy, preventing a one-to-one mapping of mass to
formula.136 Thus, a single mass can represent many possible formulae and this leads to relationships
implied by formula mass that do not actually have equivalent formulae. As mass error increases, the
number of false positive relationships will also increase. Similarly, the number of combinations of
peaks increases rapidly as the number of peaks increases. The combinatorial explosion can quickly
overwhelm the specificity offered by accurate masses. This limitation makes annotation of direct
infusion data and spectra with over 5,000 peaks challenging.137,138
Relationship Ambiguity
Even with perfect formula information, some peak relationships have multiple interpretations
that cannot be resolved without additional information. Common neutral losses such as a [H2O]0
loss could relate either a fragment analyte pair or two distinct analytes. Consider the following two
interpretations of a relationship between peaks [133.0142]1- and [115.0037]1-.
A. [Malate - H]- - [H2O]0 = [Malate - H2O]-
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B. [Malate - H]- - [H2O]0 = [Fumarate - H]In case A, the smaller peak is a fragment and the two peaks are degenerate, while in case B both
peaks are distinct analytes. The two interpretations of this relationship are identical in terms of mass
and charge, and additional information is required to determine which is true.
Similarly, fragments and adducts are challenging to discriminate on the basis of mass and charge
alone. In both cases, two formulae sum to a third. Consider the relationship [163.0401]1- + [NH3]0 =
[180.0666]1-. This could represent a fragment of tyrosine, in which case the [180.0666]1- peak would
be relevant. Alternatively, this could be an ammonium adduct of coumaric acid, in which case the
[163.0401]1- peak would be relevant. This ambiguity is true of all distal fragment and mer
relationships. The two competing interpretations imply the relevance of different peaks:
fragmentation events imply the heavier peak’s relevance, while mer relationships imply the relevance
of the two lighter peaks.

4.2.6

Dataset Generation

For evaluation of mz.unity, we experimentally generated spectra in positive and negative polarity
by using the Q-Exactive Plus mass spectrometer and the HESI-II ion source coupled to an Agilent
1260 capillary flow liquid chromatography system. Spectra were collected with the following
settings: aux gas, 15; sheath gas, 30; counter gas, 0; capillary temperature, 310 ℃; sheath gas
temperature, 200 ℃; spray voltage, 3.2 kV; needle diameter, 34 ga; s-lens, 65 V; mass range, 85–1165
Da; resolution 140,000; micro scans, 1; max injection time; 200 ms; automatic gain control target:
3e6. Hydrophilic interaction liquid chromatography (HILIC) was performed as described
previously with the Phenomenex Luna NH2 (1.0mm 150 mm 3 mm) column and a flow rate of 50
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μL/min.122 Spectra were collected in negative and positive ion mode during two different injections.
Solvents were: A, 95% water + 20 mM ammonium hydroxide + 20 mM ammonium acetate; B,
100% acetonitrile. An injection volume of 1 μL was used with a linear gradient of (minutes, %A): 0,
5; 40, 100; 50, 100; 50.5, 40; 54.5, 15; 55, 5; 65, 5.
Spectra were taken from a dataset of Escherichia coli (E. coli) strain K12, MG1655 metabolic
extract. This design allowed us to inspect real-world data, including co-elution and background ions.
Metabolic extract was generated as described previously.88 Briefly, cultures of E. coli were harvested
by pelleting 10 ml of culture at OD600 = 1.0. Pellets were extracted by using 1 ml of 2:2:1
methanol:acetonitrile:water, and reconstituted in 100 μL of 1:1 acetonitrile:water.
Liquid chromatography/mass spectrometry (LC/MS)-based techniques generate a series of mass
spectra. Peaks that appear in several sequential scans with a Gaussian like profile are termed
features (peaks whose intensity rises and falls around a regional maximum over chromatographic
time). Chromatographic feature detection was performed on the dataset by using the centWave
algorithm.71 Features eluting from 21 to 22 minutes were used as a test set (FG). This included
features from both positive and negative analyses. The set of background peaks (BG) was obtained
by retaining all mass spectral peaks appearing in 80% of the scans within this range, regardless of
peak shape. Peak lists used for annotation can be found in Appendix 2.2-6 and a spectrum can be
found in Appendix 2.7.
Standards of glutamate and NAD were analyzed by direct infusion to validate the detected
relationships. A solution of NAD and glutamate both at 50 μg/mL in buffer A was infused at 10
μL/min and spectra were collected at a resolving power of 280,000 in both positive and negative
mode.
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4.2.7

Dataset Annotation

Mass spectra from an LC/MS analysis of E. coli metabolic extract were searched for relationships
by using mz.unity. Several mz.unity searches were performed, each for different relationship types.
In brief, the following relationships were searched by altering the supplied granular formulae and
search depth: isotopes, charge carriers, neutral gains, cross polarity, common fragments, distal
fragments, and mers. Isotopes were detected and omitted from later searches. Charge states were
assumed to be to 1 unless carbon isotope support for a higher charge state existed. Searches were
performed with a ppm error limit of 2 ppm per observed mass. Exact parameters for each search,
including supplied granular formulae and search depth, can be found in Appendix 2.7-8. Putative
relationships detected by mz.unity were visualized as graphs and spectral graphs (Figure 3) by using
built-in plotting functionality. The graph of relationships was parsed to reveal sets of peaks
generated by a single analyte. From the relationship graph, fine isotopic patterns were extracted.
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4.3

Results and Discussion

Figure 4.2. A. Output of mz.unity represented as a graph structure. Edges represent peak relationships. The modification relating the peaks is noted as
text on each edge. Nodes represent detected m/z peaks. The identity of each is noted with grey text by each node. Nodes are colored by polarity:
positive (green) and negative (red). Edges are colored by relationship type: charge carrier (yellow), cross-polarity (grey), self-mer (purple),
isotopic (green), and heteromer (red). B. The graph structure in Figure 1 superimposed on the mass spectrum of the relevant peaks. Intensity in
this graph is scaled as I0.3 so small peaks are visible.
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4.3.1

Annotation of a Spectrum Containing Glutamate and NAD

We demonstrate mz.unity, our charge-aware framework for detecting and exploring peak
relationships, with a set of peaks observed from the LC/ESI/MS analysis of an E. coli extract. The
extract was a complex mixture of small molecule analytes that gave rise to approximately 46,000
total features when analyzed in both positive and negative polarities. The spectrum used to evaluate
mz.unity was a composite taken from the time range 21 to 22 minutes consisting of 454 features
(peaks with a Gaussian like shape in the chromatographic domain) and 2,212 background peaks.
This spectrum was annotated with incremental relationship searches covering various relationship
types.
Two groups of peaks were considered, features and background peaks. In LC/MS techniques, all
detected analytes of interest appear as features and therefore annotation typically seeks to remove
redundancy from the set of peaks that are features. Still, to fully annotate the features, background
peaks must be considered as participants in adduct formation. The chromatographic domain was
used only to classify mass peaks as features or background peaks, and mz.unity analysis relied only
on the mass and charge of the classified peaks.
We consider three general types of relationships in this discussion of results. Simple annotations
relate two detected peaks through supplied, granular-mz. Distal fragment and mer relationships
relate three or more detected peaks and some number of granular-mz. Finally, background
relationships are mers formed between features and the background peaks. All relationships were
searched, combining both positive and negative polarities.
Simple Annotations
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Isotope searches detected 64 monoisotopic features having isotopic support. This isotopic
support consisted of 101 isotopic features identified in 141 relationships. The remaining 289
features lacked isotopes, indicating low abundance or various types of detector noise. Fine isotopic
structure of analytes could be annotated below ~300 Da where resolution permitted.
Charge-aware search, as implemented in mz.unity, allowed for relationships between positive and
negative mode ions to be detected simply. These included relationships like [Glu-2H+K]1- + [2H]2+
= [Glu + K]1+. The charge-aware search also enabled the inclusion of a neutral mass, [Glutamate]0,
in the search and easy retrieval of all transformations of this specific mass. In targeted mining
approaches, the annotation search can be seeded with relevant analyte neutral masses for simple
compound spectra generation. Charge carrier searches between the 64 monoisotopic features with
isotopic support detected 104 relationships, 52 of which were cross-polarity relationships. (Figure
3A)
Ambiguous relationships have two interpretations that are indistinguishable by mass and charge
alone. These relationships can be drawn between two distinct analytes as well as analyte-fragment or
analyte-adduct pairs. We detected 91 ambiguous neutral losses corresponding to loss of [NH3]0 and
[H2O]0. Manual review of these ambiguous relationships suggested that each of these were true
neutral losses and not distinct analytes. Review consisted of evaluating chromatographic peak shape
and the elution time of the possible derivative analytes as well as fragmentation spectra of the
putative parent. An example confirmation was the relationship [Glu - H]1- - [H2O]0 = [128.0351]1-,
which was confirmed by using the fragmentation spectrum of a glutamate standard as seen in
Appendix 2.10. The automated resolution of ambiguous relationships is one of the challenges that
remains to be addressed by an automated annotation solution.
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Table 4.1.

Breakdown of types of relationships detected

Table 4.1.

Breakdown of common neutral losses detected

Unambiguous simple relationships included additional neutral losses and several adducts
common to this chromatography such as [CH3CN]0 and [SiO3H2]0. These relationships are
unambiguous as the fragments are rare and the related formulae are unlikely to coelute. Within the
454 features, 193 additional neutral relationships were detected. A breakdown of these neutral
relationships can be found in Table 2. This annotation of simple relationships reduced the 64
isotopically supported features to 34 feature groups.
Annotation thus far is similar to annotations provided by traditional rule tables. The only
extension we have provided at this point is the inclusion of charge-awareness that enabled the
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linkage of analytes from positive and negative mode as well as neutrals. We extend annotation
beyond the traditional annotation scope in the next section.
Mer and Distal Fragment Annotations
A novel set of annotated relationships included mers and distal fragments. Both of these
relationship types follow the same pattern relating three or more detected features (i.e., represent
complex relationships). This contrasts with approaches based on rule tables that are limited to two
detected features. The distinction between mer and distal fragment is in the interpretation, distal
fragments imply that the heavier feature is the original analyte while mers imply that the lighter
features are the original analyte. In the absence of tools to classify relationships as mers or
fragments, we have presented summaries of these searches.
Searching for analyte-analyte complex relationships asserted 420 relationships between 263
analyte peaks (analyte peaks include peaks from features and background). Examining these,
examples of both distal fragmentation and analyte-analyte adduction were seen. For example, a distal
fragment pair of NAD was found: [123.0553]1+ + [540.0536]1- - [H]1+ = [NAD-H]1- and confirmed
by MS/MS. The analyte-analyte adduct [Glutamate – H]1- + [NAD-H]1- + [H]1+ = [Glutamate +
NAD - H]1- was also detected (Figure 3B). The reduction of complex relationships into analyte
groups relies on classification of the relationship as mer or distal fragment. Accordingly, we cannot
present known analyte groups.
As described above, mass measurement error contributes to false positive peak relationships.
Combinatorial searching for peak relationships can rapidly exceed the specificity offered by the mass
accuracy of the technique. Ultimately, a solution to probabilistically evaluate each putative
relationship is needed for automated annotation. In the absence of this solution, we have manually
evaluated a portion of putative relationships to control for the possibility of false positives. Known
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constituents of the spectrum were checked for incorrect relationships. If the search produced a
significant number of false positive relationships, we expected to find these peaks implicated in
incorrect relationships. The peaks corresponding to glutamate and NAD had no false positive
relationships, indicating that in general these results are valid.

Figure 4.3. Visualizing the subset of peaks derived from analytes glutamate and NAD. A. After annotation of simple relationships. B. After annotation
of complex relationships. Peaks derived from the GluNAD heteromer are shown in the blue area. Each node is an m/z peak and each edge is a
detected relationship. This plot includes isotopes, heteromers, homomers, charge carriers, and neutral losses but omits fragments and
background mers. C. The spectral graph of B.
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Similarly, mers between analytes and background peaks were searched. Ideally, this search
should exclude the possibility of fragment relationships because fragments would appear as features.
In practice, some fragment features are detected but not recorded as features and thus enter the
background pool. For this reason, we again omit the generation of analyte groups. A search of
relationships with background peaks resulted in 474 relationships between 373 peaks. Of those 373
peaks, 129 were background peaks and 244 were features. We show an example of a background
mer relationship later. A summary of the detected relationships is shown in Table 3.
Fragment Annotations
To examine the ability of mz.unity to detect fragments, we collected the targeted fragmentation
spectrum of a neat NAD standard (Appendix 2.9). This obviates the possibility of mer formation
because only the NAD precursor m/z was experimentally selected by the quadrupole for
fragmentation. Fragment annotation is enabled by mz.unity’s charge-aware complex relationship
searches. Spectra from a variety of collision energies and both positive and negative polarity were
de-isotoped and combined into a composite spectrum consisting of 283 peaks (two of which were
the protonated and deprotonated parent peaks). Fragment relationships were detected within this
composite spectrum.
Mz.unity detected 404 pairs of fragmentation relationships (Figure 4A-B). These are pairs of
detected fragments that correspond to the two liberated portions of the parent ion (Figure 4A).
Interestingly, mz.unity’s charge-aware annotation is a major advantage for this type of search. In 250
of the detected fragment relationships, one fragment portion was detected in positive mode while
the second fragment portion was detected in negative mode (Figure 4C). We also evaluated how
intensity impacted the probability of finding both fragment halves. As expected, more intense
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fragments were more likely to result in a detected pair (Figure 4D). This implies that the number of
annotated fragments will be dependent on the sensitivity of the instrument.

Figure 4.4. Distal fragment searches. A. Schematic of NAD fragmentation resulting in two distal fragments. B. The fragmentation spectrum of NAD
and the pairs of distal fragments that sum to the positive and negative molecular ions. C. The number of fragment pairs detected in each polarity.
Most fragments were detected by combining positive and negative polarities. D. The portion of peaks with detected distal fragments at varying
intensity.

We supplemented the distal fragment search with several common fragments that were unable to
be detected on our mass spectrometer due to their low mass. In their neutral form, these were
[H2O]0, [NH3]0, [CO2]0, and [CO]0. The possibility of ambiguous relationships was excluded because
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this was a targeted MS/MS experiment omitting other analyte species. These common neutral
losses resulted in the annotation of 86 additional fragmentation relationships.
Of the original 283 peaks in the fragmentation spectrum of NAD, a combination of common
neutral loss and distal fragment annotation included 171 peaks (60% of all detected fragments). The
remaining fragments were both not in our list of common fragments and lacked a detectable distal
second half. Annotation of this type of fragment remains an open challenge to future annotation
techniques.
Annotation Summary
This work represents the most thorough annotation of a complex LC/ESI/MS spectrum to date
and has important implications for the analysis of metabolomic data. We show that commonly
occurring complex spectral relationships lie beyond the scope of previous annotation approaches.
Consequently, the amount of spectral degeneracy in mass spectrometry-based datasets has been
underestimated. The two analytes in this spectrum provide a somewhat contrasting picture of this
degeneracy. Both glutamate and NAD were of relatively high abundance with intensities of 1x109
and 3x108, respectively. Although they were present at similar intensities, glutamate produced 98
peaks and NAD only produced 23. The results presented here underscore the need for thorough
analysis of metabolomic datasets to ensure that the myriad of redundant peaks and noise sources do
not obscure relevant analytes.

4.3.2

Application to 2-Hydroxyglutarate Metabolism

Mz.unity enables the most complete annotation of metabolomic features to date. Although
additional work is required to implement mz.unity as an automated annotation solution on a
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comprehensive scale, even in its current form mz.unity provides a powerful resource for interpreting
LC/MS-based untargeted metabolomic data. In this section, we provide one brief example
application to highlight the utility of our mz.unity software package in processing untargeted
metabolomic results.
The metabolite 2-hydroxyglutarate (2HG) is known to accumulate in several types of cancer due
to gain-of-function mutations in isocitrate dehydrogenase 1 and 2.139–141 However, the biochemical
effects of 2HG accumulation are incompletely understood. We were interested in testing the
hypothesis that cancer pathogenesis might be at least partially mediated by the downstream
metabolism of 2HG.
We first needed to determine if 2HG is transformed into downstream products in cells. This
was accomplished by comprehensively tracking the transformation of uniformly labeled 13C 2HG
(U-13C 2HG) into downstream metabolites.142,143 From the thousands of features we screened by
untargeted metabolomics, we found 10 features that were greater than fivefold enriched with 13C
carbon compared to natural-abundance samples.
To investigate the identity of these 10 enriched features, we first analyzed the data with the ruletable based annotation package, CAMERA.86 CAMERA indicated that 6 of the 10 features were
adducts of 2HG, leaving 4 of the 10 features to represent biochemical transformations of 2HG.
Importantly, this result seemed to support the metabolism of 2HG into downstream products.
Therefore, we applied the conventional untargeted metabolomic workflow to identify these features
as unique metabolites. When the accurate mass and MS2 data did not match those in databases, we
began to explore the exciting possibility that these features might represent novel “unknown”
metabolites. Fortunately, before committing to this path, we further analyzed the data with mz.unity
to search for complex relationships and fragments. With mz.unity, we discovered that the remaining
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4 features were indeed complex adducts and fragments of 2HG (Appendix 2.11). The mz.unity
result fundamentally altered the conclusion of our experiment, showing that 2HG is not readily
metabolized in the cells we tested. This brief example illustrates how the mz.unity software package
can be used in untargeted metabolomic workflows to analyze and refine lists of potentially
interesting features.

4.3.3

Observed Failures of Current Annotation Assumptions

In-depth analysis of the aforementioned datasets revealed several assumptions made by current
annotation approaches that do not hold in practice. The application of these assumptions therefore
prevents the annotation of several relationships in our datasets.
EIC Correlation
Analytes detected by LC/MS techniques elute over sequential spectra with a Gaussian like
profile. A common assumption made by current annotation approaches is that related features will
have similar peak shapes. This similarity is commonly measured as the Pearson product moment
correlation (Pearson’s r) between the extracted ion chromatograms (EICs) of the two peaks. 10 Two
risks exist: high correlation and assertion of a relationship between unrelated peaks, and low
correlation and segregation of related peaks. We find both of these cases to be common in our
datasets. We present two cases in which related peaks exhibit low correlation.
Figure 5A shows three salt adducts of glutamate (Glu) that were annotated by mz.unity in our
dataset: [Glu-H]1-, [Glu-2H+Na]1-, and [Glu-2H+K]1- corresponding to m/z 146.0455, 168.0276, and
184.0015 respectively. The EIC of the deprotonated form exhibits a smooth peak shape typical of
our chromatography, but the EICs of both salt adducts exhibit a strikingly different profile. Each
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initially rise in tandem with the elution of the deprotonated form but quickly plateau. It is clear that
each of these salt adducts is related to the [Glu-H]1- peak, yet their correlation is far below useful
cutoffs (r of 0.59 and 0.53, respectively).144

Figure 4.5. Surprising annotation examples. A. The sodiated (middle) and potassiated (bottom) forms of glutamate exhibit different peak shapes than
the deprotonated form (top) (Pearson’s r of 0.59 and 0.53). B. Overlapping peaks glutamate and NAD (top) adduct to form a glutamate-NAD
mer (bottom). C. An artifactual peak (bottom) is formed from the adduction of glutamate (top) and a background peak that lacks a
chromatographic peak shape (middle). D. A single m/z peak with two charge states and two formulae. The base peak at 662 is comprised of
[NAD-H]- and [2NAD-2H]2- as evidenced by the annotated isotopic packet.

A second example of poor EIC correlation between related peaks occurs when two adducting
species elute at different times. This is the case in the adduction of glutamate and NAD to form the
GluNAD adduct. As can be seen in Figure 5B, glutamate and NAD have a very low correlation (r of
0.09) yet, these two ions are related through the glutamate-NAD mer (GluNAD). The heterodimer
GluNAD also does not correlate well with either of its parent species (r of 0.34 and 0.78,
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respectively). Interestingly, the convolution of the glutamate and NAD EIC traces exhibits strong
correlation with that of the mer (r of 0.97), suggesting a possible improvement to this test.
Importantly, when EIC correlation is used to group detected features prior to relationship detection,
the identification of relationships such as these is precluded.
Background Ions
Peaks lacking a chromatographic peak shape (i.e., background peaks) represent chemical species
that can be involved in the ionization process. Current annotation approaches consider only ions
displaying a chromatographic peak shape and in doing so they fail to annotate relationships that
involve background ions. Background ions have various sources including column bleed, previously
eluted compounds washing off the column, solvent impurities, and other contaminants. It is
important to emphasize that background ions contribute to detected features with chromatographic
peak shapes. As shown in Figure 5C, the adduction of a bonafide feature with a background ion
results in a feature with a peak shape. With current annotation approaches, this background-derived
artifact would be confused as an additional analyte during later processing. Annotation of this
feature is only possible when background peaks are considered during the annotation process.
The adducts in figure A and the background ion in figure C demonstrate characteristics of ion
suppression. This general term refers to the reduction in the intensity of a signal due to the presence
of other species. It is interesting to note that reduction in the signal of the background ion is not
necessarily due to the mechanisms traditionally thought to underlie ion suppression. Rather than
competition for charge or alteration of droplet dynamics an additional source of “suppression”
could be the scavenging of the monomer signal by other adduct signals. The result being that the
same number of species are ionized and detected, but the distribution of signal among masses is
altered. This is clearly visible in the background trace in which the signal of the mer necessarily
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takes signal from the background peak; notably this phenomena may also contribute to non-linearity
as peaks reach high intensities. The complexity of this type of ion suppression is further indicated by
the adducts in figure A. Adduct formation during droplet shrinkage is a dynamic chemical process
involving multiple species. As concentrations change over the course of analyte elution rates and
equilibria will also be altered. In the case of the salt adducts above it is possible that glutamate
sequestered all available salt or alternatively dimer formation became more favorable than the
monomer production. The link between adduct formation and ion suppression is worthy of further
study.
Charge-States Assignment
A mass spectral peak is generally taken to represent a single species. Figure 5D demonstrates that
this is not true in general but rather, it is possible to detect a single m/z peak which corresponds to
two distinct formulae. This is common in the case of multiply charged dimers. In the spectrum of
NAD found in Figure 5D, two distinct isotopic envelopes can be seen. The major pattern is the
result of [NAD-H]1-. The second pattern has spacing of (13C-12C)/2, representing a compound of
charge state 2-. This pattern is produced by the ion [2NAD – 2H]2-. The m/z of these two ions is
identical, 662.1020, but both species have a different charge state, different formulae, and therefore
different mass. The assignment of a single charge state can only explain one of the isotopic
envelopes. Full annotation requires the consideration of multiple charge states.

4.3.4

Future Directions

Increases in the mass accuracy and resolving power of mass spectrometers have enabled more
thorough analyses of metabolomic datasets. The tools described here, mz-sum and mz.unity,
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leverage these advances to provide a comprehensive list of possible spectral relationships. Still,
several relationship classes require information beyond mass and charge to make definitive
annotation assignments. Both ambiguous relationships and fragment/mer relationships have
multiple interpretations that cannot be distinguished based on mass and charge alone.
We see four distinct challenges remaining for an automated annotation solution: (i)
discrimination between distal fragments and adducts; (ii) discrimination between fragments and
distinct analytes; (iii) annotation of rare, non-distal fragments; and (iv) evaluation of confidence in
each asserted relationship. Metabolomic datasets offer many rich sources of information to tackle
these challenges. Peak intensity, chromatographic profile, mass decomposition, isotope pattern,
convolution of adduct constituent’s isotopic patterns, and the web of putative relationships are all
expected to offer predictive power in the context of these problems. Network based optimization
problems and probabilistic assessments have addressed similar problems like fragmentation tree
calculation and analyte identification with much success.126,131,145
A challenge distinct from annotation is the prediction of underlying neutral masses that give rise
to the spectrum. The web of annotated relationships and additional information sources can be
combined to assert the masses and identities of the untransformed analytes. These untransformed
masses are of interest for metabolite identification and data interpretation in the context of
biochemistry. Ultimately, an automated annotation solution will allow faster and more robust
metabolomic data analysis while also enabling reliable analyte identification.

4.4

Conclusions
Current approaches fail to annotate a significant fraction of relationships in mass spectrometry-

based datasets. We have shown that metabolites such as glutamate produce 100 or more spectral
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peaks, yet current approaches annotate only a fraction of these. This resulting peak degeneracy is a
major challenge to the further analysis of MS data, requiring time intensive manual curation and
increasing the number of false positive and misleading hits. Here we have presented mz-sum and
mz.unity, which provide a novel framework for assessing these complex mass spectral relationships
and enable identification of degenerate peaks that would not be found with current annotation
approaches.
Referring to relationships as mz-sums accurately represents any possible analyte transformation,
including complex and cross polarity relationships. Consideration of all possible analyte
transformations is critical to building thorough and robust dataset annotation tools for several fields,
including metabolomics.42 Here we have expanded upon the relationship approaches based on rule
tables by developing the mz.unity R package. While current annotation approaches are based on
common and universal transformations, the true set of possible relationships searched for by
mz.unity is much broader, encompassing both complex adducts and distal fragments. Mz.unity is
both a convenient tool for manual annotation and interpretation of mass spectra as well as a step
towards automated annotation of omic scale datasets.
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Chapter 5.

Credentialed Features: A Platform to Benchmark and Optimize
Untargeted Metabolomic Methods *

The aim of untargeted metabolomics is to profile as many metabolites as possible, yet a major
challenge is comparing experimental method performance on the basis of metabolome coverage. To
date, most published approaches have compared experimental methods by counting the total
number of features detected. Due to artifactual interference, however, this number is highly variable
and therefore is a poor metric for comparing metabolomic methods. Here we introduce an
alternative approach to benchmarking metabolome coverage which relies on mixed Escherichia coli
extracts from cells cultured in regular and 13C-enriched media. After mass spectrometry-based
metabolomic analysis of these extracts, we “credential” features arising from E. coli metabolites on
the basis of isotope spacing and intensity. This credentialing platform enables us to accurately
compare the number of nonartifactual features yielded by different experimental approaches. We
highlight the value of our platform by reoptimizing a published untargeted metabolomic method for
XCMS data processing. Compared to the published parameters, the new XCMS parameters decrease
the total number of features by 15% (a reduction in noise features) while increasing the number of
true metabolites detected and grouped by 20%. Our credentialing platform relies on easily generated
E. coli samples and a simple software algorithm that is freely available on our laboratory Web site
* This work is based on the following publication: “Credentialing features: a platform to benchmark and optimize untargeted metabolomic
methods”. NG Mahieu, X Huang, YJ Chen, GJ Patti, Analytical chemistry, 2014. NGM developed and evaluated the credentialing algorithm and ran
all LC/MS experiments. XJH and YJC provided data and insight during the development process.

94

(http://pattilab.wustl.edu/software/credential/). We have validated the credentialing platform with
reversed-phase and hydrophilic interaction liquid chromatography as well as Agilent, Thermo
Scientific, AB SCIEX, and LECO mass spectrometers. Thus, the credentialing platform can readily
be applied by any laboratory to optimize their untargeted metabolomic pipeline for metabolite
extraction, chromatographic separation, mass spectrometric detection, and bioinformatic processing.

5.1

Introduction
In the last chapter we attempted to understand the context of detected signals in order to remove

degenerate signal. This process, though, is unable to discern between analytes derived from the
sample under investigation and contaminants. In this chapter we implement the credentialing
algorithm, a strong experimental filter which removes contaminants and noise.

The objective of untargeted metabolite profiling is to assay as many endogenous small molecules
in a biological sample as possible.5 Mass spectrometry-based metabolomics represents an established
analytical platform that has been widely applied toward this goal and has already yielded many
fundamental biological insights.146–149 Nevertheless, experimental strategies to maximize the number
of metabolites profiled are still being developed.120,150,151 A major challenge in optimizing
metabolomic methodologies has been the difficulty in comparing the number of metabolites
profiled in each. Given that the size and identity of the complete metabolome is unknown, it is
currently not possible to assess metabolome coverage directly. Consequently, the most common
metric used to compare different experimental approaches has been the number of features detected
in a sample.87,88,120,152,153
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We show here that a method detecting a maximal number of features does not necessarily
provide the greatest metabolome coverage. We present a solution for the evaluation of untargeted
metabolomic method performance that enables us to distinguish between two types of features:
artifactual features and biologically derived features. Artifactual features are peaks in metabolomic
data that arise from contaminants, chemical noise, and bioinformatic noise. In contrast, biologically
derived features are peaks that arise from metabolites in the biological sample being analyzed. We
refer to the process of distinguishing artifactual features from features of biological origin as
“credentialing”. In the credentialing workflow (Figure 1), standard samples are prepared from
Escherichia coli grown in either natural-abundance media or uniformly 13C (U-13C) enriched media.
After performing metabolomic experiments utilizing the methods to be compared, our algorithm
finds and credentials features based on expected isotope-intensity ratios. This number of
credentialed features represents a more reliable metric of metabolome coverage than total feature
count because credentialed features are known to be of biological origin and hence are
representative of true metabolites. Upon optimizing our bioinformatic workflow by counting
credentialed features, we reduce noise features by 15% and increase properly detected and grouped
features by 20%. Further, we select several biological features for tandem mass spectrometry
(MS/MS) analysis without any prior knowledge of their identity or physiological significance. It is
important to emphasize that the credentialing platform described herein is not intended to identify
differences between various biological phenotypes (discovery profiling). Rather, the credentialing
platform is designed only to compare the performance of different untargeted metabolomic
methods. We provide a step-by-step protocol for performing credentialing with E. coli. While other
cell types could potentially be used, E. coli is a simple model system whose optimized results will be
applicable to the vast majority of metabolomic optimizations.
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Figure 5.1. Overview of the feature credentialing process. A sample is generated from two cultures of E. coli grown in parallel, one grown on naturalabundance glucose and a second grown on 13C-glucose as the sole carbon source. These two cultures are mixed in distinct ratios prior to
harvesting, here 1:1 and 1:2. Extraction and LC/MS analysis is then performed on the standard samples. The resulting data are searched for pairs
of coeluting peaks which satisfy the following requirements: (i) the intensities of the peaks must reflect the mixing ratio, (ii) the U-13C peak must
predict a feasible number of carbons for the mass in question, and (iii) the exact masses of the peaks must predict an integer number of carbons.
These requirements define a “credentialed space” in which the apex of a second peak must be found to qualify as an acceptable isotope. These
candidate peaks are then aligned and grouped between the two samples. Each peak pair is compared across samples and a second, stricter
intensity check is performed. This requires that the ratios of each sample (Ia12/Ia13 and Ib12/Ib13) are proportional to the mixed ratios of each
sample. Peaks that pass these filters are considered credentialed.
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5.2

Background
Metabolomic studies are complex, multistep experiments with a large number of parameters to

optimize. The choice of sample extraction, chromatography, and ionization method strongly
influences which metabolites are detected. Establishing protocols which survey the broadest number
of metabolites during untargeted profiling has received detailed attention in recent years.88,120,154–156
Previous studies have explored a multitude of experimental variations to improve global
metabolome coverage that include the addition of ammonium fluoride and ion-pairing reagents to
chromatographic mobile phases, separation strategies ranging from reversed-phase to hydrophilic
interaction liquid chromatography (HILIC), different mass analyzers such as time-of-flight and the
Orbitrap, and various informatic software solutions for subsequent data processing.84,88,156–158 The
extensive list of mutually exclusive experimental possibilities is confounding, particularly to scientists
just entering the field of untargeted metabolomics. Yet, to date, comparisons of different methods
have been impractical because there is no robust metric for performance evaluation.
Most published comparisons of mass spectrometry-based, untargeted metabolomic methods are
evaluated by counting the total number of features detected. A feature is defined as a peak in the
metabolomic data set with a unique retention time and mass-to-charge ratio. The number of features
detected depends on numerous factors including sample type, metabolite extraction protocols,
analyte separation, mass analyzer, and bioinformatic processing. For liquid chromatography/mass
spectrometry (LC/MS)-based metabolomics, it is common to detect thousands of features from a
biological sample. Importantly, a single metabolite often leads to many features159 due to: (i) isotopic
peaks from naturally occurring 13C, (ii) adduct formation such as hydrogen, ammonium, and
sodium adducts, (iii) neutral-loss fragments (loss of a hydroxyl group as water or a carboxylate as
carbon dioxide), (iv) other fragmentation (breakage at labile bonds such as esters), (v) multiple98

charge states, and (vi) chromatographic effects which result in a single metabolite eluting at more
than one retention time.
Informatic solutions have been established to annotate isotopes, adducts, and neutral losses in
untargeted metabolomic data sets86,157,160 Although these approaches are effective, they cannot
distinguish signals as endogenous or artifactual. Thus, even after data reduction, a subset of the
remaining features are likely the result of contaminants introduced during sample preparation,
carryover from previous experiments, chemical noise, or bioinformatic error. These highly variable
artifactual signals found in untargeted metabolomic data sets make it challenging to estimate the
number of true biologically derived metabolites that are assayed by a particular untargeted LC/MSbased metabolomic experiment. There is therefore a great need to develop a robust metric to the
evaluate performance of untargeted metabolomic methods.

5.3

Experimental Section
Our filtering process relies on the generation of standard samples derived from a mixture of E.

coli grown on 100% natural-abundance glucose and E. coli grown on 100% U-13C-glucose as the
sole carbon source. Two standard samples are required for the filtering process; these are generated
by mixing natural-abundance E. coli cultures and U-13C-glucose E. coli cultures at either 5 mL/5 mL
or 3 mL/6 mL ratios, respectively. The mixed E. coli samples are then extracted, yielding a standard
sample for analysis and optimization.

5.3.1

Materials
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U-13C-d-Glucose was purchased from Cambridge Isotope Laboratories Inc. (Andover, MA). E.
coli strain K12, MG1655 was purchased from ATCC (Manassas, VA). Lennox LB broth powder, 5×
M9 salts, and all LC/MS-grade solvents were purchased from Sigma-Aldrich (St. Louis, MO). Cell
culture was performed with ultrapure water provided by a Milli-Q system (Millipore).

5.3.2

Growth of E. coli Standards

Cultures were grown in a rotary shaker at 37 °C and 250 rpm. A preculture of E. coli was grown
in LB broth for 16 h. Prior to inoculation, 3 mL of preculture was pelleted and resuspended to
OD600 = 0.6 in M9 salts. M9 salts were prepared with the following concentrations in sterile
Erlenmeyer flasks: 6.8 g/L Na2HPO4·7H2O; 3 g/L KH2PO4; 1 g/L NH4Cl; 0.5 g/L NaCl; 240
mg/L MgSO4; 11 mg/L CaCl2. Salts were divided into two 100 mL aliquots, and to each aliquot, 2
mL of 20% glucose was added with a fresh-filtered syringe. The filter was rinsed with 2 mL of
ultrapure water to ensure complete transfer of glucose. One aliquot received U-13C-glucose and the
second received natural-abundance glucose. The M9 media was then inoculated with 1 mL of the
resuspended preculture per 100 mL of media. Cultures were grown to OD600 = 0.6, at which point
they were harvested as described below.

5.3.3

Harvesting of E. coli Standards

Upon reaching OD600 = 0.6, flasks were removed from the shaker and placed on ice. Appropriate
volumes of the 12C and 13C cultures were pipetted together into 15 mL centrifuge tubes, also on ice,
generating samples with ratios of 1/1 of 1/2 12C/13C culture. These mixtures established two distinct
ratios of 12C to 13C feature intensities that could then be used in our credentialing algorithm,
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described below. Cells were pelleted by centrifugation at 2000g for 10 min at 4 °C. The supernatant
was removed via pipet, and the cell pellets were snap-frozen in liquid nitrogen. In addition to the
mixed 12C and 13C cultures, natural-abundance (12C) cultures were used as controls. We refer to the
mixed samples as “labeled” and the natural-abundance extracts alone as “unlabeled.”

5.3.4

Metabolite Extraction

The mixed E. coli pellets were extracted as previously described.120 Briefly, cells were lysed by
three freeze–thaw cycles in 2/2/1 methanol/acetonitrile/water along with sonication and vortexing.
The soluble portion was then vacuum concentrated and reconstituted in 100 μL of 1/1
acetonitrile/water for LC/MS analysis.

5.3.5

LC/MS Analysis

The data shown herein were obtained from an Agilent 6540 UHD QTOF interfaced with an
Agilent 1260 Capillary LC. The column used for separation was a Phenomenex Luna NH2 (150 mm
× 1 mm, 3 μm). HILIC solvents were A, 95% water in acetonitrile with 10 mM ammonium
acetate/10 mM ammonium hydroxide (pH 9.8), and B, 95% acetonitrile in water. HILIC was
performed at 45 μL/min with the following linear gradient (minutes, %B): 0, 100%; 5, 100%; 45,
0%; 50, 0%; 51, 100%; 60, 100%. For all experiments, 5 μL of extract was injected. MS parameters
were as follows: gas, 300 °C 9 L/min; nebulizer, 35 psi 1000 V; sheath gas, 350 °C 11 L/min;
capillary, 3500 V; fragmentor, 175 V; scan rate, 1 scan/s.
To demonstrate the wide applicability of our credentialing approach to other metabolomic
platforms, we also analyzed our samples and subsequently validated correct credentialing with
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multiple chromatographic and mass spectrometric technologies. In addition to the Agilent QTOF,
we credentialed data from the Thermo QE, the AB SCIEX TripleTOF, and the LECO Pegasus GCHRT. Chromatographic methods we credentialed include reversed-phase LC and HILIC. Effective
parameters for credentialing each of these experimental platforms are listed in the Appendix 3.2.

5.3.6

Data Analysis

Analysis was performed with a custom filtering script that utilizes the XCMS84 and CAMERA86
R121 packages as well as the METLIN161 database. The script is available on our laboratory Web site
at http://pattilab.wustl.edu/software/credential/. The algorithm identifies features of biological
origin through two rounds of data filtering, as depicted in Figure 1. Prior to filtering, features are
detected from the MS raw data with the XCMS findPeaks.centWave algorithm. In the first round of
filtering, coeluting peaks within a single sample are assessed for potential isotopologue pairs
differing by [(n)1.003355/z] Da in mass, where n is a whole number, z is the ion’s charge, and the
constant is the mass difference between 12C and 13C. Upper and lower bounds of n for each m/z in
question were calculated from the distribution of mass per carbon number from the compounds in
ECMDB162 (E. coli Metabolome Database, Appendix 3.1). The ratios of the putative 12C and 13C
peak intensities are then evaluated. Each measured ratio that is not within a set percentage of the
mixture ratio of the 12C and 13C culture is disqualified. For credentialing, the default value of 400% is
effective.
The two filtered samples with distinct mixture ratios of 12C and 13C are then taken together for a
final round of filtering. Peaks from each sample are aligned and grouped. Surviving features found in
both samples are evaluated such that
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where xi is the 12C/13C mixing ratio of the ith sample, ri is intensity ratio (I12C/I13C) of the ith
sample, and e (ratio_tol) sets the acceptable tolerance for the intensity ratio relative to the mixing
ratio. This two-round intensity filter allows for features with varying 12C and 13C intensity ratios (due
to the kinetic isotope effect or carbon fixation of atmospheric CO2) to pass the relaxed first round
and stricter second round as long as their intensities vary systematically between samples. All passing
features are termed credentialed. Credentialed features are output as a summary table that includes
all U-12C peaks determined to be of biological origin.

5.4

Results and Discussion
Each step of the untargeted metabolomic workflow can introduce artifactual signals that are not

endogenous to the biological sample being analyzed. It is generally not possible to discriminate
features of biological origin from artifactual features a priori, and thus, artifactual signals significantly
complicate interpretation of untargeted metabolomic results. These artifactual signals can arise from
sample contamination during metabolite extraction, carryover from previous experiments,
background noise detected by the MS, or misannotation of data during bioinformatic processing.
While efforts are made to minimize artifactual signals, it is not possible to completely eliminate them
from the features list. We therefore attempted to filter out artifactual signals by using isotopic
signatures of cellular metabolism that are easily identified by informatic analysis. We utilized the
widely available and extensively characterized E. coli strain K12 to generate isotopically enriched
biological extracts. Two cultures were prepared in parallel, one containing 12C (natural-abundance)
glucose and the other containing 13C glucose as the sole carbon source in M9 minimal media. The
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cultures were mixed in defined ratios and processed through the metabolomic workflow together.
By searching the resulting features list for pairs of unlabeled and fully labeled isotopologues and
comparing their intensities to the values expected from the culture volume ratios, signals of
biological origin can be distinguished from artifactual ones. The output of the approach is a list of
credentialed features arising from the biological sample of interest. These features reflect the extent
to which the methodology employed was able to capture the metabolome.
The power of stable isotope labeling in conjunction with mass spectrometry has long been
leveraged to improve quantitative measurements. Mixing labeled and unlabeled samples has proven
to be an effective approach to perform quantitation in proteomics,163–165 and similar approaches have
recently been extended to metabolomics.166 Mashego et al. developed “mass isotopomer ratio
analysis of U-13C labeled extracts” (MIRACLE) in which U-13C labeled metabolites obtained from
yeast grown in defined culture medium are mixed with unlabeled sample extracts to improve
quantitation.167 More recently, an innovative variation of 12C–13C metabolite mixing was developed in
which cells are grown in either 5% or 95% randomly enriched 13C glucose. This experimental
strategy, termed isotopic ratio outlier analysis or IROA, leads to a diagnostic isotopic pattern for
naturally occurring compounds that can be used for quantitation and metabolite identification
during untargeted profiling.90,168 Here, we introduce another experimental approach which involves
mixing 12C and 13C metabolic extracts. We then use the unique isotopic signals that result from the
metabolic transformation of the label as a mechanism to identify features of biological origin.

5.4.1

Contrasting the Credentialing and IROA Platforms

It is worth distinguishing IROA from our credentialing approach. Fundamental to the distinction
is that mixing a natural-abundance sample with a U-13C labeled sample in a single ratio does not
104

provide a specific enough signature to effectively discriminate features of biological origin from
artifactual features. IROA introduces additional specificity to the isotopic pattern by enriching one
sample with 5% 13C and a second sample with 95% 13C, instead of using natural-abundance and U13C samples. In contrast, credentialing introduces additional specificity to the isotopic pattern by
mixing different ratios of natural-abundance and U-13C samples. In credentialing, one sample is
made by mixing natural-abundance and U-13C cells at a ratio of 1/1 and a second sample is made by
mixing natural-abundance and U-13C cells at a ratio of 1/2. There are experimental benefits of each
approach that make the platforms better suited for each of their unique experimental applications.
IROA has been used to identify and quantitate differences between biological phenotypes during
untargeted profiling. Given that the relative ratio of any given peak between biological phenotypes is
unknown during untargeted profiling, the credentialing strategy based on defined ratios is
incompatible with this type of discovery analysis. The objective of credentialing, on the other hand,
is to identify features of biological origin exclusively from standard E. coli samples. While IROA
could be used for this purpose in principle, the credentialing platform is not constrained by the aim
of discovery analysis and therefore offers several advantages. First, media needed to produce labeled
E. coli samples for credentialing is easily synthesized in any laboratory, whereas IROA media can
only be obtained commercially. Second, the credentialing platform is better suited to identify lowintensity features of biological origin. In IROA, the signal intensity of any given metabolite is shifted
away from the U-12C peak and the U-13C peak as a function of carbon number. For a metabolite
with 10 carbons, as an example, 50% of the signal intensity is lost from the U-12C peak or the U13C peak. This decrease in signal intensity prevents low-abundance E. coli derived metabolites that
are detected in unlabeled samples from being detected with IROA. Because the credentialing
platform only uses natural-abundance and U-13C samples, it is not subject to this limitation. Indeed,
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detection of low-abundance metabolites is of particular importance when optimizing metabolomic
methods as these compounds are the most challenging to measure, but can be of great biological
importance. Finally, because credentialing only uses E. coli samples, the analysis of the resulting
isotopic data can exploit the known relationship between mass and carbon number derived from
ECMDB (Appendix 3.1).

5.4.2

Parameters for Credentialing

To accomplish the filtering of artifactual signals, we created a simple R package. The core
function, credential(), has several adjustable parameters allowing various chromatographic and
instrumental platforms to be credentialed. These parameters include (i) iso_ppm, the ppm tolerance
when searching for 13C isotopes, (ii) iso_rt, the retention-time window in which a peak and its
isotope must elute, (iii) mix_tol, the tolerance for the intensity ratio of the 12C and 13C peak, (iv)
ratio_tol, the tolerance for the ratio of the intensity ratios between two samples, and (v) mpc_tol, the
tolerance for compounds with unusually high or low mass compared to the number of carbons they
contain. (Details concerning the calculation of mass per carbon based on the ECMDB can be found
in Appendix 3.1.)
We have determined effective parameters for reversed-phase and hydrophilic interaction liquid
chromatography as well as for the Agilent QTOF, Thermo QE, AB SCIEX TripleTOF 5600+, and
the LECO Pegasus GC-HRT. These parameters have been experimentally validated and are listed in
the Appendix 3.2.
Evaluation of the filtering effectiveness was accomplished by comparing the number of
credentialed features found in unlabeled and labeled extracts. In addition to the labeled extracts,
natural-abundance (unlabeled) extracts were generated as controls. An unlabeled extract should have
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no credentialed features if it is not mixed with a labeled extract. Therefore, the number of passing
features in an unlabeled extract represents the false positive rate. Initial experiments indicated that
filtering based on a single mixed-extract sample was not sufficiently selective to remove the majority
of artifactual peaks. We found that a two-sample, relative-intensity filter was most effective. As
shown in Table 1, this filtering process is selective. The process credentialed only 0.6% of the
negative-control features, whereas 9% of the 12C/13C mixture features were credentialed.

Table 5.1.

A summary of the results of the credentialing process after being applied to several different data sets. The rows labeled “no

injection” and “extraction blanks” represent credentialed peaks due to carryover from previous credentialing runs. Natural-abundance E.
coli is a negative control that estimates the false positive rate of the credentialing process.

To further validate the filtering process, we examined the natural isotopic peaks that were
credentialed in our 12C/13C sample. Consider that in a 12C sample many peaks will contain a
natural-abundance M + 1 peak which by definition satisfies the mass requirement to be an isotope.
The filtering process credentials some of these natural isotopes along with the monoisotopic peak.
These are easily detected and removed by established deisotoping methods, but these peaks allowed
us to assess how often an M + 1 is credentialed when the M + 0 is not. If this occurs often, it would
indicate that the algorithm is inappropriately disqualifying features. We detected 385 credentialed
natural isotopes in our mixture sample. Out of the 385 credentialed, natural isotopes only one did
not have a corresponding U-12C in the final credentialed features list. This indicates the filtering
approach is performing reliably.
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5.4.3

Application: Reoptimization of a Previously Published XCMS Method

With an established method to credential features as biological in origin and exclude various
noise sources, we set out to optimize our XCMS-based informatic workflow. XCMS is a widely used
informatic package suited for the analysis of untargeted LC/MS data sets. The general XCMS
workflow involves peak finding, peak grouping across samples, and retention-time alignment.
Settings for each step in this process affect the quality of features returned and therefore the overall
performance of the untargeted metabolomic workflow. For example, we found that settings for peak
picking that cause the annotation of spurious noise peaks as features lower the quality of peak
grouping and retention-time alignment (data not shown). Further, using poor grouping parameters
can lead to XCMS splitting a single peak into multiple groups, thereby resulting in erroneous
statistics.
To generate data for XCMS optimization, a previously published method was replicated.120 The
same LC/MS system, extraction method, and chromatography protocols were utilized as published
and described in the Experimental Section. When processing the data, however, we varied several
parameters of the XCMS functions findPeaks.centWave(), group(), and retcor(). As the filtering
depends on each of these functions, the final number of credentialed features is representative of the
quality of XCMS data processing. Previous approaches to optimizing untargeted metabolomic
parameters such as these have relied on counting the total number of features detected. Here, we
applied our filtering approach to instead count the number of credentialed features and use this as a
benchmark for parameter optimization. Our results show that the published method parameters
based on total number of features are suboptimal (Table 2). The published parameters do return a
greater number of total features, but the number of features of biological origin accurately detected
and grouped is substantially lower with these settings. These data highlight that a larger feature
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number does not necessarily indicate better metabolome coverage and therefore an improved
untargeted metabolomic method.

Table 5.1.

Parameters used and the results of each step in the optimization process are shown. Published parameters were taken from a

previously published method. The column labeled “with optimized peak finding” shows results for the optimization of
findPeaks.centWave().

Reoptimization of XCMS parameters resulted in a substantial improvement. Our XCMS
parameters led to an increase of 20% in credentialed features (an increase of 342 features), while
reducing the total number of features by 15% (a decrease of 4750 features). Parameters for
findPeaks.centWave() were determined to be the most critical to the analysis, while further
optimization of group and retcor qualified only an additional 41 peaks. It is notable that, prior to
optimizing findPeaks.centWave(), optimization of group() parameters increased the number of
credentialed features, partially overcoming the negative impact of artifactual signals.

5.4.4

Characterizing Features in Untargeted Metabolomic Data Sets

To translate metabolomic data into biochemical insight, the features generated in a typical
untargeted experiment must first be structurally characterized. The standard workflow for
structurally characterizing features requires matching MS/MS data of the features of interest to the
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MS/MS data of authentic standards. Identifying features is the most time-demanding step of the
untargeted metabolomic workflow and is generally performed in a targeted manner. That is, MS/MS
data are only acquired and interpreted for a handful of features determined to be interesting, usually
on the basis of statistical thresholds. While this worfklow is often applied to identify tens of
metabolites in a metabolomic study, attempting to identify each of the thousands of features
detected in a typical sample with this approach is impractical. New technologies to reduce the time
required to establish metabolite identifications are an active area of research, but high-throughput
methods to structurally characterize metabolites are not widely available. Moreover, many of the
MS/MS data are challenging to interpret. When the MS/MS pattern of a feature does not match any
of the MS/MS patterns in metabolite databases, it is difficult to determine if the MS/MS data
correspond to an unknown metabolite or merely MS/MS data from an artifactual feature.
The feature credentialing approach offers a mechanism to rapidly filter features that should not
be pursued for identification, namely, those features that do not correspond to signals of biological
origin. When we applied credentialing to E. coli extract, we reduced the number of features that
represent candidates for MS/MS from 23 567 to 2192. The resulting subset of credentialed features
can be targeted for MS/MS analysis with standard workflows. As an example, we performed
targeted MS/MS on 250 compounds in a single experimental run. These data illustrate that MS/MS
experiments could be performed on every feature of biological origin over a minimal and feasible
number of analytical runs. Select data are presented in Figure 2A–C. The MS/MS data collected on
these features were matched to the METLIN metabolite database and resulted in the identification
of three metabolites: uracil, ADP (adenosine diphosphate), and UDP-GlcA (uridine diphosphate
glucuronic acid). MS1 spectra and chromatograms for these compounds can be found in Appendix
3.3.
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Figure 5.2. MS/MS spectra from six representative credentialed features. MS/MS spectra were collected at four collision energies (0, 10, 20, and 40 V)
on six credentialed ions. Three of these ions (A) uracil, (B) ADP, and (C) UDP-GlcA were identified based on accurate mass, carbon number,
and METLIN database hits. These identifications were confirmed by comparing the experimental MS/MS spectra to the METLIN MS/MS
reference spectra as shown. The upper spectrum of each plot is the experimental data, and the lower spectrum is the METLIN reference data.
Unmatched peaks are depicted in red. The second three ions (D) 578.0093, (E) 1169.3011, and (F) 848.7473 were classified as unknowns as they
did not match any METLIN database entries as either a fragment or parent mass. The MS/MS spectrum of each ion is displayed as normalized
intensity at the same four collision energies.

In addition to generating MS/MS data for metabolites included in databases, it is possible to
reliably generate MS/MS data on biological peaks which currently cannot be annotated by
metabolomic databases. Because credentialed features have passed our filtering rounds, we know
that they are true metabolites of biological origin even if they do not return any database hits. Of the
1827 credentialed features, 392 were not found in METLIN or the METLIN fragment databases.
Three such example features are seen in Figure 2D–F. Previously these features may have been
discarded as artifacts, but the credentialing platform provides confidence in their authenticity such
that they can be reported and referenced in future experiments.
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5.5

Conclusion
The feature credentialing strategy presented here is a powerful platform to discriminate biological

features from the various noise sources prevalent in untargeted metabolomic data. The process is
experimentally straightforward and can be easily implemented in any metabolomic laboratory.
Feature credentialing reliably removes artifactual features such as those arising from chemical and
informatic noise, thereby resulting in a valuable list of features of biological origin. These
credentialed features address many of the drawbacks associated with feature counting in comparing
method performance on the basis of metabolome coverage. As such, counting credentialed features
can be used in the development and optimization of untargeted metabolomic approaches as
demonstrated by the reoptimization of XCMS parameters. Credentialing features is also an effective
data reduction strategy for untargeted metabolomic results such that a smaller number of peaks can
be targeted for MS/MS analysis. In summary, the feature credentialing platform introduced here
represents a step toward defining optimal untargeted metabolomic platforms and provides a
standard metric to facilitate collaboration between different metabolomic laboratories.
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Chapter 6.

Contextual Annotation of Metabolomics Data Reduces 25,000
Features to Less than 1,300 Metabolites *

When using liquid chromatography/mass spectrometry (LC/MS) to perform untargeted
metabolomics, it is now routine to detect tens of thousands of features from biological samples.
Poor understanding of the data, however, has complicated interpretation and masked the number of
unique metabolites actually being measured in an experiment. Here we place an upper bound on the
number of unique metabolites detected in Escherichia coli samples analyzed with one untargeted
metabolomic method. We first group multiple features arising from the same analyte, which we call
“degenerate features”, using a new contextual annotation approach. Surprisingly, this analysis
revealed thousands of unexpected degeneracies that reduced the number of unique analytes to
~2,961. We then applied an orthogonal approach to remove non-biological features from the data
by using the 13C-based credentialing technology. This further reduced the number of unique analytes
to < 1,000. Accurate mass, retention time, and MS/MS fragmentation data as well as annotations of
credentialed features can be freely browsed and downloaded from the creDBle database
(http://creDBle.wustl.edu).

* NGM ran all LC/MS experiments, extended mz.unity to full datasets, developed the creDBle database, and
catologued credentialed features.
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6.1

Introduction
It has become increasingly popular to perform untargeted metabolomics by using liquid

chromatography/mass spectrometry (LC/MS). This is at least in part due to the large number of
signals or features that are typically detected from most biological samples.169–171 While it is often
assumed that these tens of thousands of detected signals provide "global" coverage of the
metabolome, the exact number of metabolites being measured in an experiment has not been
rigorously assessed. The major barrier preventing this type of analysis has been the challenge of
identifying metabolites40. To date, the overwhelming majority of the detected signals in any one
untargeted metabolomics experiment have not been named. Even comprehensive efforts to identify
as many metabolites as possible in a data set by using the most advanced informatic resources
currently available have resulted in relatively small percentages of the total number of signals being
identified.92,172,173 Thus, the basic question of how many unique metabolites are being profiled in an
untargeted metabolomics experiment has remained outstanding.
It is important to note that uncertainties related to experimental coverage have not prevented the
widespread application of the untargeted metabolomics technology. Improvements in
instrumentation and software have made performing untargeted metabolomics with LC/MS
relatively routine.1 Accordingly, the number of research cores offering LC/MS untargeted
metabolomics services has increased dramatically over the last decade.174 The conventional
workflows used by most research facilities, however, essentially sidestep the issue of experimental
coverage.175 Their experimental output is a long list of signals or features, without thorough
annotation. The data sets are either mined in a targeted fashion for specific metabolites with known
retention times and fragmentation patterns, or only the small subset of signals that have a statistically
significant difference between sample classes are further investigated.98 For many of these signals
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altered between sample classes, further investigation does not lead to identification because their
accurate mass and fragmentation patterns do not match the accurate mass and fragmentation
patterns of any known reference standard in metabolomic databases.113 Although it is common to
refer to these unmatched signals as "unknowns", rarely is such a designation justified. Signals
associated with contaminants, artifacts, and many adducts also do not return matches from
metabolomic databases. These possibilities and others must be ruled out before gaining confidence
that a signal is a bonafide, unique metabolite with an unknown structure.
The number of signals or features in an LC/MS-based metabolomics data set that result from the
combination of contaminants, artifacts, and degeneracies (such as complex adduct formation) has
not been comprehensively evaluated. We speculated that these may represent an underestimated
portion of signals in untargeted metabolomics data. The goal of the current study was to quantitate
contaminants, artifacts, and degeneracies in order to get an upper estimate of the number of unique
metabolites detected in a representative LC/MS-based metabolomics experiment. For the purposes
of this work, contaminant refers to a detected signal that does not originate from the biological
sample being measured (e.g., solvent impurities and plastic leechables). Artifacts refer to features
detected due to informatic error. As an example, artifacts can be caused by baseline fluctuations and
poorly resolved components.176,177 Finally, degeneracy refers to multiple signals arising from a single
analyte. There are many causes of degeneracy including: fragmentation, analyte adduction with
various charge carriers (e.g., a proton, sodium, potassium, etc.), and the detection of naturally
occurring isotopes (e.g., 13C, 15N, etc.)3 A final, largely under-annotated source of degeneracy is the
adduction of an analyte with other species present, including other analytes or the chemical
background.
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Although some degenerate relationships are well known and commonly annotated, the
prevalence of many degenerate relationships has not been previously estimated.86 Here we introduce
and apply an approach that recovers relationships implied by the experimental data, rather than
relying on a hypothetical predetermined list. The approach allows for more comprehensive
annotation, especially in the case of under-annotated adducts that may be specific to a single
laboratory or experiment. To the best of our knowledge, the algorithms introduced below are the
first to assess these degeneracies.
In this work, we have focused on Escherichia coli cells that were extracted and analyzed with a
representative untargeted metabolomics method. In positive-ion mode, we detected 25,230 highquality metabolomic signals or features. Strikingly, we found that more than 90% of these detected
signals were due to contaminants, artifacts, and degeneracy. These results have important
implications for the experimental coverage of untargeted metabolomics, which influence the design
and interpretation of discovery profiling experiments. Our data indicate that caution should be
employed when evaluating unidentified features from metabolomic data sets at the systems level.

6.2

Results and Discussion

6.2.1

Generating a representative untargeted metabolomic data set

In untargeted metabolomics, signals are often referred to as features, a convention we will follow
here. A feature is a detected ion with a peak shape, unique m/z, and retention time. To estimate the
number of unique analytes detected in a representative untargeted metabolomics data set, we set out
to annotate three types of features: (i) degenerate features, (ii) contaminant features, and (iii)
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artifactual features. We annotated degenerate features by using mz.unity and a new contextual
approach to find degeneracies implied by the data. We annotated contaminant features and
artifactual features by using the credentialing approach (Mahieu et al., 2014). A requirement of the
credentialing approach is uniform 13C-labeling. Given that there are convenient and well-established
methods to culture E. coli on a uniformly labeled carbon source, we chose to focus our work on E.
coli.
Metabolites from E. coli cells were extracted and analyzed with an LC/MS-based untargeted
metabolomics platform, as detailed in Methods. In brief, metabolite extraction was achieved by
using a combination of methanol, acetonitrile, and water. Extracted metabolites were separated with
reversed-phase chromatography prior to being analyzed in positive polarity by a Q Exactive Plus
mass spectrometer. These experimental methods (or variations thereof) are commonly applied in
untargeted metabolomics.178–180,120 To process the resulting LC/MS data, we employed a custom
informatic workflow (Figure 1). The workflow used an iterative, two-phase peak detection process.
An in-house model-based feature detection algorithm was run on each of five individual replicates.
Many of the resulting features are inconsistent between replicates due to subtle differences in the
chromatograms from each file. It is common for some peaks to go undetected, or some peaks to be
integrated differently between runs.2 These errors make further analysis challenging because a oneto-one feature grouping cannot be specified between replicates, and the established groups contain
artificial variation in feature areas. To refine the features detected in the five replicates, we utilized
the Warpgroup algorithm.2 Warpgroup considers all files in concert to identify “consensus features”,
a set of feature integrations supported by all replicates. The result is a near one-to-one matching of
features between samples (Figure 2A-B) and decreased variation introduced by informatic
processing (Figure 2C-D). The Warpgroup refined feature detection is highly sensitive, allowing the
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recovery of features that, when processed in isolation, would be challenging to detect (Figure 2E).
Here, we retained only features with a signal-to-noise ratio >5 and a coefficient of variation <0.5
after Warpgrouping. This resulted in 25,230 high-quality features in our representative data set.

Figure 6.1. Our informatic workflow. Raw data were processed with in-house algorithms to first identify high-quality, consensus features (i.e.,
recurring features between replicates) and discriminate against processing artifacts. This consensus data set was further characterized by mz.unity
(to estimate signal degeneracy) and credentialing (to estimate contaminants and artifacts). The resulting annotated data set was catalogued in the
creDBle database.
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Figure 6.2. An overview of the consensus data set. (A) The base peak chromatogram of a representative run. The number of features detected during
each second is overlaid. (B) The number of features detected in each group before (pink) and after (green) Warpgroup. Inconsistencies are
resolved by Warpgroup. (C) The within group CVs of peak areas is decreased by Warpgroup. (D) The within group CVs of peak width are
decreased by Warpgroup. (E) Several representative features detected by the informatic workflow. The estimated baseline is plotted in red.
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We note that there is no universally accepted experimental platform for untargeted metabolomics
at this time. The extraction techniques, chromatography, mass spectrometers, and peak detection
algorithms used vary between laboratories and are often multiplexed.181,182 However, it is routine to
detect tens of thousands of signals from a biological sample in most LC/MS experiments.77,183 Our
detection of 25,230 consensus features from five replicates resulted in a data set with complexity
that is typical of an untargeted metabolomics experiment.

6.2.2

Simple annotations

As a first step to place an upper bound on the number of unique metabolites detected in our
experiment, we performed a background subtraction. Specifically, we filtered features that were not
at least two-fold higher than the signal detected in extraction blanks. These features represent
contaminants or artifacts that are introduced during the sample extraction or data-processing steps.
This reduced our list of 25,230 features to 12,797 (Figure 3A).
Next, we set out to annotate degenerate features (i.e., those features arising from the same
analyte). We started our analysis by identifying simple relationships that are already commonly
annotated in untargeted metabolomics.86,126,184,185 This included degeneracy due to carbon and other
isotopes as well as common adducts and neutral losses. Annotations were made by using mz.unity,
and degenerate features were grouped together.3 Because features within the same group arise from
the same analyte, the number of “feature groups” provides a much better estimate of the maximum
number of unique analytes detected in an experiment than the number of total features (Table 1 and
Figure 3 B-C). In our subsequent descriptions, we will therefore transition from counting features to
counting feature groups. A feature for which no degeneracy has been identified constitutes its own
feature group, which we refer to as a singlet. Figure 3B shows the progressive decrease in the
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number of feature groups as isotopes, common charge carriers, and common neutral losses are
annotated.
Table 6.1.

A breakdown of the analyte number observed after each annotation step.

Stage
Blank Subtracted
Isotopes
Charge Carriers
Neutral Losses
Multimers
Commons n>200
Commons n>50
Background

Groups with more than one feature
All Features
Credentialed
Features
0
0
3986
1066
3620
1137
3640
1174
3400
1117
2809
1063
2149
864
1673
659

Singlets
All Features
Credentialed
Features
12797
2462
5071
1326
4384
992
3678
790
3381
712
2472
495
1620
353
1288
233

When isotopes, common charge carriers, and neutral losses are annotated, the number of feature
groups decreases from 12,797 to 7,318. We note that currently employed annotation approaches end
here with the identification of simple relationships (see vertical line in Figure 3B). These results
might suggest that there are as many as 7,318 unique analytes detected in the sample, but two
observations suggested that much degeneracy still remained unannotated in our E. coli data set.
First, about 50% of our feature groups still contain only a single feature (i.e., singlets with no
detected relationships). Although in some cases singlets result from low-abundance analytes with no
natural isotopes detected above noise level, the prevalence of singlets suggested that additional
relationships remained unannotated. Second, we also know that the set of relationships annotated
thus far are only a small subset of the possible degeneracies. A recent targeted study of glutamate
demonstrated that many additional, complex sources of degeneracy can exist in LC/MS-based
metabolomics.3 Glutamate was found to produce over 100 spectral peaks and exhibited complex
adduct formation. Our objective was to comprehensively characterize these additional sources of
degeneracy within our E. coli data set.
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Figure 6.3. Plotting the maximum number of unique analytes detected throughout the steps of our annotation process. (A) Removal of features
occurring in the blank. (B) Features are grouped as additional relationships are annotated. This reduces the maximum number of unique analytes.
When a feature group contains multiple features, it is shown in green. When a feature group contains only a single feature (i.e., is a singlet), then
it is shown in pink. Relationships from left to right: no relationships; isotopes; charge carriers; neutral losses; complex dimers (homo and hetero);
frequent intrinsic relationships; situational adducts (background). (C) Similar annotation of features that were credentialed.
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6.2.3

Homo and hetero multimers

We then expanded our search for degenerate relationships to complex adducts (i.e., two or more
species non-covalently bound to one another, such as dimers, trimers, etc.). Our search included
analytes adducted with themselves (homo-relationships), as well as analytes adducted with different
analytes (hetero-relationships). We considered all coeluting features as potential multimer partners
evaluating all [m, z] values as possible adduct formers. The charge state was specified based on
observed isotopes, or assumed to be a charge state of 1. As our conditions generally form ions with
a single charge, we balance the +2 charge from the observed ions with the loss of a proton [1.00783,
+1] for each multimer. Thus, a complex hetero-relationship between three detected features will
satisfy: [m1, z1] + [m2, z2] – [1.00783, 1] = [m3, z3]. Grouping these detected complex adducts
reduced the number of feature groups in our data set to 3,400 (see “multimers” bar in Figure 3B-C).
Frequent intrinsic relationships show previously unannotated degeneracy
All current annotation approaches in untargeted metabolomics face the major challenge of
determining the specific relationships to search for. While some relationships are well known and
occur ubiquitously (such as the commonly annotated sodium or potassium adducts), constraining
annotation to only these is significantly limiting. Other degenerate relationships are specific to
experimental methodologies or the materials and reagents used during the analysis. Since there is no
way to determine these relationships a priori, they have gone unannotated to date. Here we
introduce an informatic approach to find data set wide, experimentally unique relationships that are
implied by their context in the data. We then estimate their prevalence within our E. coli data set.
Common adducts and fragments will always coelute with the original analyte and will occur
multiple times throughout the run.3 We leverage this fact and recover “frequent intrinsic
relationships” by performing a frequency analysis of mass differences between all pairs of features
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eluting within one second of each other. Unrelated but coeluting analytes will exhibit mass spacing
that is random and, as such, will not be enriched in the frequency distribution. Thus, frequently
occurring mass differences represent probable degenerate relationships. Mass differences were
calculated assuming a charge state of 1, a simplification that limits the analysis to relationships that
do not include a charge-state conversion. A Gaussian kernel density estimation was performed on
the observed mass differences with a bandwidth of 0.00001 Da (our observed scan-to-scan mass
error) (Figure 4A). The heights of the local maxima represent the frequency and mass dispersion of
each mass difference. Mass differences that are frequent and similar in mass will have large density
estimates. The 24 most frequently observed mass differences are listed in Table 2.

Table 6.2.

Recovered frequent intrinsic relationships. Not all recovered relationships shown were used in the annotation. The local

maxima of the density ordered by number of occurrences. These frequently occurring differences are good candidates for peak
relationships. Several well-known relationships are present, including alternative charge carriers at the top of the list.

Δ Mass
21.9820
4.9554
23.0760
18.0107
17.0266
28.0314
45.0580
14.0157
65.1230
87.1046
42.0470
44.0262
39.9926
7.1020
15.9740
70.0783
29.0518
36.0713
15.9949
1.9967
56.0627
12.9952
35.0373
20.9292

Δ Charge
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Density
60.4
55.2
33.6
32.5
30.5
26.7
23.4
23.2
19.6
18.2
16.6
15.3
13.3
13.1
13.0
12.5
11.6
11.3
10.1
9.3
9.3
8.7
8.7
8.5
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Known Species
gain:H+ loss:Na+
gain:NH4+ loss:Na+
loss:H2O
loss:NH3
C2H4
C2H7N
CH2
C5H13N
C3H6
C2H4O
C2O
gain:K+ loss:Na+

gain:k41 loss:k39

gain:NH4+ loss:K+

Figure 6.4. Detection of frequent intrinsic relationships. (A) The Gaussian kernel density of all pairwise peak relationships in the data set. Inset is a
zoomed-in section around 14 Da. Known relationships are labeled with a formula. Unknown relationships are labeled with mass and charge
transitions [m, z]. (B) Peak pairs of the recovered frequent intrinsic relationship [23.0760, 0] plotted in mass/charge and retention time (points).
Line segments connect pairs with the specified spacing.
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The effectiveness of the approach was confirmed by the recovery of two commonly known
relationships as the most frequent relationships in our data set: the exchange of H+ and Na+ and the
exchange of Na+ and NH4+. This result indicated that the analysis of frequent intrinsic relationships
offers novel insight into the nature of features detected in metabolomic data sets. Notably, the
approach returned a multitude of relationships that had not been included in our prior searches.
These commonly occurring relationships are likely adducts or fragments, and may be specific to our
sample or experimental equipment/materials. Figure 4B shows the peak pairs observed with mass
difference [23.0760, 0] throughout the data set.
We recognize that the recovery of frequent intrinsic relationships can also return relationships
between commonly coeluting, non-degenerate analyte pairs. Fully saturated and partially unsaturated
lipids, for example, commonly coelute and have a mass difference of [2.0156, 0] (H2) (Han et al.,
2012). We observed 176 occurrences of such a mass difference in our experiment. To minimize the
risk of grouping unrelated features, we removed relationships with mass differences smaller than 15
Da and we applied two frequency cutoffs to illustrate the possible range of degeneracy. The
conservative cutoff annotated and grouped frequent intrinsic relationships occurring more than 200
times (see bar labeled “commons n>200” in Figure 3B-C), while the aggressive cutoff annotated and
grouped frequent intrinsic relationships occurring more than 50 times (see bar labeled “commons
n>50” in Figure 3B-C). The inclusion of frequent intrinsic relationships in our data set annotation
reduced the number of feature groups to 5,281 or 3,769, depending on the cutoff.

6.2.4

Situational adducts due to background ions contribute significantly to degeneracy

To further expand the scope of our annotation, we considered a source of adduct ions that are
present throughout the run: the chemical background. These ions lack a chromatographic peak
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shape, but they are detected throughout the experiment due to the ionization of solvents, their
additives, or any contaminants present. Because the background ions coelute with every feature, it is
reasonable to expect that they will produce many adducts. We refer to adducts between analytes and
other presently observed species (such as background ions) as “situational adducts”.
A low-mass spectrum was collected, deisotoped, and background ions appearing at intensities
higher than 200,000 were used as potential participants in situational adduct formation (Figure 5).
Annotation of the identified situational adducts reduced our number of feature groups to 2,961 (see
bar labeled “background” in Figure 3B-C). This significant reduction in feature groups indicates that
background ions are indeed a major source of feature inflation in our experiment. We also note that
annotation of situational adducts reduced the number of feature groups containing only a single
feature (i.e., singlets) to 1,288.

6.2.5

Background ions give rise to some frequent intrinsic relationships

Some frequent intrinsic relationships that we detected are indicative of novel adduction or
fragmentation phenomena in our untargeted metabolomic data set, and we were interested in the
origin of these unknown relationships. We speculated that some of the frequent intrinsic
relationships that we discovered were the result of analyte adduction with the chemical background
described above. In the simplest of cases, we found that some frequently occurring mass-to-charge
differences between features corresponded to the mass-to-charge values of background ions. In
more complex cases, however, a single analyte formed adducts with multiple background ions
(Figure 5 and Figure 6) and therefore multiple situational adducts were detected for the same
analyte. As the spacings between the background ions fix the spacings in the situational adduct
features, we expect these repeatedly occurring spacings to be returned as frequent intrinsic
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relationships. Inspecting the returned frequent intrinsic relationships, we found several mass
differences that also appear in the chemical background. This result is an additional confirmation of
the effectiveness of frequent intrinsic relationship discovery and suggests that chemical background
is a large source of feature inflation.

Figure 6.5. Situational adducts. (A) The persistent background spectrum observed in this experiment. The three indicated background peaks have mass
spacings that correspond to a methylene group. These are likely an alkyl amine series with carbon numbers 5, 6, and 7. When these background
species adduct with an analyte, situational adducts are formed. (B) An example of a situational adduct forming between background ion 102.1280
(a six carbon alkyl amine) and an eluting analyte. This process likely occurs with all three alkyl amine species throughout the run, giving rise to the
frequent intrinsic relationships of mass 14.0157 (see Table 2, Row 8).

Figure 6.6. Schematic showing how background ions give rise to frequent intrinsic relationships. Analyte A is detected as an adduct of each
background ion (B1 and B2). The spacing between the adducts (A+B1-H and A+B2-H) is equal to the spacing between the background ions.
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We also performed formula decomposition on the frequent intrinsic relationships to further
elucidate their origins. Interestingly, chemical formula CH2, C2H4, and C3H6 were found in the
frequent intrinsic relationships exhibited by the chemical background. Additional analysis of the
background ions indicated that they were an alkyl amine series. These species are known to form
strong adducts and are commonly found as contaminants in alcohol solvents.94 We note that our
laboratory has never performed ion-pairing experiments and the source of these reagents was
solvent impurity as indicated by the series rather than sole presence of triethylamine. In developing
our methods, we attempted to find solvents with the lowest possible levels of chemical background
(Burdick & Jackson brand purchased from Honeywell). Unfortunately, alkyl amines seem to be
ubiquitous in methanol and isopropanol LC/MS solvents.

6.2.6

Removing artifacts and contaminants by credentialing

The degenerate relationships that we annotated above led to a striking reduction in the number
of feature groups, indicating that fewer than 15% of the total 25,230 features that were detected in
E. coli correspond to unique analytes. Even after this extensive annotation process, however, two
sources of feature inflation remained in artifacts and contaminants. We applied an alternative
experimental approach called credentialing to filter these features associated with artifacts and
contaminants. The credentialing process introduces an isotopic signature into biological analytes
during E. coli growth.4 Features in our data set displaying this isotopic signature are deemed
“credentialed”, as they are known to be of E. coli origin. In contrast, features that do not display this
isotopic signature are annotated as artifacts or contaminants. Credentialing does not rely on any of
the relationship annotation approaches that we described above, and is thus an orthogonal and
highly complementary approach to data analysis.
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We first filtered non-credentialed features from the raw data set on the basis of isotopic
signatures. The resulting set of features is free of artifacts, noise, and contaminants. This process
returned 2,462 high-quality, credentialed features. We then took these credentialed features through
the same annotation process as the full data set to remove degeneracy. Annotation of degeneracy
reduced the estimated number of unique E. coli analytes being measured to 832 (Figure 3C).

6.2.7

creDBle: a database for thoroughly annotated reference data sets

An alternative approach to each investigator having to identify the relatively small number of
features corresponding to unique, bona fide metabolites from every experiment is to create
thoroughly annotated reference data sets. Reference data sets have been shown to be effective in
other profiling sciences, such as genomics (for example, during the EST collection era of gene
identification in the 1990's).186,187 The idea is for one laboratory to first identify all of the unique
metabolites that can be detected from a given sample with a given experimental methodology. Then,
other laboratories performing the same experiment benefit by having to target only these reference
analytes in their subsequent experiments. Of course, the major challenge of this strategy is that there
are a multitude of experimental methods currently being used in untargeted metabolomics, each of
which will have to be annotated for different sample types.181
There may also be other benefits to having a repository of thoroughly annotated data sets.
Knowing the comprehensive list of unique metabolites that can be detected with specific
experimental protocols, for example, will be invaluable to designing LC/MS-based metabolomic
experiments. Although the number of detected features is often used as an indicator of experimental
coverage, our work suggests that this is an unreliable metric. 87,88 Instead, it would be preferred if
researchers based their experimental design on the numbers of unique metabolites known to be
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detected. Additionally, even if the sample of interest has not been annotated, researchers might be
able to use annotated data from other sample types (e.g., E. coli) as a touchstone to evaluate data
from their experiments and to compare it to others.
As a first step in establishing a repository for thoroughly annotated reference data sets, we have
created the creDBle database. All credentialed features for the reference E. coli data set described
here have been deposited in creDBle. Degeneracy annotations as well as accurate mass, retention
times, and fragmentation patterns are included. creDBle is freely available on the Web at
http://creDBle.wustl.edu/ and provides a convenient companion resource for credentialed E. coli
standards (Figure 7). All data within creDBle (including fragmentation patterns for identified
metabolites) can be freely downloaded.
The addition of more analyses to creDBle will greatly expand its applicability. Our first goal is to
repeat the annotation processes above for credentialed E. coli samples analyzed with different
methods (e.g., different extraction protocols, chromatography, mass spectrometers, etc.). Notably,
identification of metabolites from these annotated experiments will provide a readily available set of
complex standards. As the number of credentialed E. coli experiments within creDBle increases, we
hope that it will eventually provide a common reference point with enough observations in each
experiment to model and normalize some of the variation that has historically prevented crosslaboratory data comparisons. This, in turn, would make data sets present in repositories, when run
with a credentialed standard extract, more amenable to reprocessing and meta-analysis.
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Figure 6.7. Screenshots from the creDBle database. (A) The list of credentialed features showing m/z, retention time, polarity, grouping, and intensity.
(B) A credentialed features page showing the extracted ion chromatogram, credentialed isotopes, and fragmentation data.
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6.3

Conclusion
Detecting tens of thousands of LC/MS features from biological samples is typical in untargeted

metabolomics, however, to date it has been unclear how many unique metabolites are actually being
profiled. Our work here evaluated one representative untargeted metabolomics data set from E. coli
to set an upper bound on the number of unique metabolites being measured. By using a new
context-driven approach to identify degenerate features arising from the same metabolite, we
determined that the ~25,000 features detected in our experiment corresponded to fewer than 2,961
unique analytes. An orthogonal and complimentary approach using credentialing isotope signatures
to identify artifacts and contaminants similarly reduced the number of unique analytes detected. Out
of the total ~25,000 features detected, only 832 passed both our degeneracy and credentialing filters.
Accurate masses, retention times, fragmentation patterns, and degeneracy annotations for these 832
features have been deposited in the creDBle database.
We wish to emphasize that our work is unrelated to the size of the E. coli metabolome and
should not be interpreted as an indication of the total number of intracellular metabolites present.
There are certainly more than 832 E. coli metabolites.188 The purpose of our work was only to assess
how many unique metabolites are being measured in a representative untargeted metabolomics
experiment. Additionally, we note that our context-driven analysis of degeneracy is not exhaustive.
Relationships that are uncommon and not indicated by background ions remain unannotated and
may further reduce the number of unique analytes detected. Notwithstanding, our results suggest
that there are an order of magnitude more features than unique metabolites in untargeted
metabolomics experiments. This has important implications for designing untargeted metabolomics
experiments and influences strategies for interpreting the data produced before establishing
metabolite identifications.
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6.4

Methods

6.4.1

Materials

U-13C-D-glucose was purchased from Cambridge Isotope Laboratories Inc. (Andover, MA). E.
coli strain K12, MG1655 was purchased from ATCC (Manassas, VA). Lennox LB broth powder and
5x M9 salts were purchased from Sigma-Aldrich (St. Louis, MO). Cell culture was performed with
ultrapure water provided by a Milli-Q system (Millipore). LC/MS grade, Burdick & Jackson brand
water, acetonitrile, methanol, and isopropanol were purchased from Honeywell (Morris Plains, NJ).
Cortecs T3 reversed phase UPLC columns and column guards were purchased from Waters
Corporation (Milford, MA).

6.4.2

Generating credentialed samples

E. coli was grown in a rotary shaker at 37 ⁰C and 300 rpm as previously described (Mahieu et al.,
2014). M9 minimal media was used with a glucose concentration of 2 g/L. Two cultures were
grown in parallel, one using natural abundance glucose and a second using U-13C-glucose as the only
carbon source. Cultures were grown to OD600 = 0.7, at which point they were harvested.
For harvest, flasks were removed from the shaker and placed on ice. The contents of each flask
were pipetted into 50 mL conical tubes and centrifuged at 3200 g for 10 minutes. The supernatant
was decanted and remaining media was gently rinsed off the top of the pellet with 0.5 mL of water.
Conical tubes were then placed in liquid nitrogen and lyophilized for 24 hours, or until dry. This
powdered, credentialed E. coli standard was then extracted to generate samples for untargeted
metabolomic analysis.
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Several replicate extractions were performed in parallel by using a previously described method.4
Briefly, five 2.5 mg samples of each 12C and 13C material were weighed out, while two empty tubes
were included as extraction blanks. To these, 1,000 μL of 2:2:1 methanol:acetonitrile:water was
added, followed by three freeze-thaw cycles with sonication and vortexing. After centrifugation, the
supernatant was vacuum concentrated and reconstituted in 100 μL of 1:1 acetonitrile:water with
internal standards. From these extracts, three samples were aliquoted for LC/MS analysis: natural
abundance extract, a mix of 1:1 natural abundance extract and 13C extract, and the blank extract.

6.4.3

Data set generation

Each sample was analyzed five times as analytical replicates. The untargeted LC/MS data set was
generated in positive polarity on a Q Exactive Plus mass spectrometer with a HESI II source
coupled to a Dionex 3000RSLC. The data set was collected with the following settings: aux gas, 5;
sheath gas, 35; sweep gas, 2; capillary temperature, 300 ºC; aux gas temperature, 200 ºC; spray
voltage, 3.5 kV; needle diameter, 34 ga; s-lens, 75 V; mass range, 100–1500 Da; resolution 70,000;
micro scans, 1; max injection time; 100 ms; automatic gain control target: 1e6. Reversed-phase
chromatography was performed with the Waters Cortecs T3 (2.1mm x 50mm, 1.6um) column at a
flow rate of 300 μL/min and a column temperature of 50 ºC. Solvents were: A, water + 5mM
ammonium acetate + 5uM ammonium phosphate; B, 9:1 isopropanol:methanol + 5mM ammonium
acetate + 5um ammonium phosphate. An injection volume of 2 μL was used with a linear gradient
of (minutes, %A): 0, 100; 28, 0; 30, 0; 30, 100; 35, 100.
Chromatographic features were detected by using a set of in-house algorithms. Mass traces were
retained if they were longer than 10 scans, excluding missing peaks. Baselines for each mass trace
were calculated by using the iterative restricted least squares method from the baseline R package.
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Model based peak detection was performed by using the skew normal distribution as a model peak
distribution. This process resulted in a set of features detected in each replicate run. Features were
grouped by mass and retention time using a density based method. Retention time drift and mass
drift were corrected by fitting a loess curve of degree 2 to the distance from the mean value of each
group against the mean retention time of each group.
Subtle variations from run to run cause many features to be integrated differently and sometimes
not integrated in each file. Further, closely eluting peaks often lead to incorrectly grouped features.
To refine the individual datasets and get a set of detected peaks consistent with all replicate runs, we
applied the Warpgroup algorithm.2 Warpgroup is available at https://github.com/nathanielmahieu/warpgroup. Warpgroup takes as input the raw data and each file’s detected features
combining them to output a set of consensus features. Parameters: sc.aligned.lim, 9; pct.pad, 0.1;
min.peaks, 3.
This consensus data set set is the standard output of an untargeted metabolomics experiment. As
such, it was taken as a representative dataset for annotation of detected signals.

6.4.4

Mz.unity based annotation

Mz.unity was applied to the dataset to detect mass and charge ([m, z]) relationships between
eluting signals derived from a single analyte.3 We use [m, z] to denote the mass and charge of a
species, where both are specified as opposed to m/z where the two are convolved. These searches
find sets of features that have [m,z]s differing by a specific amount. Differences are specific to
relationships, for example, loss of 12C and gain of 13C ([+1.003355, 0]), or loss of water ([-18.01057,
0]).
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Searches were first performed for the following relationships: isotopes, common charge carriers,
common neutral losses, and common adducts. We then searched for dimers between coeluting
features. The dimer search posits each eluting [m, z] as a possible adduct former. The charge state
was specified based on observed isotopes, or assumed to be a charge of 1. As dimers are normally
formed with a charge from only one constituent, we also assumed the loss of a proton [1.00783, +1]
for each pair.
Mz.unity is available at https://github.com/nathaniel-mahieu/mz.unity.

6.4.5

Frequent intrinsic relationships

Groups of features eluting within 1 second of each other were taken, and their pairwise [m, z]
differences were calculated after assuming a charge state of 1. A Gaussian kernel density estimation
was performed on the mass differences with a bandwidth of 0.00001 Da (our observed scan-to-scan
mass error). Local maxima of the density estimate were detected along with the estimated density at
those locations. The heights of the local maxima represent the frequency and mass dispersion of
each mass difference. Mass differences that are more frequent and more similar in mass will have
larger density estimates.
We took enriched mass differences larger than 15 Da and occurring more than 50 times
throughout the dataset into the mz.unity search.

6.4.6

Situational adducts

Background ions that lack a chromatographic peak shape are an ever-present set of species that
often form adducts with eluting analytes. These situational adducts are then detected as features
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having a chromatographic peak shape. A low mass background spectrum was collected, containing
detected ions above 50 Da. This spectrum was deisotoped and background species appearing at
higher than 200,000 intensity were used to seed possible adduct relationships. The [m, z]s of each
background peak were included in the dimer search, as above after specifying the charge state based
on observed isotopes or assuming a charge of 1.

6.4.7

Credentialing

A high-confidence set of features were recovered from the 12+13C dataset by applying version 3.0
of the credentialing algorithm, which is available at https://github.com/pattilab/credential.
Credentialing searches for pairs of peaks that have precise isotopic spacing expected from U-12C and
U-13C analytes.4 This provides a filter against many forms of noise, contaminants, and artifact
features. Credentialing was run with the parameters: ppmwid, 8; rtwid, 1.2; cd, 1.00335; mpc, c(12,
120); ratio, 1; ratio.lim, 0.1; maxnmer, 4. Credentialed features from the 12+13C data set were then
matched to the 12C dataset by applying retention time and mass correction as above before grouping.

6.4.8

Credentialed feature characterization

The set of credentialed features were further characterized for deposition in the creDBle
database. Targeted MS/MS was performed on the credentialed features with a 0.4 Da window width
and a stepped collision energy of 10, 30, and 90 V. Annotations and feature groupings of the
credentialed features were taken from the previously performed mz.unity annotations.

6.4.9

The creDBle database
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Characterization of all credentialed features from this data set was deposited in the creDBle
database. The data are freely available at http://credble.wustl.edu/ and easily downloadable in JSON
format via the REST API. This includes m/z, retention time, annotation grouping, MS/MS spectra,
credentialed isotopes, and extracted ion chromatograms.
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Chapter 7.

Concluding Remarks

Metabolomics remains a rapidly expanding field even 20 years after its inception. Still, the
exceptional promise of untargeted analysis remains impeded by complex variance and massive
dataset degeneracy.189 Warpgroup, mz.unity, credentialing and creDBle address these critical needs
and chart a course to truly systems-level metabolomics.

7.1

The Big Picture
When attempting to comprehensively understand metabolomic datasets it became apparent that

preprocessing steps were critically important to downstream analysis. In particular the peak
detection process preceded all feature-dependent analysis and as such any interpretation of
individual features relies on accurate peak detection. Warpgroup was developed to improve the
reproducibility of peak detection and decrease noise – these advances made the later steps including
credentialing and mz.unity annotation tractable problems.
While forming a contextual understanding of features in metabolomic datasets it became
apparent that current approaches were limited to only the simplest relationship types. Exploration
of complex adducts and distal fragments required a more flexible search approach. To this end
mz.unity was developed in a manner that allows one to search for any specified relationship. This
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advance allowed the systematic evaluation of complex and cross polarity adducts and contextual
relationship recovery – two major contributions to dataset annotation.
Finally, it was clear that though great effort had been undertaken to minimize the contribution of
contaminants and informatic error to features, many mistakes were still being made. As such the
credentialing methodology was introduced to recover reproducible sets of biological features.
In concert these developments enabled the first unbiased catalog of analyte features from an
untargeted dataset - creDBle. Additionally the combined application of these algorithms have
provided insight into the analyte content and degeneracy of metabolomic datasets – a result that will
guide the design of next generation metabolomic experiments.

7.2

Future Work
Though these contributions represent major conceptual advances to the metabolomic workflow,

many challenges remain in the field.
Relationship annotation is the most promising approach developed herein. Current applications
of mz.unity take a conservative approach in order to minimize false positive annotations. Truly
comprehensive relationship annotations necessitate a statistically driven evaluation of each putative
relationship. The likelihood of a relationship can be conditioned on many observations – expected
mass error, prior knowledge of the likelihood of occurrence, intensities of the involved species,
gradient conditions, source conditions, and other observed relationships all contribute information
relevant to putative relationships. The problem of evaluating putative relationships can be stated as
finding the optimum graph subsets which describe the observed signals, minimizing some measure
of over-aggregation while maximizing some relationship based score. Further, evaluating self versus
non-self-relationships and predicting the original analyte mass based on the observed signals are
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additional goals amenable to this framework. The development of mz.unity into a comprehensive,
easy to use algorithm will certainly improve our ability to compute on metabolomic datasets.
Additionally, Warpgroup offers one solution to the isolated peak detection problem. It would be
ideal to improve the peak detection problem in a prospective manner. To this end incorporating
additional information into the peak detection step will have a major impact. The relationship
search as described above offers a major unused constraint on the peak detection process. Base
peaks have been used to predict and reinforce isotopic peaks during peak detection for example.
This should be extended to encompass the entire relationship graph – sodium adducts, dimers, even
across polarities. The detection of peaks and the annotation of relationships are interdependent, and
can be co-optimized to maximize the robustness of both steps.
Current approaches treat each experiment with identical chromatographies but different polarities
or ionization types as independent (ESI +/- and APCI +/- for example). This results in another
large form of degeneracy that is yet to be annotated. The mz.unity approach offers the ability to
search for relationships between these disparate datasets, and unifying peak detection across
polarities and ionization types is only feasible with annotation driven peak detection.
Ultimately, improved computational comprehension of metabolomic datasets will enable the full
power of the technology. Currently datasets are redundant and challenging to interpret.
Incorporating the relationship graph and peak detection will allow an abstract representation of
metabolomic datasets including the context of all detected signals. The resulting dataset will be
computable, offer a strong foundation to train machine learning models for analysis, and allow for
rapid extraction of biologically relevant information from these datasets. The future of
metabolomics is bright.
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Appendix 1.

Warpgroup: increased precision of metabolomic data processing by
consensus integration bound analysis

[154]

Appendix 1.1. The residual drift before and after retention time correction.
Retention time drift before (A) and after obiwarp (B) for sample numbers 3, 4, 5 and 15 from the HILIC dataset.
Samples were aligned with sample 1 as the reference. It is clear that global retention time correction does shift the
average drift towards zero (A and B). Importantly, even after retention time correction many peak retention times still
present considerable drift. Figure C displays the change in residual drift for each peak, negative values represent a move
further away from alignment while positive numbers are a shift towards alignment.

A.

B.

C.

[155]

Appendix 1.2. The retention time drift of all samples in the data set.
Retention time drift of 16 samples including samples which were run to monitor equilibration of the LC system before
(A) and after (B) Obiwarp alignment to sample 3.

A.

B.

[156]

Appendix 1.3. Visualization of dynamic time warping inputs and output
A visualization of the input and output of dynamic time warping for a simple case. The two time series supplied as
inputs are displayed on the X and Y axes. Dynamic time warping was performed on these, traces resulting the in “warp
path” drawn as a line plot. This warp path relates the time domain of each series. Drawn arrows represent the
projection of hypothetical peak bounds in the query series into the time domain of the reference series.

[157]

Appendix 1.4. Walktrap community detection on an example graph structure
In this graph structure peaks are drawn as nodes. Edges are drawn between peaks when they are
determined to describe the same chromatographic region between samples. This is based on the
agreement of transformed peak bounds across multiple sample pairs. Two edges are drawn per
sample pair (one for A → B and a second for B → A) as DTW is not a symmetric technique. This
graph structure is subjected to walktrap analysis to find communities of detected peaks which
describe similar chromatographic regions.

[158]

Appendix 1.5. XCMS Integration
A prerequisite task to group.warpgroup() is the rough grouping of features between samples,
such that all features which could possibly represent the same signal reside in a single group (as
recorded in @grouped). This initial grouping should err on the side of inclusion, allowing the
warpgroup algorithm to divide the rough groups into the appropriate sub-regions. This can be
achieved with the default XCMS approach group.density(), but in cases of high retention time
variance or small m/z drift a hard cutoff may be more appropriate.
The provided group.warpgroup() function iterates over each group in the xcmsSet and performs
an initial setup before calling the algorithm. This setup includes the generation of an EIC trace for
each sample based on the detected peak bounds and masses in that group. The EIC traces and
detected peaks are then supplied to the warpgroup algorithm for processing. Returned groups are
reintegrated and used to repopulate the xcmsSet.
The XMCS implementation uses the foreach package to handle parallelization. In the presence
of a registered parallel backend (Eg. doRedis, doParallel) the warpgroup algorithm will be
parallelized, each thread handling one warpgrouping. The generation of EIC matrices is performed
in the parent thread to minimize the amount data to be transferred. When no parallel backend is
registered the processing continues single threaded with a warning message.

[159]

Appendix 1.6. Pairwise comparison of CV before and after warpgroup
The CV of each group before and after warping was compared for each dataset by taking the
difference (CVbefore – CVafter). The red line indicates no change in CV while positive values indicate a
decrease in CV. In most cases the CV was decreased by the warpgroup algorithm.

[160]

Appendix 1.7. An overview of differences between workflow outputs for the HILIC dataset
with various group subsets
Subset of Peaks
Workflow

All
Traditional

Shared
Warpgroup

Traditional

Filtered 5 > n > 13

Warpgroup

Warpgroup

39%

24%

31%

18%

20%

90 Percentile CV

79%

50%

63%

33%

38%

Number of
Groups

18,341

38,658

7,846

7,846

10,383

Mean CV
th
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Appendix 1.8. Warpgroup of general timeseries data in the form of ecocardiograms

[162]

[163]

Appendix 2.

Defining and Detecting Complex Peak Relationships in Mass
Spectral Data: The mz.unity Algorithm

[164]

Appendix 2.1. Description of the combinatorial search problem for complex peak
relationships.
Let O be the set of all observed <m,z>. Let M be a user supplied set of <m,z>. Find multisets R
and S that satisfy:

𝑅, 𝑆 ⊂ 𝑂 ∪ 𝑀
𝑅, 𝑆 ⊄ 𝑀

𝑅∩𝑆=∅

� 𝑥𝑚 − � 𝑥𝑚 < 𝛿

𝑥∈𝑅

𝑥∈𝑆

� 𝑥𝑧 − � 𝑥𝑧 = 0

𝑥∈𝑅

𝛿=

𝑥∈𝑆

𝜀
∗
1𝐸6

�

𝑥∈𝑅,𝑆∩𝑂

𝑥𝑚
|𝑥𝑧 |

Given a set of <m,z> pairs where m and z are positive or negative real numbers, find two submultisets whose summed mass is within error δ and whose summed charge is equal. Exclude pairs of
multisets which share a member.
In broader terms, we have found a set of mass and charge transformations (corresponding to
deprotonation, adduction, etc.) which convert a detected <m,z> value to a second <m, z> value.
Thus this search ensures that the transformations of each <m,z> as described by members of each
multiset results in an equal mass and charge.

[165]

Appendix 2.2. Features from negative mode included in the composite spectrum
mz
-146.046
-128.035
-102.056
-147.049
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-810.158
-664.108
-541.057
-662.603
-332.058
-306.077
-758.09
-88.0403
-168.028
-357.087
-129.019
-333.053
-294.102
-320.011
-847.11
-184.001
-349.09
-316.084
-133.033
-148.052
-811.16
-358.118
-228.049
-244.023
-146.025
-416.108
-993.655
-831.137
-760.078
-353.037
-130.039
-874.173
-146.104
-151.062
-378.152
-994.157
-317.039
-146.071
-146.02
-129.032
-244.119
-104.06
-103.053

maxo
2.76E+09
3.52E+08
3.12E+08
1.64E+08
1.37E+08
1.15E+08
58812040
44957360
35751240
32867860
31911818
30048056
29273104
28147298
24049586
20168718
15625474
12138567
11558971
11044240
10539088
9959694
6937656
5288482
5039852
4757833
4592574
4585383
4487963
3955738
3907644
3892937
3772248
3454026
3302731
3277035
3091660
3036758
2891467
2886159
2825622
2595229
2563522
2491125
2471267
2384161
2370798
2345890
2325020
2294203
2244784
2227558
2207934
2033520
1948270
1836020
1833876
1619828
1601470
1589578
1572900
1561877
1533376
1487027

source
Psn
Psn
Psn
Psn
Psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn

mz
-400.134
-188.002
-665.11
-542.059
-189.088
-246.118
-540.039
-269.054
-848.114
-335.055
-206.012
-301.065
-516.063
-894.207
-500.09
-232.096
-345.178
-450.11
-456.246
-994.657
-881.311
-572.344
-134.034
-100.04
-187.109
-115.003
-456.166
-832.14
-333.059
-875.176
-687.107
-337.063
-598.36

maxo
1216220
1182428
1176081
1156010
1126616
1123492
1110298
1099994
1090830
952685.8
938092.4
923233.9
921326.4
886170.4
873459.1
835217.1
834453.8
815158.2
809889.1
808162.4
808151.8
790534.1
789540.4
785416.2
781978.1
758465.8
758344.9
720119.6
683614.1
680699.4
673873.8
672261.3
661826.6

[166]

source
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn
psn

-369.011
-744.105
-284.072
-149.053
-759.093
-350.083
-346.021
-233.103
-436.095
-397.988

1482860
1443245
1440297
1427846
1331007
1323925
1306265
1248925
1239505
1222801

psn
psn
psn
psn
psn
psn
psn
psn
psn
psn

Appendix 2.3. Features from positive mode included in the composite spectrum
mz
148.06
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233.2447
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245.2447
190.2025
234.2479
271.0688
276.2871
427.306
157.1447
257.2446
131.0531
350.102
453.3216
247.1287
150.0642
227.1644
191.1865
234.1163
265.0503
666.1227
200.1869
295.1138
259.2604
304.1618
147.1604
214.2025
349.1181
314.2092
434.2795
255.0949
134.0447
251.0346
436.295
104.1181
275.2555
469.3164
261.2396
467.3007
234.242
410.2795
246.2481
149.0573
202.2025

maxo
1.81E+09
3.02E+08
2.6E+08
1.96E+08
1.22E+08
91513336
61472984
54190284
50223776
48069948
28252376
26949514
21521252
20748364
19735338
18880884
18655262
17018116
15073590
15012519
14912596
14645601
13957159
13730655
12932350
10756661
10674766
10418991
10269037
8838102
8177553
7950535
7811584
7632175
7174908
6942368
6566525
6280206
6058636
6045015
5943378
5848210
5828522
5793045
5786659
5718033
5668431
5659415
5610463
5554419

source
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp

170.0422
424.2588
341.222
481.3163
159.1603
240.172
243.2291
261.276
124.0587
226.1565
234.1538
235.1617
231.2293
383.2324
702.0733
171.0762
248.1696
226.0376
283.132
116.1184
493.3163
269.2447
131.0338
103.0582
428.3099
451.306
477.3215
175.1553
686.0993
277.2905
450.2744
229.2137
234.2288
426.2745
379.2011
99.0916
397.2115
136.0618
191.2058
601.3956
454.3255
210.1713
271.2604
495.3319
443.3009
365.2218
323.0393
411.2635
233.1645
455.3009

3883824
3865671
3865225
3849028
3844951
3813592
3693398
3614619
3491213
3441997
3437938
3252422
3219105
3199432
3124695
3102233
3073251
2991801
2975036
2972269
2965840
2952662
2910072
2891140
2856149
2814969
2653451
2644349
2641257
2631271
2600441
2572000
2559343
2514821
2492418
2480767
2450742
2449351
2432413
2407377
2396598
2380743
2371772
2369524
2356544
2339415
2321906
2312104
2304944
2298684

psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp

465.3215
463.306
230.1976
318.2982
207.9982
438.2743
308.1639
205.6433
241.2133
150.0665
267.1369
359.1025
153.0405
346.1889
483.2956
117.1263
369.2168
142.1339
435.311
228.1819
232.1567
432.1362
203.1866
273.0669
485.3112
285.2398
222.1541
132.1131
667.1254
241.1616
440.2537
223.9721
304.2823
296.1167
271.224
235.2513
355.2012
408.2639
158.1481
496.3636
155.129
285.0829
422.2432
353.2219
360.1324
287.2555
335.7307
163.1552
333.0643
235.1172

[167]

1884285
1875812
1848160
1844858
1824690
1823870
1808380
1763577
1737384
1731420
1702268
1688196
1673078
1665952
1661078
1638529
1625681
1621513
1610065
1591366
1547727
1543830
1531236
1513754
1481398
1461184
1426840
1426403
1425935
1415203
1412062
1405962
1398901
1398888
1397299
1393120
1372936
1360118
1357751
1350771
1348961
1342086
1319220
1308334
1293417
1280357
1272806
1251915
1236596
1228381

psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp

173.0919
425.2428
196.1556
380.0776
352.1902
246.2419
393.2531
192.0241
85.02834
253.2133
299.1636
368.1851
201.1903
289.2712
350.1212
327.2175
234.1102
305.696
260.6854
442.1668
323.215
422.2795
507.3319
225.1486
511.3267
191.1024
996.1745
319.3297
412.2589
675.1086
289.2347
497.3113
176.0737
1014.651
410.2432
427.2585
150.647
454.2693
495.2955
256.1209
489.3215
273.276
215.1024
392.2689
372.0838
396.2639
267.0483
398.2431
703.077
440.29

1058835
1038059
1034444
1032436
1021926
1021253
1016436
1013983
1011348
1004417
1002699
1000992
991107.1
978187
962097.6
961277.2
956079.1
948127.1
946392.5
945906.9
943317.6
942465.8
936827.4
928799.9
928654.2
925484.1
923613.8
923008.4
920321.3
918688
901264.7
896755.7
893954.2
888278.3
887668.1
883956.6
883463.1
877597.7
870804.2
866752.1
863220.1
862540.6
861544.3
854450.4
849048
846665.8
837923.8
837573.2
835253.9
828606.9

psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp

288.2871
332.5624
255.229
298.1796
354.1695
269.1162
374.148
128.0707
385.2481
384.2641
85.04767
218.6511
439.306
320.1642
186.0162
322.1798
452.29
340.1903
239.1642
367.2375
198.1713
273.2396
216.2183
248.2318
595.4037
428.2903
375.1518
266.0537
375.1989
256.2324
440.31
335.2148
352.0979
411.2806
687.1026
341.1378
152.1182
411.2273
148.0339
264.1827
203.206
322.7088
309.1479
269.6907
356.1851
394.0932
385.2679
531.2981
325.1431
582.3642
148.1637
1015.153
298.1513
386.252
314.1745
271.1318
481.2799
238.1104
404.1949
189.1791
235.245
120.1133
399.2272
395.1958
293.1164
355.1735
277.2846
527.3216
290.0722

5536289
5531230
5406180
5280998
5181576
5132939
5068381
5005582
4837042
4743927
4690118
4430709
4337509
4316508
4303773
4289709
4236093
4202912
4089331
4082911
4067356
4020422
3967400
3908586
753921.4
752444.6
751830
749370.5
749054.3
740162.6
734644.9
721214.6
718792.9
717596.1
709065.9
705273.1
695237.9
691263.7
689500.3
684786.1
678903.4
663479.8
649027.9
638324.9
623756.9
618761.9
615982.9
614656.4
606670.4
606210.6
593393
591243.8
589913.8
586079.9
568435.3
568325.4
561573.8
553831.4
543094.6
538244.8
531464.8
530622.3
530437.9
520012.8
515396.7
509952.2
505453.8
500390
491646

psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp

326.1748
218.1975
258.2481
479.337
314.7111
594.4002
388.1456
217.6432
108.6127
272.0722
247.1618
138.6471
388.0578
132.0541
406.2483
468.2848
351.1054
509.3111
226.2026
409.2954
100.0994
409.2477
322.207
248.1321

2271483
2269794
2242889
2236099
2185420
2179335
2168571
2141469
2123574
2101159
2075201
2071239
2069616
2067111
2063521
2022243
2003873
1973029
1969459
1941976
1925514
1907389
1892691
1892027

psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp

192.19
227.1979
129.1261
310.1796
186.1713
436.2588
143.1292
228.2184
226.6486
131.0469
185.1761
183.1604
483.332
153.0768
247.2239
995.6728
285.0848
448.2951
351.2062
431.1876
395.2321
339.2062
356.1375
269.1107

[168]

1226547
1225753
1218545
1211365
1206633
1201589
1200430
1197925
1191097
1184284
1183860
1172474
1158942
1157504
1154023
1127385
1110661
1108775
1105669
1081482
1076854
1075096
1073961
1062688

psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp

256.167
120.613
151.0674
342.1219
505.3164
286.1317
556.3486
460.295
151.6549
239.1977
780.2363
1006.664
317.0835
242.1696
298.2719
148.0006
406.1561
542.0681
121.6208
402.2345
418.2846
214.0916
475.2136
304.0153

827247.1
826322.6
824307.5
822430.4
815663.2
798008.8
795780.7
794064.2
793066.4
791010.1
789338.8
781422.4
781141.6
780253.4
780054.4
779222.2
777100.1
770435.9
769528.5
767691.8
764103.7
763270.1
759841.3
756906.7

psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp
psp

252.1722
270.1196
341.9714
212.6328

487311.1
474292.3
469674.1
468559.9

psp
psp
psp
psp

Appendix 2.4. Background peaks from postive mode
85.07597, 86.05996, 86.07934, 87.05958, 87.09155, 88.02144, 88.07563, 89.07086, 89.10725, 90.05492, 91.05417,
92.03683, 93.12071, 94.06508, 95.0603, 96.08069, 96.99513, 97.07597, 98.07123, 98.08307, 98.98, 99.05523, 99.09154,
100.07561, 100.08836, 100.09939, 100.11199, 101.05966, 101.07089, 101.079, 101.10728, 102.09128, 102.10251,
103.08651, 104.01614, 104.07051, 104.11812, 104.99225, 105.10219, 105.12099, 107.07019, 108.61268, 109.11416,
111.01075, 111.05527, 111.09161, 111.11676, 112.08948, 112.09863, 113.07085, 113.10723, 114.09157, 114.10279,
114.11087, 114.61299, 115.0212, 115.09201, 115.10702, 116.07081, 116.11841, 117.00044, 117.06609, 117.10243,
117.12156, 117.12624, 118.03207, 118.06534, 118.08644, 118.09768, 118.13401, 119.01608, 119.08167, 120.0113,
120.06568, 120.11322, 120.61293, 121.01186, 121.62073, 122.00814, 122.07141, 123.09179, 123.12619, 124.08704,
125.03632, 125.07104, 125.10743, 125.12361, 126.10266, 127.08668, 127.10709, 128.08193, 128.09011, 128.11828,
128.61031, 129.06721, 129.07548, 129.10231, 129.12098, 129.12615, 130.0863, 130.09756, 130.1339, 130.15906,
131.01594, 131.08153, 131.11858, 131.13906, 132.11315, 133.03156, 134.02723, 135.0108, 135.07242, 135.10157,
135.12607, 136.0118, 136.02156, 136.08691, 136.13386, 136.94014, 137.00786, 137.02641, 137.04574, 137.12346,
137.6393, 138.1025, 138.6471, 139.08654, 139.1229, 139.1485, 140.00183, 140.08176, 140.11816, 141.10215, 141.11338,
141.12131, 141.12599, 142.03375, 142.09748, 142.13386, 143.08149, 143.12002, 143.12912, 143.14067, 143.58723,
144.0475, 144.11311, 144.64713, 145.0315, 145.09713, 145.1178, 145.14376, 146.0268, 146.10048, 146.12877, 147.04714,
147.10153, 147.11277, 147.16038, 148.14423, 148.16268, 149.02329, 149.02641, 149.12245, 150.02785, 150.10252,
150.64706, 151.02325, 151.09657, 151.65489, 152.11815, 152.12807, 153.1134, 154.03181, 154.09741, 154.13378,
155.11813, 155.12903, 155.15419, 156.04746, 156.11312, 156.1495, 157.09714, 157.11936, 157.14472, 158.02675,
158.03935, 158.12874, 158.14175, 158.14875, 159.04713, 159.11274, 159.16035, 160.04238, 160.04885, 160.10796,
160.14435, 160.16328, 160.16815, 161.04393, 161.06277, 161.092, 161.176, 162.1236, 163.04201, 163.13277, 163.15523,
164.13632, 165.05087, 165.11229, 166.13327, 167.03699, 167.12907, 168.11308, 168.13219, 168.14949, 169.14469,
170.09636, 170.12872, 170.14839, 171.11272, 171.12396, 171.14912, 171.16031, 172.04236, 172.10797, 172.14434,
172.15241, 172.16302, 173.06283, 173.0808, 173.13967, 173.17604, 174.12368, 174.12769, 174.16006, 174.1794,
175.11884, 175.1553, 176.07364, 176.15865, 177.05769, 178.05941, 179.05017, 179.11939, 179.12908, 180.08658,
180.15934, 181.02837, 181.14467, 182.12883, 182.14002, 182.16519, 183.12404, 183.16042, 184.10809, 184.14445,
184.1572, 185.13968, 185.17607, 186.12371, 186.14282, 186.16008, 186.1713, 187.10771, 187.12666, 187.15532,
187.63268, 188.13934, 188.15886, 188.1757, 188.18692, 189.14256, 189.17097, 189.17909, 190.17403, 190.20248,
191.07326, 191.15016, 191.18648, 191.19955, 191.20588, 192.0729, 192.07663, 192.12287, 192.13817, 192.18369, 192.19,
192.63546, 193.07023, 193.07803, 193.14406, 194.08424, 194.14, 195.16039, 196.00386, 196.14419, 196.15638,
197.13006, 197.13962, 197.17604, 198.12368, 198.16005, 198.17127, 199.1553, 199.17315, 199.18045, 199.19166,
199.6326, 200.07372, 200.13934, 200.15872, 200.17577, 200.1869, 200.64022, 201.13444, 201.17093, 201.18341,
201.19028, 202.15464, 202.20253, 203.15027, 203.18662, 203.20595, 204.06863, 204.13407, 204.17066, 204.18185,
204.18999, 204.63545, 205.16596, 205.18971, 205.64328, 206.14122, 206.1975, 207.18149, 207.20089, 208.09998,
208.15572, 209.13001, 209.1396, 209.15261, 209.17605, 210.13803, 210.17129, 210.63581, 211.15529, 211.17424,
211.1916, 211.64323, 212.0948, 212.13945, 212.15023, 212.1869, 212.63283, 213.07879, 213.09428, 213.09817,
213.13451, 213.14873, 213.15972, 213.17084, 213.17876, 213.19025, 213.6406, 214.09161, 214.09928, 214.1565,
214.16874, 214.20251, 214.65799, 215.15217, 215.15837, 215.18661, 215.19963, 215.20594, 216.1427, 216.17067,
216.18184, 216.21823, 216.63547, 217.05013, 217.10706, 217.16596, 217.17918, 217.20226, 217.22087, 217.64327,
218.08436, 218.1396, 218.14574, 218.15914, 218.19751, 218.23386, 218.65107, 219.15206, 219.18127, 219.2009,
219.64064, 219.65049, 220.15656, 220.65807, 221.14953, 222.15401, 222.17124, 222.19245, 222.65578, 223.09661,
223.16716, 223.6432, 224.18692, 224.63293, 224.65101, 225.11225, 225.14906, 225.17085, 225.18178, 225.64072,
225.65032, 226.11058, 226.15659, 226.16604, 226.20263, 226.64862, 226.65824, 227.09452, 227.11292, 227.15022,
[169]

227.16439, 227.18729, 227.1979, 227.20615, 227.65944, 227.66625, 228.15422, 228.16232, 228.16944, 228.18196,
228.21841, 228.23212, 228.65962, 229.16609, 229.18622, 229.20254, 229.21365, 230.10557, 230.15002, 230.19766,
230.21678, 230.65119, 231.1491, 231.18175, 231.20077, 231.22928, 231.65925, 232.15681, 232.2133, 232.23184,
232.65825, 233.02438, 233.14719, 233.16457, 233.1987, 233.24464, 233.65661, 233.66631, 234.13359, 234.15387,
234.19217, 234.22883, 234.24205, 234.24782, 234.64771, 234.65561, 234.66968, 235.06063, 235.1516, 235.16193,
235.16631, 235.25076, 235.66326, 235.67739, 236.06246, 236.161, 236.16874, 236.17908, 236.18658, 237.02412,
237.05862, 237.1484, 237.18179, 238.11043, 238.15628, 238.20249, 238.6484, 238.65809, 239.16419, 239.18626,
239.19773, 239.6572, 239.66609, 240.08975, 240.12591, 240.15383, 240.16149, 240.17197, 240.18179, 240.21804,
240.61737, 240.65967, 240.67344, 241.16165, 241.16814, 241.17952, 241.21326, 241.22154, 241.66313, 241.67752,
242.1515, 242.16956, 242.19738, 242.21646, 242.23385, 242.66819, 243.15933, 243.18127, 243.19275, 243.20078,
243.2291, 244.12101, 244.15676, 244.17684, 244.21309, 244.23191, 245.12302, 245.16367, 245.1972, 245.20831,
245.24465, 246.07904, 246.15394, 246.1722, 246.19239, 246.22886, 246.24187, 246.24802, 246.65695, 246.67097,
247.16184, 247.17743, 247.21256, 247.2239, 247.2497, 247.26028, 247.66341, 247.67756, 248.15147, 248.1696,
248.17926, 248.208, 248.23172, 248.67112, 248.68535, 249.07634, 249.15932, 249.18051, 249.18775, 249.2395,
250.07828, 250.24198, 251.03464, 251.07009, 251.17476, 251.19762, 252.03428, 252.03791, 252.17217, 252.18178,
252.21818, 252.67116, 253.03279, 253.12126, 253.16164, 253.17849, 253.21334, 253.62562, 253.67786, 254.10541,
254.15149, 254.16949, 254.19757, 254.21688, 254.23396, 254.66789, 254.68532, 255.13691, 255.1592, 255.178,
255.18947, 255.22754, 255.66094, 255.67412, 256.12099, 256.139, 256.16712, 256.17692, 256.21303, 256.23087,
256.6827, 257.1337, 257.17442, 257.18369, 257.19763, 257.20824, 257.21646, 257.24454, 258.15903, 258.19237,
258.22875, 258.2421, 258.24801, 259.16665, 259.22411, 259.26029, 259.67765, 260.16949, 260.20795, 260.23153,
260.26289, 260.68543, 261.17771, 261.18764, 261.23959, 261.27593, 261.67401, 261.69311, 262.16712, 262.24226,
262.27937, 262.66465, 262.68286, 263.10568, 263.15769, 263.17417, 263.21891, 263.67206, 264.16438, 264.18269,
264.22663, 264.6814, 265.05028, 265.12126, 265.21334, 265.23449, 266.05218, 266.15301, 266.6855, 267.0489,
267.13697, 267.22803, 268.18746, 268.21301, 268.23164, 268.68285, 269.05054, 269.11622, 269.18161, 269.19864,
269.20832, 269.24466, 269.6907, 270.10021, 270.11834, 270.18269, 270.19228, 270.20799, 270.22869, 270.24805,
271.13185, 271.16881, 271.20036, 271.22372, 271.26031, 272.18013, 272.208, 272.22993, 272.26132, 273.19008,
273.23956, 273.27596, 274.22367, 274.24223, 274.27119, 275.10568, 275.25545, 275.27423, 275.29182, 275.69085,
276.19087, 276.25893, 276.28701, 276.68058, 277.12175, 277.17784, 277.19065, 277.19658, 277.23478, 277.2711,
277.28455, 277.29038, 277.68872, 278.04575, 278.20763, 278.29251, 279.13714, 279.15919, 279.18826, 279.2293,
279.6801, 280.13942, 280.18132, 281.13399, 281.15278, 281.20842, 282.1004, 282.1522, 282.15616, 282.22891,
283.13207, 283.14966, 283.2238, 283.26055, 284.13545, 284.20813, 284.2603, 285.1892, 285.23981, 285.27617,
286.13173, 286.19616, 286.22381, 286.24295, 286.27138, 287.21911, 287.25545, 288.19299, 288.20311, 288.23948,
288.25883, 288.28703, 289.23469, 289.27108, 289.29033, 290.07215, 290.23877, 290.26774, 291.25037, 291.27357,
292.19599, 292.2819, 292.68804, 293.1165, 293.18868, 293.28532, 293.66857, 295.13235, 295.22421, 295.26085,
296.11647, 296.1319, 296.13571, 296.16399, 297.14801, 297.23985, 297.27643, 298.15044, 298.17961, 298.22406,
298.24315, 298.27011, 299.16372, 299.18176, 299.25581, 300.17708, 300.19364, 300.25913, 300.2873, 300.6861,
301.2015, 301.27133, 301.29058, 301.69359, 301.70335, 302.18203, 302.20197, 302.26839, 302.30293, 302.67416,
303.25057, 303.30628, 304.25034, 304.2822, 304.31861, 304.68828, 305.66894, 305.69622, 306.14833, 306.19876,
306.67689, 306.68611, 307.16889, 307.20153, 307.24562, 307.28186, 307.70341, 308.09127, 308.16379, 308.18148,
308.19084, 309.14789, 309.16736, 309.1989, 309.70074, 310.17951, 310.20666, 310.70853, 311.16358, 311.18733,
311.25577, 312.15867, 312.19332, 312.28727, 313.14302, 313.20142, 313.2713, 313.69346, 313.70296, 314.17439,
314.18194, 314.2092, 314.26678, 314.30291, 314.67399, 314.70108, 314.71105, 315.19019, 315.19959, 315.21086,
315.25084, 315.68219, 315.69183, 316.18951, 316.20709, 316.25407, 316.28247, 317.19663, 317.26647, 317.31416,
318.14863, 318.20389, 318.29814, 319.20172, 319.23441, 319.28218, 319.32977, 320.05693, 320.16417, 320.2096,
320.21849, 321.14835, 321.16778, 321.19018, 321.19918, 321.25022, 321.6912, 321.70101, 322.16119, 322.17983,
322.20698, 322.70887, 322.72279, 323.16393, 323.18237, 323.18767, 323.2142, 323.22119, 323.67975, 323.71705,
324.15917, 324.19546, 324.69705, 325.14315, 325.17973, 325.1945, 325.19885, 326.17475, 326.20948, 326.30326,
327.00869, 327.17815, 327.19026, 327.21742, 327.71923, 328.19805, 328.20704, 328.28252, 328.69965, 328.72269,
329.00663, 329.18776, 329.19673, 329.21426, 330.20296, 330.29815, 330.72025, 331.00281, 331.21213, 331.24577,
331.28213, 331.32975, 332.16414, 332.19279, 332.27733, 333.08845, 333.2978, 333.309, 334.07234, 334.1798, 334.20708,
334.72284, 335.09852, 335.18775, 335.32462, 335.71669, 335.73065, 336.1591, 336.19703, 336.23243, 337.18957,
337.20292, 337.21229, 338.17472, 338.22004, 339.15872, 339.17831, 339.20624, 340.15386, 340.17151, 340.19029,
341.19309, 341.22192, 342.20607, 342.22592, 342.29807, 342.72012, 343.02814, 343.21227, 343.72801, 344.19293,
344.22943, 344.24364, 344.73619, 345.20032, 345.25045, 345.34531, 346.17987, 346.18881, 347.19201, 348.19553,
348.73844, 349.0833, 349.18939, 350.17466, 350.211, 350.32421, 351.20642, 351.22876, 351.72668, 352.19029,
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352.20907, 353.22188, 354.16954, 355.17206, 355.20119, 356.18535, 357.21686, 357.25161, 360.23312, 361.19064,
363.20625, 363.26064, 363.30825, 364.19033, 364.20989, 364.29225, 365.203, 365.22181, 366.20627, 366.23014,
366.72957, 367.12423, 367.20101, 367.23746, 368.22159, 368.24103, 369.21678, 373.24082, 373.25648, 373.74263,
375.20629, 375.23839, 375.30818, 377.2218, 379.20112, 379.2384, 379.73293, 381.21674, 381.23821, 382.2008,
382.22053, 382.24831, 383.23237, 384.23631, 384.26402, 385.24804, 385.26783, 386.18444, 386.2518, 387.18835,
387.24164, 388.1457, 388.24618, 388.74791, 389.14928, 389.22694, 389.24916, 389.72823, 390.20586, 391.20105,
391.23749, 391.28463, 392.23269, 392.24087, 392.28794, 393.21673, 393.25309, 394.24766, 395.19604, 395.23213,
396.22764, 396.24207, 396.26389, 397.21157, 397.24791, 397.75289, 398.23216, 398.24313, 399.2273, 400.25888,
401.24325, 401.25386, 401.75569, 402.23447, 402.73608, 404.23273, 405.21667, 405.31864, 406.15618, 406.24828,
407.23231, 407.25198, 407.3343, 408.23749, 408.2639, 409.2115, 409.24766, 409.26746, 409.76712, 410.23236, 410.2432,
410.25131, 410.25929, 410.27954, 411.22731, 411.2398, 411.26359, 411.28318, 411.74113, 412.25884, 412.26691,
412.27764, 413.24277, 413.26161, 418.24827, 419.2319, 419.33428, 420.22767, 420.26391, 421.21161, 421.24809,
421.2676, 422.24322, 422.27955, 423.22728, 423.24676, 423.26356, 423.27829, 424.25881, 425.24284, 425.2628,
425.29049, 426.24728, 426.27447, 427.2585, 427.27851, 427.30596, 428.29021, 428.30985, 429.22642, 429.30278,
429.31082, 430.23021, 431.18772, 432.26379, 433.24782, 433.26747, 434.243, 434.2794, 435.28324, 436.25882,
436.27694, 437.24273, 437.2793, 437.29881, 438.23799, 438.27432, 438.2918, 438.31071, 439.22204, 439.25847,
439.27804, 439.30598, 440.25366, 440.28999, 440.30989, 441.23763, 441.27397, 441.28809, 442.2692, 442.2931,
443.30094, 444.26372, 446.27942, 447.27787, 448.25868, 449.26204, 449.29015, 449.29839, 450.27437, 450.29362,
451.27811, 451.30594, 452.25366, 452.28996, 452.30965, 453.29065, 453.32153, 454.26929, 454.28784, 454.306,
454.32544, 455.24204, 455.30091, 455.31787, 455.32696, 455.33688, 456.30446, 456.32158, 457.20331, 458.2793,
459.27452, 459.29583, 460.25853, 461.29022, 461.29846, 462.14658, 462.27433, 462.29332, 462.31062, 463.26962,
463.30604, 464.25352, 464.28986, 464.30948, 465.2855, 465.32144, 466.26917, 466.28819, 466.30552, 467.30071,
468.30445, 468.3323, 469.2982, 469.31632, 470.32027, 470.34799, 471.29586, 471.31291, 471.32169, 471.3514,
472.26841, 473.2527, 473.29007, 474.2297, 474.27361, 474.31057, 475.2137, 475.2694, 475.2908, 475.30566, 475.7919,
476.27121, 476.28973, 476.309, 476.32616, 477.32141, 478.26913, 478.30556, 479.3007, 479.33703, 480.22821,
480.32115, 480.34088, 481.27995, 481.31629, 481.35256, 482.26392, 482.30048, 482.3202, 482.34784, 483.29564,
483.33191, 484.27959, 484.29799, 484.31619, 484.3358, 485.27629, 485.3112, 486.34274, 487.30603, 488.20891,
489.3214, 491.30058, 491.33696, 492.30386, 492.33185, 493.28016, 493.31629, 494.30048, 494.32014, 494.34787,
495.29589, 495.3319, 496.29817, 496.31614, 496.3359, 496.36353, 497.31127, 497.34764, 497.36724, 498.2841,
498.34273, 499.28905, 499.32682, 501.32141, 501.34254, 503.30054, 503.33694, 505.28239, 505.31629, 505.35266,
506.2437, 507.29554, 507.3318, 508.31601, 508.32754, 508.36339, 509.31109, 509.34742, 510.34264, 511.32669,
512.25818, 512.33022, 512.35825, 513.34237, 514.27939, 515.31041, 516.24001, 517.31606, 519.33175, 520.36342,
521.31104, 521.34741, 522.34262, 522.37908, 523.29034, 523.32663, 524.35818, 525.30601, 525.34231, 526.33748,
527.32162, 527.35798, 531.29806, 534.3424, 535.32666, 536.35808, 537.34231, 538.37389, 539.35803, 541.3261,
541.3372, 547.29117, 551.32165, 552.35308, 557.26712, 557.36905, 558.35315, 559.33731, 559.3563, 561.2985,
569.36916, 584.33241, 584.3689, 585.37255, 586.33019, 598.34821, 599.37975, 600.30936, 600.36385, 601.39536,
602.39869, 603.35673, 608.36893, 610.33068, 613.39597, 614.39928, 617.39086, 619.40672, 623.37891, 625.39606,
626.38008, 627.41167, 628.34136, 629.37316, 629.39054, 639.41166, 641.3909, 643.35214, 643.40674, 644.4098,
644.43824, 645.36803, 645.42242, 653.42756, 655.40663, 659.40167, 669.42247, 670.4539, 671.38357, 776.48833,
777.44678, 801.50109, 125.09311, 132.10192, 146.08126, 203.62768, 228.08982, 232.64885, 238.16619, 241.14351,
251.1615, 255.67603, 262.1905, 267.69313, 268.08485, 275.67271, 276.6987, 280.17136, 299.21931, 326.19219,
329.17434, 329.71163, 330.15849, 336.72069, 344.22006, 353.19859, 354.20606, 356.73598, 370.22028, 383.21353,
384.21719, 389.22104, 394.20079, 435.26357, 446.24197, 447.237, 459.28054, 460.29332, 468.28477, 469.28837,
470.30066, 473.27211, 480.30437, 488.26101, 488.29839, 501.30612, 506.31955, 516.31375, 539.3216, 553.33726,
194.11754, 210.13356, 285.14773, 294.14819, 307.13258, 320.71048, 321.16349, 327.25083, 437.26234, 455.27324,
602.37937, 336.22246, 449.19828, 283.1687, 350.12131,
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-86.02469, -87.00343, -87.00867, -87.04507, -88.01205, -88.04032, -89.02437, -90.01876, -90.02772, -91.05041, 92.03252, -93.0345, -94.02978, -94.98056, -95.02504, -95.98015, -96.9764, -97.1843, -98.0247, -99.00797, -99.01997, 100.04037, -101.00628, -101.02429, -101.06069, -102.02006, -103.03999, -105.01917, -108.04543, -109.02929, 109.04053, -110.03587, -111.01982, -112.04024, -112.98545, -113.02427, -113.03553, -113.98874, -114.01943, 114.05585, -115.03989, -115.05112, -115.07627, -116.03591, -116.07154, -116.07965, -116.92839, -117.00118, 117.01918, -117.05557, -118.05084, -119.0168, -119.03478, -120.0179, -121.01363, -121.02934, -122.02458, -122.03272, 123.01176, -125.03549, -127.00114, -129.05563, -129.092, -130.08719, -130.99242, -131.03483, -131.07123, -132.01212, 132.99615, -133.01221, -133.05136, -134.02951, -134.0471, -134.97547, -135.02998, -136.93661, -136.99104, -137.02751,
-137.03553, -138.01956, -139.04313, -140.9861, -141.01683, -141.06691, -141.09202, -142.02012, -142.05082, -142.97531,
-143.02082, -143.03483, -143.04608, -143.07124, -143.10763, -144.03011, -144.11102, -144.99172, -145.05053, 145.06175, -145.08693, -145.09814, -146.02087, -146.0264, -148.9524, -149.0494, -151.04001, -152.03532, -154.06219, 154.94736, -155.00166, -155.10771, -155.94691, -156.00217, -156.94384, -156.95105, -156.99069, -156.99769, 157.00577, -157.03231, -157.06157, -157.08685, -157.1232, -157.99403, -158.04569, -158.09299, -158.1266, -158.98943, 159.07732, -159.10249, -159.99224, -160.04107, -161.02743, -161.04546, -163.06114, -165.02228, -165.04029, -165.979, 169.08703, -171.07752, -171.10274, -171.13907, -172.14253, -172.95785, -173.95753, -174.05915, -174.9543, -174.95981,
-174.96711, -175.00939, -175.01731, -175.04301, -175.06107, -175.07071, -175.07691, -175.11895, -176.04273, 176.04619, -176.05593, -177.02231, -177.03986, -177.0474, -178.04317, -178.04919, -178.98346, -179.038, -179.05593, 180.0395, -180.05927, -180.9893, -180.99922, -181.07165, -183.03289, -185.05668, -185.07729, -185.09301, -185.11815, 185.1546, -187.04309, -187.0975, -188.03835, -189.02245, -189.05875, -189.08799, -190.01796, -190.05406, -192.03341, 192.06975, -193.0536, -193.0713, -194.05329, -194.05698, -194.06678, -194.08211, -194.98854, -195.03294, -195.05075, 195.05819, -196.99423, -197.01137, -197.04857, -197.99386, -199.13395, -199.1703, -200.17371, -201.02549, -202.05413,
-203.05369, -203.05753, -204.03309, -204.05087, -205.05372, -205.15971, -206.05013, -206.0571, -207.03308, -207.0512,
-207.06926, -208.0543, -208.06469, -208.07119, -208.93454, -209.06727, -209.07609, -210.04381, -210.06975, -210.9733,
-211.06427, -211.13386, -212.06385, -212.06763, -213.06115, -213.186, -215.0328, -215.06739, -216.06963, -217.00295, 217.02977, -217.1013, -218.08584, -218.11449, -218.96332, -219.04441, -219.17532, -220.06463, -221.03029, -221.06356,
-221.06777, -222.06144, -223.01999, -223.0643, -223.0823, -225.01701, -225.04366, -225.08002, -226.08247, -227.20173,
-229.0304, -230.98613, -231.97848, -232.06469, -232.9247, -232.97913, -233.09839, -233.15469, -233.92427, -233.97953,
-234.08034, -234.15807, -234.92133, -234.97716, -235.03943, -235.0644, -235.07781, -235.11199, -235.95363, -236.05968,
-236.09602, -237.06157, -238.07533, -238.09329, -238.99375, -239.05944, -239.07732, -240.0807, -241.02088, -241.21743,
-242.0519, -243.08058, -244.9855, -245.09639, -247.04109, -247.17036, -248.04282, -248.09606, -249.03817, -249.08015,
-249.09137, -249.14974, -250.07565, -251.10697, -253.02069, -253.21744, -254.02174, -254.07427, -254.07842, 254.22083, -254.9612, -254.96809, -255.01766, -255.07209, -255.23308, -256.04958, -256.23648, -256.96118, -257.01576,
-257.04655, -257.07002, -257.23982, -258.0717, -259.11186, -260.97409, -261.05594, -261.12776, -262.07538, -262.13042,
-263.05382, -263.07809, -263.10705, -264.10945, -264.16072, -265.08649, -265.14807, -266.07057, -266.10669, 266.15146, -267.07243, -267.09078, -267.23316, -267.94553, -268.06653, -268.08679, -268.23652, -269.21248, 269.24885, -270.04732, -270.1017, -270.93524, -271.03145, -271.08563, -271.10453, -271.28679, -272.08778, -273.02044,
-273.08129, -273.08973, -274.05255, -274.0602, -274.0872, -275.062, -275.10727, -276.04892, -276.05874, -276.09093, 276.10941, -277.05697, -277.12257, -277.18095, -278.15424, -279.13834, -280.08596, -280.98312, -281.06996, 281.11765, -281.24872, -282.06701, -282.25215, -283.2644, -284.08087, -284.26774, -285.047, -285.10121, -286.04808, 286.10335, -287.04319, -287.09973, -287.22015, -288.07586, -289.0781, -289.08631, -289.12237, -290.05224, -291.10201,
-291.13837, -292.10163, -292.10538, -292.89169, -293.11773, -293.17765, -294.14929, -294.18017, -294.98231, 295.06749, -295.09927, -295.13312, -296.08079, -297.24355, -298.09645, -299.08043, -300.0826, -300.1386, -301.07062, 301.0961, -302.07329, -302.09839, -303.02103, -304.07074, -304.16995, -305.11795, -306.07672, -306.14923, -307.24649,
-308.06295, -309.04698, -309.08325, -309.11255, -310.09946, -310.90227, -311.12828, -311.16887, -311.90183, 312.11231, -312.98764, -313.04196, -313.0963, -313.14389, -314.0987, -314.928, -315.08899, -315.1119, -315.25413, 316.10925, -317.09203, -318.14913, -319.13087, -320.09226, -321.09565, -321.11248, -321.19645, -323.24134, 325.01848, -325.05738, -325.18445, -326.09143, -327.12312, -329.23355, -330.90194, -330.95627, -330.9981, -331.08171,
-331.99836, -333.2622, -334.14424, -335.12832, -335.14774, -336.15997, -337.14398, -337.19158, -339.03404, -339.07288,
-339.12296, -339.15934, -340.10699, -340.16263, -341.11007, -341.13863, -342.12266, -343.08126, -344.11321, 344.97917, -345.01363, -345.06802, -345.08916, -347.21215, -347.24136, -348.15986, -349.06296, -349.10739, 349.19145, -349.25703, -350.10989, -350.28868, -351.09376, -351.12309, -352.03752, -352.08199, -352.15473, 353.08961, -353.13878, -354.12278, -354.14212, -355.15443, -356.11337, -356.18609, -358.12899, -361.01066, -361.1916,
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-363.0788, -363.20726, -364.2389, -365.10937, -365.13865, -365.2226, -365.28819, -366.05303, -366.15903, -367.11801, 367.15427, -368.10189, -368.12021, -368.91205, -369.06256, -369.10447, -369.13355, -370.12876, -370.86888, 372.10812, -373.11142, -374.12378, -376.16619, -377.18648, -378.1704, -379.20204, -380.18607, -381.13375, -381.21771,
-382.20174, -383.12017, -383.14937, -383.2334, -384.16984, -384.18108, -385.17951, -386.12395, -386.13115, -387.15579,
-388.13152, -390.25458, -391.23858, -392.2334, -393.1523, -394.97591, -395.19685, -396.18086, -397.12857, -398.19652,
-399.15547, -399.22816, -400.13929, -401.17105, -404.23363, -405.12561, -406.24931, -407.28095, -408.87925, 409.20138, -410.1967, -411.0074, -411.16263, -412.01076, -412.17595, -414.25445, -415.15063, -416.27024, -418.24949, 419.14138, -419.28114, -420.22878, -421.21262, -422.2444, -423.22844, -423.27605, -424.17609, -424.2601, -425.24413, 425.29172, -426.19177, -426.24761, -427.21183, -427.22302, -429.16902, -433.29656, -434.30039, -435.27589, 437.20749, -438.23916, -439.22315, -440.17078, -441.23883, -441.28643, -442.19777, -442.27047, -443.25448, 444.19098, -445.29664, -446.15226, -446.22906, -447.13629, -447.27601, -448.26002, -449.12792, -449.29164, 450.32321, -451.25969, -451.30724, -453.23898, -453.28656, -454.27065, -455.21828, -457.2815, -458.19278, -459.31254,
-461.15203, -461.29174, -461.31234, -463.27133, -463.30744, -465.23864, -465.28629, -466.27032, -467.25432, 467.30207, -468.12112, -468.2496, -468.28597, -469.2336, -469.27009, -469.28982, -471.26045, -475.30713, -476.33871, 477.28648, -478.27046, -479.30208, -480.24969, -480.28613, -481.28133, -481.318, -482.26539, -483.29698, -484.28104, 485.23973, -485.31263, -486.31657, -487.23317, -487.30891, -488.28718, -489.29062, -491.30228, -492.28619, 493.28981, -493.31789, -494.26564, -494.30184, -495.2607, -495.3059, -496.2811, -497.27721, -497.31273, -498.2604, 498.2793, -498.31662, -499.29203, -499.32839, -501.30769, -502.31151, -506.30158, -507.29669, -508.28085, -509.31246,
-510.29652, -511.32797, -512.27599, -512.33185, -513.27078, -513.30734, -513.33215, -514.30247, -516.28166, 517.30229, -520.31728, -521.3124, -522.29656, -523.29116, -523.32816, -524.27597, -524.31243, -525.30737, -525.34382,
-526.29153, -526.31155, -527.32307, -528.28181, -528.32704, -529.26652, -529.30199, -529.35814, -530.29732, 533.31242, -535.32825, -537.30753, -537.34393, -538.29166, -538.32805, -538.34774, -539.28608, -539.32317, 540.31819, -540.32756, -541.30242, -541.33875, -542.29721, -543.31812, -544.34962, -549.3075, -551.32329, -553.30243,
-553.33896, -554.34209, -554.37026, -555.31794, -555.37388, -556.31253, -556.33844, -565.30083, -565.33867, 567.31776, -568.34924, -569.33378, -571.34938, -580.38617, -581.3338, -581.37019, -599.38092, -601.34236, -607.38605,
-611.38059, -615.37571, -617.39142, -625.39646, -627.35787, -641.39147, -642.42304, -643.40719, -659.40216, 662.37677, -671.4022, -675.39678, -685.41758, -686.42072, -687.37903, -688.39221, -701.4125, -773.4698, -775.43115, 102.04053, -201.11324, -209.98953, -226.047, -231.08067, -292.94611, -293.89124, -312.89892, -351.221, -357.09883, 499.25605, -554.29749, -252.09103, -310.95664
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Appendix 2.6. Composite spectrum from 21-22 minutes of a HILIC analysis of E. coli extract

[174]

Appendix 2.7. List of granular formula used

Isotopes: M.iso
m

z

d

C12-13

1.003355

0

1

N14-15

0.997035

0

1

O16-18

2.004245

0

1

S32-33

0.999387

0

1

S32-34

1.995796

0

1

Cl35-37

1.99705

0

1

Br79-81

1.997953

0

1

Si28-29

0.999568

0

1

Si28-30

1.996843

0

1

K41-39

1.998119

0

1

Charge Carriers: M.z
z

m

d

H+

1

1.007825

0

Na+

1

22.98977

0

K+

1

38.96371

0

Cl-

-1

34.96885

0

Br-

-1

78.91834

0

[175]

Neutral Formula: M.n
z

m

d

-H2O

0

-18.0106

1

-CO2

0

-43.9898

1

-NH3

0

-17.0265

1

+HCOOH

0

46.00548

1

+CH3COOH

0

60.02113

1

+CF3COOH

0

113.9929

1

+CH3CN

0

41.02655

1

+CH3OH

0

32.02622

1

-CO

0

-27.9949

1

+H3PO4

0

97.9769

1

+SiO3H2

0

77.97732

1

+SiO4H4

0

95.98789

1

+SiC2H6O

0

74.01879

1
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Appendix 2.8. Mz.unity parameters used for annotation of the composite spectrum
The code used to annotate this spectrum can be found online in the repository referenced in the
main text. A summary of the annotation workflow is listed here.

Find peaks with isotope support for higher charge states
All peaks in the spectrum were searched with proposal charge 𝑧 = 2 ∗ 𝑠𝑠𝑠𝑠(𝑚/𝑧) and mass

𝑚 = 𝑎𝑎𝑎(𝑚/𝑧) ∗ 2. Any isotopes found support the higher charge state assignment. Search was
performed on peaks of both polarities.
•

M = M.iso, ppm = 1, BM.limits = cbind(M.min = c(1), M.max = c(1), B.n = c(1))

Find peaks with isotope support for charge state z = 1
All peaks in the spectrum were searched with proposal charge 𝑧 = 1 ∗ 𝑠𝑠𝑠𝑠(𝑚/𝑧) and mass

𝑚 = 𝑎𝑎𝑎(𝑚/𝑧) ∗ 2. Any isotopes found support the higher charge state. Search was performed
on peaks of both polarities.
•

M = M.iso, ppm = 1, BM.limits = cbind(M.min = c(1), M.max = c(1), B.n = c(1))

Annotate simple relationships
Peaks with a isotope support for charge state 2 were included along with all peaks for charge state
1. Search was performed on peaks of both polarities.
•
•
•

Cross Polarity: M = M.z, ppm = 10, BM.limits = cbind(M.min = c(2), M.max = c(2), B.n = c(1)
Single Charge Carriers: M = M.z, ppm = 2, BM.limits = cbind(M.min = c(1), M.max = c(1), B.n = c(1)
Neutral losses and adducts: M = M.n, ppm = 2, BM.limits = cbind(M.min = c(1), M.max = c(1), B.n = c(1)

[177]

Annotate analyte-analyte mers and distal fragments
Peaks with a isotope support for charge state 2 were included along with all peaks for charge state
1. Search was performed sequentially first for negative and then for positive mode.
•

M = M.z (only H+), ppm = 2, BM.limits = cbind(M.min = c(1), M.max = c(1), B.n = c(2)

Annotate analyte-analyte mers and distal fragments across polarities
Peaks with a isotope support for charge state 2 were included along with all peaks for charge state
1. Search was performed on peaks of both polarities.
•

M = M.z (only H+), ppm = 2, BM.limits = cbind(M.min = c(1), M.max = c(1), B.n = c(2)

Annotate background mers
Peaks with a isotope support for charge state 2 were included along with all peaks for charge state
1. Features and mers were included in this search.
•

M = M.z (only H+), ppm = 2, BM.limits = cbind(M.min = c(1), M.max = c(1), B.n = c(2)

[178]

Appendix 2.9. Fragmentation spectrum of NAD
Spectra taken at collision energies 0, 10, 20, 40, 60, 90, and 120 were averaged from both positive
and negative mode. The composite spectrum is shown below.

[179]

Appendix 2.10.

Fragmentation spectrum of glutamate

Spectra taken at collision energies 0, 10, 20, 40, 60, 90, and 120 were averaged from both positive
and negative mode. The composite spectrum is shown below.

[180]

Appendix 2.11.

Annotation of 2-hydroxyglutarate Metabolic Products

2-Hydroxyglutarate (2HG) corresponds to the node with a thick black border. Large nodes are
features. Small nodes are relationships. Red nodes were detected as enriched by X13CMS. Grey
nodes were not detected as enriched by X13CMS.
Analysis by mz.unity revealed that all enriched features were transformations of 2HG. This
indicates that 2HG is not significantly metabolized in colorectal cancer cells.14

(14) Gelman, S. J.; Mahieu, N. G.; Cho, K.; Llufrio, E. M.; Wencewicz, T. A.; Patti, G. J. Cancer
Metab. 2015, 3 (1), 1.

[181]

Appendix 2.12.

Intensitites, Masses, and Retention Times of Adducts

Maximum intensities from each chromatogram are inset. Retention times are in seconds. Masses
from top to bottom and left to right: A, 146.0455, 168.0273, 184.0012; B, 146.0455, 662.1015,
809.1547; C, 146.0455, 98.0246, 436.0948.

[182]

Appendix 3.

Credentialing Features: A Benchmarking Platform to Optimize
Untargeted Metabolomic Methods

[183]

Appendix 3.1. Calculation of Mass Per Carbon (mpc) From ECMDB.
A histogram of mass in Daltons divided by carbon number (mpc) are shown below. The mass of a methylene (CH2, 14
Da) unit is a logical lower bound for mass per carbon. ECMDB contains four compounds which have an mpc lower
than 14, all of which are more reduced (contain more rings and double bonds). An mpc of 141 is the largest in ECMDB
and corresponds to carbamoyl phosphate. The most common mass per carbon is 18-19 Da/C with 850 compounds
falling in this range. Based on the data, a carbon number dependent limit is placed on the mass range in which to search
for isotopes. This is depicted in the lower plots.

[184]

Appendix 3.2. Suggested Parameters for Various Instrumentation Platforms.
The credentialing technique is flexible and can be applied to many types of instrumentation and chromatography. Below
are suggested values for different instrumentation that have been shown to be effective experimentally.

Parameter

Suggested Defaults

Explanation

iso_ppm

Time of Flight*: 4
Orbitrap**:
FT-ICR:
0.1

mix_tol

4

This is a coarse filter that ensures the 12C peak and 13C peak are of
comparable intensity to their mixed ratios. This should allow a large
error as many effects cause the U12C and U13C peaks to vary in
intensity. A stricter filter is applied in the second round.

ratio_tol

1.8

This is a fine filter which ensures the intensity ratio between the two
samples approaches the ratio of mixing (See Data Analysis). This is
the most sensitive parameter and can be set according to the user’s
needs. Values approach 1 are more selective. 1.8 offers a false
positive rate of approximately 0.6%

iso_rt

HILIC: 0.1 x (peak fwhm)
C18:
0.05 x (peak fwhm)

This is the acceptable tolerance (in seconds) when matching a U12C
peak to a U13C peak. Ideally the peaks have an identical retention
times but in some cases poor peak shape causes the detected
retention time to vary between isotopes. For chromatography
which generates consistant peak shapes this can be lowered.

mpc_tol

1

Mass per carbon (mpc) is calculated as described above in
Supplement S-2. The mpc_tol parameter is useful if a user is
attempting to credential peaks with extremely large masses per
number of carbons such as highly phosphorylated or metal
containing compounds.

1

This is the mass error allowed when considering the difference
between a 12C and 13C peak. This should be set according to the
intra-scan mass error, rather than the absolute mass error of the
instrument.

*Agilent QTOF, AB SCIEX TripleTOF, LECO Pegasus
**Thermo QE
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Appendix 3.3. Raw Data Credentialed Features
Mass spectra and extracted ion chromatograms are shown for the three knowns targeted for MS/MS. The
labeling pattern exhibited by credentialed features can be seen in the inset. (A) Uracil, (B) ADP, (C) UDPGlcA. Inset mass spectra are averaged over the highlighted region of each chromatogram.
A. Uracil, 4.8 minutes, 4 carbons

115.0347

x10 5 -ESI EIC(111.0197) Scan Frag=175.0V R2NM46A_09_FilteringSamps_2NM38M_12t13_5t5.d
1.7 1
1.6
1.5
1.4
1.3
1.2
1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0

111.0212

1

B. ADP, 48.5 minutes, 10 carbons
x10 5 -ESI EIC(426.0211) Scan Frag=175.0V R2NM46A_09_FilteringSamps_2NM38M_12t13_5t5.d
9
1

436.0576

1
426.0239

8
7
6
5
4

424.9785

3

431.0405

434.0088

2
1
0

C. UDP-5’-GlcA, 43.8 minutes, 15 carbons
x10 5
2.8

579.0286

-ESI EIC(579.0250) Scan Frag=175.0V R2NM46A_09_FilteringSamps_2NM38M_12t13_5t5.d
1

1
594.0789

2.6
2.4
2.2
2
1.8
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0
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